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1 ANTIMICROBIAL USE IN VETERINARY 
MEDICINE 
1.1 INTRODUCTION 
e term ‘antimicrobial agent’ or ‘antimicrobial’ has been defined by the 
World Organisation for Animal Health (OIE) as an active substance of 
synthetic or natural origin which destroys bacteria or suppresses their 
growth or their ability to reproduce in animals or humans, excluding anti-
virals and antiparasites (OIE ). is is consistent with the wording 
used by, among others, the Codex Alimentarius (FAO ) and the Euro-
pean Food Safety Authority (EFSA) (EFSA ). is definition will be 
applied throughout this thesis. 
Antimicrobials are used extensively in both human and veterinary 
medicine for treatment and prevention of bacterial infections and to im-
prove production efficiency in food-producing animals. e latter is not 
approved anymore in the EU since  (EP ) but is still common 
practice in countries like the US and China. Antimicrobials are one of the 
most important tools available to modern medicine. However, soon aer 
the discovery of antimicrobials, it became clear that bacteria could acquire 
resistance to these products. is phenomenon, antimicrobial resistance, 
is defined as the ability of a microorganism to multiply or persist in the 
presence of an increased level of an antimicrobial agent relative to the sus-
ceptible counterpart of the same species (FAO ). Today, the use of an-
timicrobials in humans and animals is recognized worldwide as a major 
driving force in the emergence and spread of antimicrobial resistance. 
roughout the years, awareness grew that the selection of a suitable anti-
microbial and dosage is a crucial step in any therapeutic regimen, both in 
animal and human medicine (Collignon et al. ). To assist veterinarians 
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in their efforts towards a judicious use of antimicrobials, national and in-
ternational guidelines on the prudent use of antimicrobial agents have 
been published (AMCRA , EC ). 
Although the extent to which different sectors (human, animal, envi-
ronment) are contributing to the levels of resistant bacteria in other sectors 
is still unclear, there is a general awareness that immediate action is re-
quired to counteract the spread of antimicrobial resistance. is action im-
plies in the first place the reduction of antimicrobial use in all sectors and 
prevention of the spread of resistance (Collignon et al. , Laxminarayan 
et al. ). erefore, international, national and local organizations de-
veloped guidelines that request for action (AMCRA , EC , OIE 
, WHO ). Recently, a new Belgian legislation concerning the con-
ditions for the use of veterinary drugs by veterinarians and animal keepers 
was established (Royal Decree ). is new legislation also implies 
measurements to support the policy on reduction of antimicrobial re-
sistance. e critically important cephalosporins (rd and th generation) 
and fluoroquinolones can exclusively be prescribed aer antimicrobial 
susceptibility tests have shown that no other antimicrobials would be ef-
fective, and, it is forbidden to use these antimicrobials for preventive pur-
poses. 
All actions to counter the selection and spread of antimicrobial re-
sistance fit in the more broad principle of the ‘One Health principle’, a stra-
tegic framework that has been established in  to combat the spread of 
infectious diseases that emerge (or re-emerge) from the interfaces between 
animals and humans and the ecosystems in which they live. e strategic 
framework is guided by key principles that include the adoption of a mul-
tidisciplinary, multinational and multisector approach; the integration of 
technical, social, political, policy and regulatory issues; and the establish-
ment of broad-based partnerships across sectors and along the research-to 
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delivery continuum. Hence, the engagement of wildlife and ecosystems in-
terests, the human and veterinary medical community, as well as advanced 
research institutions is crucial to make the One Health concept successful 
(FAO and OIE ). 
1.2 ANTIMICROBIALS USED IN PIG PRODUCTION 
1.2.1 INTRODUCTION 
An antimicrobial class is defined as a group of antimicrobial agents with 
related molecular structures, oen with a similar mode of action because 
of interaction with a similar target and thus subject to similar mechanisms 
of resistance. e properties of antimicrobials within a class can vary as a 
result of the presence of different molecular substitutions, which confer 
various intrinsic activities or various patterns of pharmacokinetic and 
pharmacodynamic properties (FAO ). 
Although sulphonamides were the first produced clinically successful 
broad-spectrum antimicrobials, it was the first large scale production of 
penicillin in World War II that led to the antimicrobial revolution 
(Giguère ). At the same time, veterinarians started treating bovine 
mastitis with intramammary infusions of penicillin G, the first of the many 
representatives of the group of penicillins that were to come. Shortly aer 
the war, streptomycin and chlortetracycline were introduced in food ani-
mal production (Gustafson et al. ). Several tetracycline derivatives be-
came available later on, and they are still used extensively in veterinary 
medicine, especially doxycycline, a second generation tetracycline (see be-
low, ...). e high consumption rate of tetracyclines unavoidably creates 
a high risk on selection of tetracycline resistant bacteria.  
Nowadays, a wide range of antimicrobials is available for use in animal 
and human medicine. e antimicrobials used to treat or prevent disease 
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in animals are essentially the same as those in human medicine, although 
some antimicrobials are reserved for use in human medicine exclusively. 
e World Health Organisation (WHO) recommends that the use of anti-
microbials judged to be essential for human medicine should be restricted 
and their use in food-producing animals should be justified by culture and 
susceptibility results (WHO , WHO , WHO ). e same ac-
counts for essential antimicrobials for veterinary medicine, e.g. pleuromu-
tilins, which are the only option to treat swine dysentery (Brachyspira hy-
odysenteriae) (OIE ). 
1.2.2 QUANTITATIVE DATA ON USE OF VETERINARY 
ANTIMICROBIALS 
Concerns about the spread of antimicrobial resistance have led to the mon-
itoring of trends in antimicrobial consumption in most high-income and 
some middle-income countries through databases on antimicrobial sales. 
Sweden (Swedres-Svarm ) and Denmark (DANMAP ) were the 
first countries to start collecting veterinary antimicrobial sales data in the 
’s, later followed by other European countries, i.e. e Netherlands 
(MARAN ), Norway (NORM-VET ) and Belgium (BelVetSAC 
). Total sales of antimicrobials for food-producing animals have also 
been reported for non-European countries as the US (FDA ), Canada 
(CIPARS ) and Australia (Australian Government ). Obtaining 
reliable data on antimicrobial consumption per animal species based on 
sales data is complicated because () most antimicrobials are approved for 
use in multiple food-animal species, () off-label use (EC ) of antimi-
crobials is a common practice and () the sold antimicrobials may not have 
actually been administered to the animals (Cameron et al. ). e Eu-
ropean Medicines Agency (EMA), that collects national consumption data 
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from EU-countries in the European Surveillance of Veterinary Antimi-
crobial Consumption (ESVAC) project, uses the Population Correction 
Unit (PCU) to normalize sales data (EMA ). e PCU takes into ac-
count the size of the animal population and the average theoretical weight 
of the animal species at the time of treatment. Data on sales of antimicro-
bial veterinary medicinal products normalised by the PCU are expressed 
in mg of active ingredient by PCU (mg/PCU) and  PCU equals  kg of 
livestock (EMA ). However, it is generally accepted that normalisa-
tions with the harmonised Defined Daily Doses Animal (DDDvet) as nu-
merator (DDDvet/PCU) are the preferred reference values to compare an-
timicrobial use between countries and animal species. Efforts have already 
been made to calculate harmonised DDDvet values on European level for 
pigs, cattle and poultry. ese assigned DDDvet values are oen a com-
promise, as doses can differ between countries, indications, administration 
routes and formulations. 
Figure  gives an overview of the total sales of the different antimicrobial 
classes in the EU ( countries) in . The largest amount sold was repre-
sented by the tetracyclines (.), followed by penicillins (.) and sul-
phonamides (.). These antimicrobials are considered essential and are 
listed as veterinary critically important antimicrobial agents by the OIE (OIE 
). The pharmaceutical forms for group treatment accounted for . 
of the total sales in the EU; premixes accounted for ., oral powders for 
. and oral solutions for .. Different formulations for oral treatment 
have been developed to enable different types of treatment, i.e. individual or 
group treatment and feed or water medication (see ..). The availability of 
formulation also depends on the physicochemical or pharmacokinetic prop-
erties of the antimicrobial (see ). The preferred formulation types for an 
antimicrobial can vary significantly between countries. This depends largely 




Figure . Sales for food-producing species (including horses) in mg/PCU (Popu-
lation Correction Unit), of the various veterinary antimicrobial classes, by 
country, for  (EMA ).  
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e distribution of pharmaceutical formulations for tetracyclines and sul-
phonamides sold in Europe are shown in Figure  and Figure , respec-
tively. e Belgian Veterinary Surveillance of Antibacterial Consumption 
(BelVetSAC) showed that sulphonamides, penicillins and tetracyclines 
have been sold most frequently as premix formulations over the past years, 
as shown in Figure  (BelVetSAC ). 
 Significant efforts have been made to reduce the use of antimicrobials 
in livestock and this resulted in an overall fall in sales (mg/PCU) of  
from  to  (from  mg/PCU in  to  mg/PCU in ) in the 
participating  countries of the EU, excluding Spain. Sales data from 
Spain between - are thought to be underestimated. erefore, sales 
data from Spain are not directly comparable with the other countries and 





Figure . Distribution of sales of tetracyclines for food-producing animals (includ-
ing horses), in mg/PCU (Population Correction Unit), by the major pharma-











Figure . Distribution of sales of sulphonamides for food-producing animals 
(including horses), in mg/PCU (Population Correction Unit), by the major 




Figure . Use of antimicrobials premixes per class of antimicrobials between 









caused by the implementation of responsible-use campaigns, changes in 
animal demographics, changes in systems for collecting data, restrictions 
of use, bench-marking, increased awareness of the threat of antimicrobial 
resistance, and/or the setting of targets (EMA ). 
Data on antimicrobial use worldwide are very scarce and certainly 
incomplete. However, a statistical model estimated that, based on maps of 
livestock densities and reports of antimicrobials consumption in high-in-
come countries, , (± ,) tons of antimicrobials were globally used 
in food-producing animals in  (Van Boeckel et al. ). Per kilogram 
of produced animal, this represents approximately  mg,  mg, and  
mg for cattle, chicken, and pigs, respectively. Global antimicrobial con-
sumption was estimated to rise to up to , (± ,) tons in  (i.e. 
an increase of  compared to ), based on growth projections of the 
consumption of livestock products. is presumed increase would be 
mainly a result of the growing number of livestock in countries such as 
Brazil, Russia, India, China and South-Africa (Van Boeckel et al. ). 
Antimicrobial use in fish and shrimp farming was not included in this 
study, although it might be a major source of antimicrobial contamination 
of the aquatic environment. 
More and more countries nowadays make efforts to monitor antimi-
crobial use on farm level. Today,  European countries, amongst others 
Belgium, and Canada are thus collecting data on antimicrobial use per an-
imal species. Fieen of these countries are registering antimicrobial use in 
pig production in particular (AACTING ). In Belgium, a preliminary 
study on antimicrobial use in pig production has been performed in  
(Timmerman et al. ), which led to recommendations on correct dos-
ing, the expression of concern on the high number of prophylactic group 
treatments and a proposal to replace these treatments by other disease-
preventing measures. However, a study in  on antimicrobial use in 
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Belgian pig production detected an overall higher use of prophylactic an-
timicrobial group level therapy compared to  (Callens et al. ), 
which indicated that the guidelines for prudent use were not implemented. 
Moreover,  of the administered doses assessed in this study were not 
according to the label. Starting from , the Belgian centre for Antimi-
crobial Consumption and Resistance in Animals (AMCRA) has set the 
goal to achieve a general reduction of antimicrobial use in animals with 
 by , a reduction of  of critically important antimicrobials for 
human medicine by  and a reduction of  of antimicrobial pre-
mixes by  (AMCRA ). Although the annual BelVetSAC reports on 
antimicrobial use in Belgium show a clear reduction in antimicrobial use 
since  (total cumulative reduction of .), serious efforts will be 
needed to achieve the goals (BelVetSAC ). 
1.2.3 PURPOSES OF ANTIMICROBIAL USE IN PIG PRODUCTION  
Pig production in the EU is based on intensive production systems in 
which animals are housed in large groups. e low profit margins drive pig 
producers to keep their production as efficient as possible. is, together 
with the constant threat of possible disease outbreaks, has led to a high use 
of antimicrobial agents in pig production. Moreover, the broad availability 
of less expensive or cheap generic formulations of antimicrobials of which 
patents are expired encourages improvident use of these drugs. 
e treatment and prevention of bacterial infections by antimicrobials 
can be achieved in three different ways: therapy, metaphylaxis or prophy-
laxis (EPRUMA ).  
In case of therapeutic use, the modes of application of the antimicro-
bial agent depend on the size of the group, animal production type and 
type of infection. ese treatments are oen individual, e.g. in sows, alt-
hough in some cases group treatment of sows can be necessary, e.g. in case 
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of highly virulent infections (Schwarz et al. a). erapeutic antimicro-
bial therapy should be preceded by an examination of the diseased animal, 
preferably accompanied with laboratory analysis such as identification of 
the pathogen and antimicrobial susceptibility testing. Individual treatment 
has the advantage of a better control over the appropriate dosage (Page et 
al. , Schwarz et al. b). Unfortunately, individual therapy is not a 
practical option for food-producing animals as they are mostly held in 
large groups, such as pigs and poultry. In these large groups, an interven-
tion is required as soon as one of the animals presents symptoms of a dis-
ease as one can be sure that the others will be affected too (Schwarz et al. 
b). Metaphylaxis is defined as the treatment of an entire group of an-
imals aer diagnosis of clinical disease in part of this group, with the aim 
of treating the clinically sick animals and controlling the spread of disease 
to animals in close contact and at risk which may already be (subclinically) 
infected (EPRUMA ). Ideally, other interventions such as quarantin-
ing clinically ill animals should be considered before starting metaphylac-
tic treatment. In contrast to therapeutic and metaphylactic treatment, 
prophylaxis is a solely preventive measure, not preceded by a diagnosis 
(Page et al. , Schwarz et al. b). Animals are generally more suscep-
tible to infections at certain stages of life, and especially in the young pop-
ulation (which is the majority of the livestock) when the acquired immun-
ity is not yet fully developed. Some of these crucial periods in pig produc-
tion are vaccination, weaning, castration and transport and/or mixing of 
animals (Callens et al. , McEwen et al. , Schwarz et al. a). 
However, this approach becomes more and more controversial, because 
antimicrobial (group) treatments exert a high selective pressure on re-
sistant bacteria and their resistance genes (McEwen et al. , Schwarz et 
al. a, Schwarz et al. b). 
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1.2.4 ANTIMICROBIAL ADMINISTRATION METHODS IN PIGS 
Administration routes 
Depending on the purpose of the treatment, antimicrobials can be admin-
istered to animals through different routes. ey can be administered top-
ically, directly to the site of the infection (EPRUMA ), but more com-
mon is the systemic use, which implies both oral and parenteral admin-
istration. e parenteral route includes intravenous, intramuscular, 
transdermal and subcutaneous injection (EPRUMA , Page et al. ). 
Table  gives an overview of different routes and purposes of antimicrobial 
administration. 
Table . Worldwide purposes of antimicrobial treatment and administration 
routes in swine 
Purpose Individual or group treatment Administration routes 
Prophylaxis  Group  Oral (feed or water medication) 
Metaphylaxis Group or subgroup Oral (feed or water medication) 




Group Feed medication  
Adapted from Page et al. (). 
 
Group treatment vs. individual treatment 
e choice of administration route is usually related to the purpose of the 
treatment and location of the infection (Schwarz et al. b). As men-
tioned above, prophylactic and metaphylactic treatments are inherently 
group treatments, whereas therapeutic treatments mostly involve individ-
ual treatment of a limited number of animals. Seen the housing conditions 
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of most food producing animals and the epidemiology of most bacterial 
infections, it is clear that group treatments are practiced more oen. 
Parenteral treatment is the preferred administration route to achieve 
an accurate dosage and treatment duration, as this method does not de-
pend on the eating and drinking behaviour of the animals. Parenteral 
group treatments are rarely applied, except in case of groups of suckling 
piglets and calves, as this method is rather labour-intensive (FASFC , 
Page et al. ).  
For practical reasons, group treatment is generally achieved through 
oral administration of the antimicrobial via the feed or drinking water 
(Schwarz et al. b). Feed medication in particular is a very easy method 
of group medication from a logistical and labour technical point of view. 
On the other hand, this method has many disadvantages. Feed intake of 
animals can be variable, and anorexia in sick animals can result in under-
dosing. Furthermore, a poor health status can compromise the pharmaco-
kinetic parameters aer oral administration, as was shown e.g. for oxytet-
racycline (Pijpers et al. ). Other disadvantages are dependent on the 
type of mixing procedure (FASFC , Page et al. ). e first proce-
dure, which is the most commonly used procedure in Belgium, is the mix-
ing of the medicated feed in a licensed feed mill on veterinary prescription. 
Advantages of this procedure are the more accurate dosage of the antimi-
crobial and the homogeneity of the feed. Nevertheless, this procedure has 
several disadvantages (FASFC ). e risk of segregation of the antimi-
crobial is rather high because of the many stages of transport the feed must 
pass before is it consumed. Segregation is a consequence of physicochem-
ical properties such as particle size and electrostatic forces of the different 
feed compounds including the antimicrobial and medicated premix 
(FASFC , Page et al. ). Moreover, there is a risk of carry-over of 
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antimicrobial residues to non-medicated feed, at the feed mill, during 
transport and during storage (Filippitzi et al. ).  
Another important disadvantage of mixing at the feed mill is the in-
flexibility of the therapy. First, the therapy cannot be started before the 
medicated feed is delivered. Moreover, the farm silo cannot be filled with 
the medicated feed before the previous feed is entirely consumed (FASFC 
). Second, the therapy duration depends on the rate of feed consump-
tion, because the complete medicated feed batch needs to be consumed 
before new (blank) feed can be introduced. Hence, it is oen not possible 
to end the therapy at the proper time. Furthermore, if the feed silo is not 
entirely empty before the delivery of a new batch of feed, mixing of the two 
batches of feed can occur, which would lead to incorrect dosage and pro-
longation of the therapy (FASFC ). ird, a large number of animals 
is usually connected to the same feed line, consequently it is not possible 
to administer the feed to a subgroup of animals (FASFC ). 
Finally, the stability of some antimicrobials can be compromised due 
to the storage of the medicated feed in a silo, e.g. in summer when temper-
atures in the silo rises. ese potential stability problems have not been 
quantified before, but it has been reported that sulphadimidine and oxy-
tetracycline remain stable in feed in normal conditions, i.e. < °C. More-
over, potential interaction of the antimicrobial with feed components may 
reduce the oral bioavailability of the drug, e.g. chelation of tetracyclines 
with multivalent ions (FASFC ) (del Castillo ). 
Similar issues arise when the antimicrobial is mixed with the feed at 
the level of the silo, although this method could reduce the risk of segrega-
tion. e use of mobile dosing systems to add the antimicrobial to the feed 
at the level of the feed line on the farm reduces the risk of segregation even 
more as the feed does not have to be stored in a silo. Also, this system im-
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proves the flexibility of feed medication, with respect to both therapy du-
ration and treatment of specific groups of animals. Unfortunately, this 
method also has an important disadvantage as the control over dosage and 
homogeneity is very poor (van Krimpen ). 
Group medication can also be applied via the drinking water. is 
method requires some more effort from both veterinarian and farmer be-
cause several factors need to be taken into account to determine the correct 
dosage. Average water consumption, the physicochemical properties of the 
water (hardness, pH), antimicrobial solubility and stability in water, phar-
maceutical formulation used, water flow, etc. can influence water uptake 
and oral bioavailability of the antimicrobial. It is also recommended to 
measure beforehand the daily water uptake of the group of animals that 
needs to be treated, because the uptake is variable and depends on various 
factors such as age and ambient temperature. Moreover, the dosing sys-
tems need to be calibrated regularly, and the condition and purity of the 
water pipes needs to be controlled. Drinking water systems that are not 
maintained properly can lead to variable antimicrobial doses between dif-
ferent drinking points (FASFC , Page et al. , van Krimpen ).  
A very important advantage of water medication compared to feed 
medication is the flexibility of the therapy start and duration and the op-
portunity to select smaller groups of animals for therapy. Moreover, water 
uptake of sick animals tends to be more stable than feed uptake. Although 
the absorption of antimicrobials from drinking water is variable and de-
pends on the molecule, it is generally better than the absorption from feed, 
which is translated in a higher bioavailability (van Krimpen ). 
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2 CROSS-CONTAMINATION OF FEED 
2.1 MEDICATED FEED AND CROSS-CONTAMINATION 
‘Medicated feed’ is defined as a mixture of one or more veterinary medici-
nal products or intermediate products with one or more feeds which is 
ready to be directly fed to animals without further processing. An interme-
diate product is defined as a mixture of one or more veterinary medicinal 
products with one or more feeds, intended to be used for the manufacture 
of medicated feed (EC ). e transfer of traces of an active substance 
contained in a medicated feed to a non-target feed is referred to as ‘carry-
over’. ‘Cross-contamination’ is the contamination that results from the 
transfer of any unintended substance in feed (EC ). Feeding antimi-
crobial contaminated feeds may lead to unintended low dosage medication 
of the animals (Filippitzi et al. , McEvoy ). Carry-over of antimi-
crobials contained in medicated feed should therefore be avoided or kept 
as low as possible by applying good manufacturing practice and the 
ALARA (As Low As Reasonably Achievable) principle (EC ). 
2.2 ROUTES OF CROSS-CONTAMINATION AND RISK 
ASSESSMENT 
e occurrence and levels of cross-contamination with antimicrobials and 
other veterinary drugs during feed processing depends on various factors 
including human error, production practices and handling procedures in 
the feed mill, during transport and at the farm (McEvoy ). e feed 
batches obtained just aer production of a medicated feed are prone to 
cross-contamination (Borras et al. ). ese batches are generally re-
ferred to as flush batches. e level of carry-over is mostly expressed as the 
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percentage of the veterinary drug (or additive) from a feed batch which 
ends up in the next feed batch (Stolker et al. ). 
e specific properties of the drug and/or medicated premix (e.g., ad-
hesive strength, particle size, and electrostatic properties) affect how and 
at which level cross-contamination occurs. Especially the electrostatic 
properties of drugs in powder form can aggravate the problem because of 
the difficult purging of the equipment between batches. e use of less elec-
trostatic granular formulations (premixes) can thus reduce carry-over 
(McEvoy ). 
Retention of residual quantities of medicated feed at various points 
along the production line may also be caused by technical factors such as 
fast production lines, deficiencies in plant layout and worn equipment 
parts (especially liing screws and elevators) (EC , Vukmirović et al. 
). Cross-contamination may occur in a single piece of technological 
equipment, or may result from a combination of carry-over throughout 
the entire mixing process, manipulation and storage operations at the feed 
mill (Borras et al. , McEvoy ). Finally, cross-contamination is a 
risk not solely concerning the feed mill, as it can also occur during 
transport and delivery and at farm level, during storage and distribution 
(Filippitzi et al. , McEvoy ).  
According to the ESVAC report (EMA ), antimicrobial premixes 
were the biggest-selling antimicrobial veterinary medicinal product for 
food-producing animals in the EU and accounted for . of the overall 
sales in . ere is, however, a large variation between the different Eu-
ropean countries, for example regarding the preference of antimicrobial 
oral powders versus premixes. Although this high consumption of antimi-
crobial medicated feed suggests a substantial risk for cross-contamination, 
quantitative information on the estimated impact of the production, deliv-





Figure . Flowchart of the model that estimates the percentages of cross-con-
taminated feed produced in a certain country per year: (a) MF stands for 
medicated feed; (b) although usually three flushing batches are produced 
aer MF, the model took into consideration only the first flushing batch, 
since they contain considerably higher levels of antimicrobial residues than 
the second and the third. Adopted from Filippitzi et al. ().  
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very limited in the literature. Filippitzi and co-authors () attempted to 
assess this impact quantitatively and examined all possible pathways of ex-
posure of animals to feed which is cross-contaminated with traces of anti-
microbials from previously produced, transported and stored medicated 
feed. e study initially focussed on medicated feed in Belgian pig produc-
tion, but is applicable to a broader extent of cases such as other countries 
or animal species. is mathematical model, based on the flowchart in Fig-
ure , made it possible to estimate the percentages of cross-contaminated 
feed produced in a certain country per year. It should however be men-
tioned that no contamination levels were included in the model, because 
of the current lack of data. 
2.3 CONSEQUENCES OF CROSS-CONTAMINATION WITH 
ANTIMICROBIALS 
One of the reasons why cross-contamination of non-target feed with resi-
dues of antimicrobial compounds causes concerns is the potential for se-
lection and dissemination of resistance in both commensal and pathogenic 
bacteria (Andersson et al. , Chantziaras et al. , EC , 
Laxminarayan et al. ), as well as the potential selective pressure in the 
environment. Besides resistant pathogenic bacteria, commensal bacteria of 
animal origin may constitute a large reservoir of resistance genes. is res-
ervoir provides multiple and complex pathways through which resistance 
genes can make their way over time into human pathogens via food, water 
and sludge and manure applied as fertilizer (Marshall et al. ).  
Currently, there are no studies available that have assessed the impact 
of cross-contaminated feed on resistance selection in the intestinal micro-
biota. First of all, the antimicrobial concentrations in the gut that result 
from the consumption of feed containing low dosages of antimicrobials 
still need to be determined. To date there are only few studies available that 
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describe antimicrobial concentrations in intestinal content (Burch , 
Burch et al. , De Smet et al. , Devreese et al. ), but these do 
not include low dosages as encountered by cross-contamination levels.  
Inspired by the One Health concept, more and more researchers now 
also pay attention to aquaculture, sludge, freshwater and waste water as 
prime sites for gene exchange (Kim et al. , Sanderson et al. , Zhang 
et al. ). Antimicrobial residues can enter the environment directly via 
residues of antimicrobial medicated feed, e.g. in farm dust or via faeces and 
urine, which can be used as fertilizer on fields. It has been estimated that 
 to  of antibiotics used in food-producing animals are largely un-
metabolized excreted, suggesting that even cross-contamination levels of 
antimicrobials in feed can cause considerable contamination of the envi-
ronment with antimicrobials (Chee-Sanford et al. , Hamscher et al. 
). 
2.4 MEDICATED FEED LEGISLATION 
As stated above, the quality of a treatment via medicated feed is correlated 
with the level of manufacture standards and feed intake. Hence, the man-
ufacture, marketing and use of medicated feed in the European Union is 
currently strictly regulated by the following Directives and Regulations 
(EC ). 
Council Directive //EEC (Council of the European Commu-
nities ) constitutes the European Union’s regulatory framework for 
the manufacture, placing on the market and use of medicated feed. e 
authorisation for use of veterinary medicinal products in feed, the manu-
facture, distribution, advertising and supervision of those veterinary me-
dicinal products are governed by Directive //EC of the European 
Parliament and of the Council (EP a). 
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Medicated feed as a type of feed falls within the scope of Regulation (EC) 
No / (EP b), Regulation (EC) No / (EP ) and Reg-
ulation (EC) No / (EP ) of the European Parliament and of 
the Council and of Directive //EC of the European Parliament and 
of the Council (EP ). ese regulations lay down requirements for 
feed hygiene, placing on the market and use of feed, additives for use in 
animal nutrition and undesirable substances in animal feed, respectively.  
With the aim to update and harmonise the current rules which date 
from , the Commission adopted a proposal on  September  for 
a regulation on the manufacture, placing on the market and use of medi-
cated feed and repealing Council Directive //EEC (Council of the 
European Communities ), in which rules on carry-over and preven-
tive use are proposed (EC ). A general limit of  of the active sub-
stance of the last produced batch of medicated feed would account for 
carry-over of antimicrobials, a limit of  would account for other active 
substances. Preventive use of antimicrobial medicated feed would be pro-
hibited and criteria for homogeneity would be established (EC ).  
e proposed maximum carry-over of  corresponds with the guide-
lines that were established in Belgium since  in the covenant between 
the Federal Agency for the Safety of the Food Chain (FASFC) and Belgian 
Compound Feed Industry Association (BFA). is covenant states that, 
starting from Jan st , carry-over of antimicrobials should not exceed 
 of the minimal allowed dose, except for carry-over of tiamulin fumarate 
and tilmicosin in pelleted rabbit feed, that should not exceed .. More-
over, this covenant banned the use of the main mixer, which adds the pre-
mix in the middle of the mixing line, for antimicrobials in feed mills. In-
stead, feed mills now only mix veterinary antimicrobial drugs with feed at 
the end of the production line. is should reduce cross-contamination 
considerably. Other measures established in the covenant state that the 
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Belgian compound industry should only accept prescriptions from farm 
veterinarians (since Jan st ) for fattening pigs not older than  weeks 
(since Jan st ) (BFA and FASFC ). 
In Belgium , the product conditions, the marketing and use of medi-
cated feed and the modalities for prescription are regulated by means of 
the Royal Decree of  December  (Royal Decree ).  
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3 PROPERTIES OF FREQUENTLY USED 
ANTIMICROBIALS IN PREMIXES 
As mentioned before, tetracyclines and especially doxycycline are very 
important in veterinary medicine: they are the most sold antimicrobial 
class in Belgium as well as in Europe. Moreover, they are frequently ap-
plied as premix formulations in feed medication. It has been reported 
that tetracyclines have a low to moderate oral bioavailability in pigs 
(Baert et al. , Nielsen et al. ), but it is not known to which in-
testinal concentrations this property would lead. The low oral bioavail-
ability could possibly result in relatively high concentrations in the in-
testinal content, even at low concentration in the feed caused by cross-
contamination. This could in turn lead to resistance selection in the in-
testinal microbiota.  
To determine the effect of the oral bioavailability on intestinal con-
centrations, it is interesting to compare the tetracyclines with another 
antimicrobial group that shows a high oral bioavailability in pigs, e.g. 
sulphonamides and trimethoprim (Baert et al. ). These antimicro-
bials are also frequently applied as feed medication, and are therefore 
also prone to cross-contamination. Comparing these two classes with a 
distinct difference in oral bioavailability, can give more complete infor-
mation on the correlation between this pharmacokinetic property and 
the resulting intestinal concentrations.  
Within the group of tetracyclines, chlortetracycline and doxycy-
cline, with an oral availability in pigs of  (Nielsen et al. ) and  
(Baert et al. ), respectively, are discussed below. Being a commonly 
sold formulation, sulphadiazine-trimethoprim was chosen as a repre-




3.1.1 PHYSICOCHEMICAL PROPERTIES 
Physicochemical properties such as molecular weight, acid dissociation 
constant (pKa) and lipophilicity are important factors that determine the 
pharmacokinetics of a drug. An increase of molecular weight will decrease 
the drug’s ability to diffuse through a liquid medium. e acid dissociation 
constant of a drug is defined as the pH at which equal proportions of the 
drug exist in its ionised and unionised form. As mainly unionised com-
pounds are considered to be able to penetrate biological membranes by 
passive diffusion, the pKa is an important parameter in pharmacokinetics 
(Martinez b). e lipophilicity scale, expressed by the parameter log 
P, influences the disposition of the drug in different body compartments. 
e value of log P is used to define a drug as lipophilic (> ) or hydrophilic 
(< ) and is positively correlated with the volume of distribution and the 
ability to cross biological membranes (Grabowski et al. , Martinez 
b). 
3.1.2 PHARMACOKINETICS/PHARMACODYNAMICS 
e relationship between systemic antimicrobial drug exposure and its 
corresponding clinical and microbiological effects is referred to as ‘phar-
macokinetics/pharmacodynamics (PK/PD)’. 
Pharmacokinetics (PK) describe the time course of drug levels in 
body fluids as a result of absorption, distribution, metabolisation and elim-
ination of a drug aer administration (Levison et al. ). e pharma-
cokinetic properties of a drug, namely the extent of absorption (systemic 
availability), pattern distribution and rate of elimination are largely deter-
mined by the chemical nature of an antimicrobial drug and the related 
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physicochemical properties. Moreover, interspecies variation in bioavaila-
bility, clearance and volume of distribution can occur due to influences of 
factors such as genetic variability (breed effects), disease/stress, specific 
physiological conditions, hepatic and renal function, environment, food, 
gender and age (Martinez et al. ). Bioavailability is defined as the rate 
and extent to which the active drug ingredient or therapeutic moiety is ab-
sorbed from a drug product and becomes available at the site of drug action 
(Rescigno ). e oral bioavailability in particular is a measure of the 
rate and extent of a drug reaching the systemic circulation in its unchanged 
form through intestinal absorption (Hu et al. ). e volume of distri-
bution is used as a measure of the extent to which a pharmaceutical com-
pound distributes around the body (Yates et al. ). e volume of dis-
tribution of a specific body compartment is calculated as the ratio between 
the amount of a drug present in the body and its concentration in the com-
partment (Rescigno ). Total body clearance, the total effect of all elim-
ination processes, can be defined as the amount of drug eliminated per unit 
of time (Rescigno ). It is expressed in terms of the volume of blood that 
is totally cleared of a drug per unit of time and can be determined in terms 
of total systemic clearance or in terms of clearance associated with a par-
ticular eliminating organ such as the kidney or the liver (Martinez a). 
e elimination half-life is defined as the time needed for the plasma con-
centration, as well as the amount in the body, to decrease by  through 
the process of elimination (Desmond Baggot et al. , Rescigno ). 
e pharmacodynamics (PD) of an antimicrobial drug describe the 
relationship between its PK and the time course of the antimicrobial effects 
at the site of the infection (Levison et al. ). In other words, the PD of 
an antimicrobial drug describe the effect of the drug over time on the bac-
teria at the site of infection (Martinez et al. ). is effect is generally 
estimated based on the MIC (minimum inhibitory concentration) and PK 
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parameters of the antimicrobial, using different calculations depending on 
the antimicrobial type (dose- or time- dependent): () the percentage of the 
dosing interval for which the plasma concentration exceeds the MIC 
(T/MIC); () the maximum plasma concentration (Cmax) divided by the 
MIC (Cmax/MIC); and () the area under the concentration versus time 
curve (AUC) divided by the MIC. Clinical trials help to establish whether 
these predicted concentrations/doses generate the desired clinical and mi-
crobiological outcome (Levison , Martinez et al. ). 
3.2 TETRACYCLINES 
e tetracyclines are the most used class of antimicrobials in veterinary 
medicine (. of total sales in Europe in ). ey are first-line anti-
microbials in food-producing animals, including aquaculture, honeybees 
and exotic animals. Moreover, tetracyclines are broad-spectrum antimi-
crobials with activity against Gram positive and Gram negative bacteria, 
mycoplasmas, some mycobacteria, most pathogenic alpha-proteobacteria, 
and several protozoan and filarial parasites (del Castillo ). Conse-
quently tetracyclines are classified by the OIE as critically important anti-
microbials for veterinary medicine (OIE ). An antimicrobial is classi-
fied as critically important when it meets two criteria: () in a question-
naire, more than  of the respondents identified the importance of the 
antimicrobial class and (), the antimicrobial was identified as essential 
against specific infections, with a lack of sufficient therapeutic alternatives. 
Tetracyclines are also used for growth promotion in food-producing 
animals but concerns on emerging resistance led to a withdrawal of tetra-
cyclines from the list of authorized growth promoters in many European 
countries in – (Cogliani et al. ). However, many countries out-
side the EU including the US still allow the use of tetracyclines for growth 
promotion (Chopra et al. , Sorensen et al. ). Although growth 
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promotors are still legal in the US, the FDA (Food and Drug Administra-
tion) established a ‘Guideline for Industry’ in  which encourages phar-
maceutical companies to no longer produce antimicrobial formulations 
intended for growth promotion. is guideline also states that antimicro-
bials should only be distributed under veterinary prescription (FDA ). 
e first discovered tetracycline was chlortetracycline, which was iso-
lated from Streptomyces aureofaciens by Duggar (Duggar ). Oxytetra-
cycline, a secondary metabolite of Streptomyces rimosus, was discovered 
shortly aerwards (Finlay et al. ). Other naturally occurring first gen-
eration tetracyclines were identified further on, i.a. tetracycline and deme-
thylchlortetracycline (Nguyen et al. ). Second generation tetracyclines 
such as doxycycline and minocycline, were developed using semisynthetic 
approaches (Nguyen et al. ). ese compounds showed improved PK 
properties, increased antimicrobial potency and decreased toxicity. In the 
s, emerging antimicrobial resistance renewed interest in the develop-
ment of a third generation of tetracyclines, the semisynthetic glycylcyclines 
of which tigecycline is currently the only representative (Chopra et al. 
, Nguyen et al. ). Tigecycline shows activity against both efflux 
and ribosomal protection mediated tetracycline resistance, but is not au-
thorized for use in animals (EMA , Sum et al. ). 
3.2.1 PHYSICOCHEMICAL PROPERTIES 
e name ‘tetracyclines’ is based on the core structure typical for these an-
timicrobials, comprising four aromatic rings: -naphtacene carboxyamide 
(Stephens et al. ). e chemical structures of some first, second and 
third generation tetracyclines are given in Figure , together with the 
naphtacene core.  
 All tetracyclines are amphoteric molecules and are ionized at all 





Figure . Chemical structures of tetracyclines. Chemical structures of the first 
generation tetracyclines (A) chlortetracycline, (B) oxytetracycline and (C) 
tetracycline, of the second generation tetracyclines (D) doxycycline and (E) 
minocycline, and of the third generation tetracyclines (F) tigecycline, (G) 
omadacycline and (H) eravacycline. e year the antibiotic was discov-
ered/reported is indicated in parentheses. e inset of the DCBA naph-
thacene core provides the carbon atom assignments for rings A–D. Adopted 
from Nguyen et al. (). 
 
present in solution depend on the pH of the medium. e null net charge 
of the zwitterionic form, which predominates at pH values between  and 
, favours its passage across cell membranes.  
Tetracyclines are hardly soluble in water. erefore, they are adminis-
tered orally or parentally as acid or basic salts. Except for chlortetracycline, 
that degrades at a rate increasing with pH, the tetracyclines are fairly stable 
at physiological pH values (del Castillo ). In aqueous solution, tetracy-
clines are sensitive to U.V. degradation (Gómez-Pacheco et al. ). Tet-
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racycline-HCl in dry state is stable when stored at room temperature, re-
gardless of exposure to light (Wu et al. ). Tetracyclines are strong che-
lators, and chelation with multivalent metal ions (Ca+, Mg+, Zn+, Cu+, 
Fe+, Fe+, Al+) influences their PK properties, oral bioavailability and an-
timicrobial activity (del Castillo ). 
e chemical formula, molecular weight, pKa and log P of chlortetra-
cycline and doxycycline, the two tetracyclines that were used in the studies 
described in this thesis, are given in Table . 
 
Table . Physicochemical properties of chlortetracycline and doxycycline 
 Chlortetracyclinea Doxycyclineb 
Chemical formula CHClNO CHNO 
Molecular weight (g/mol) .  .  
pKa ., ., .  ., ., . 
log P -. . 
a Qiang et al. (), PHYSPROP () 
b Vandenberghe et al. (b)  
 
 
3.2.2 PHARMACOKINETIC AND PHARMACODYNAMIC 
PROPERTIES 
e PK properties of tetracyclines are influenced by several factors such as 
their molecular size, partition coefficient (log P), plasma protein binding, 
the acidity of biological mediums, their exposure to multivalent cations 
and the expression level of ABC transporter proteins such as P-glycopro-
tein in the cell membranes of the target tissue (del Castillo ). e four 
key PK properties (bioavailability, volume of distribution, clearance and 





Table . Estimates of the pharmacokinetic properties of chlortetracycline and 
doxycycline when orally administered in non-fasted pigs 
 Chlortetracyclinea Doxycyclineb 
Oral bioavailability () -. .- 
Elimination half-life (h) .-. . 
Volume of distribution (l/kg BW) .-. . 
Clearance (l/h.kg BW) .-. . 
a del Castillo et al. (), Nielsen et al. () 
b Baert et al. (), Sanders et al. (). BW: body weight 
 
 
e bioavailability of oral administered tetracyclines depends on the par-
tition coefficient of the tetracycline and can be negatively influenced by the 
presence of food particles and multivalent cations (Baert et al. , del 
Castillo ). e oral bioavailability of doxycycline in pigs seems to vary 
greatly, which may partly be due to differences in study design, e.g. the 
prandial state of the animals. However, even within the same study, wide 
variations between individual animals (.–) can be found (Baert et 
al. , Sanders et al. ). Also in other animal species, the oral bioa-
vailability of doxycycline is rather low. is is in contrast with the oral bi-
oavailability in humans, which is higher and does not seem to be affected 
by the presence of food (Baert et al. ). 
e volumes of distribution of tetracyclines are variable because they 
differ in lipid solubility (Desmond Baggot et al. ). e distribution of 
tetracyclines is typically highest in richly perfused organs: kidney > liver ≥ 
lungs > blood = synovia > muscle. Because of their multivalent cation-che-
lating properties, tetracyclines are deposited easily in teeth and at sites of 
new bone formation, which can have toxicological consequences (del 
Castillo ). e volume of distribution of doxycycline in pigs is gener-
ally smaller than in other species (Baert et al. ). 
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Excretion of tetracyclines primarily happens by glomerular filtration, by 
biliary excretion (at an extent that correlates with their lipid solubility) and 
by intestinal excretion via P-glycoproteins. ey undergo enterohepatic 
circulation: a large fraction of the drug excreted in the bile is reabsorbed 
from the intestines (del Castillo ).Once arrived at the site of infection, 
tetracyclines exert their broad-spectrum antibacterial activity by protein 
synthesis inhibition (Figure ). is results in a bacteriostatic effect. More-
over, a time-dependent and dose-dependent (see .,) bacteriocidic effect 
has been proven for e.g. doxycycline (Cunha et al. ). e antibacterial 
potency of the tetracyclines positively correlates with lipophilicity, as this 
determines the possibilities for intracellular diffusion, and thus varies be-




Figure . Tetracycline mechanism of action. Tetracyclines bind at the decoding 
centre of the small subunit of the ribosome, i.e. where the codon of the 
mRNA (messenger ribonucleic acid) is recognized by the anticodon of the 
tRNA. More specifically, rings C and D of the tetracycline sterically clash 
with the first nucleotide of the anticodon of the tRNA (transfer RNA) that 
interacts with the third base of the A-site codon of the mRNA. is inhibits 
the process of peptide synthesis (Nguyen et al. ).  




cycline) are most active, followed by the chlorinated tetracyclines (e.g. 
chlortetracycline) and finally oxytetracycline and tetracycline (del Castillo 
). 
3.3 SULPHONAMIDES-TRIMETHOPRIM 
Sulphonamides were the first clinically successful broad-spectrum antimi-
crobials, produced in  in Germany (Giguère ). ey inhibit bacte-
ria, toxoplasma and other protozoal organisms such as coccidia. A syner-
gistic action is obtained when combined with antibacterial diaminopyrim-
idines such as trimethoprim (Prescott ). Sulphonamides or sulpho-
namide-diaminopyrimidine combinations are classified as critically im-
portant for the treatment of a wide range of bacterial, coccidial and proto-
zoal infections in a wide range of animal species (OIE ).  
In the US, trimethoprim/sulphonamide combinations are not ap-
proved for oral use in animals (Burch ). 
3.3.1 PHYSICOCHEMICAL PROPERTIES 
e sulphonamides are derivatives of sulphanilamide, which contains the 
structural prerequisites for antimicrobial activity (Prescott ). e 
structures of sulphanilamide and sulphadiazine, the sulphonamide that 




Figure . Chemical structures of sulfanilamide (le) and sulfadiazine (right)  
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Sulphonamides are weak acids with pKa values ranging from . to .. 
e non-ionized form, that exists predominantly in biological fluids of pH 
lower than their pKa, diffuses through cell membranes and penetrates cel-
lular barriers (Prescott ). It has been shown that sulphonamides un-
dergo photodegradation, but the degradation rates of various sulphona-
mides under the same conditions are different (Zessel et al. ). Trime-
thoprim (Figure ), a synthetic drug, is a weak base with a pKa of about 
. and is poorly soluble in water (Prescott ). In contrast to sulphona-
mides, trimethoprim has been shown to be stable following natural U.V. 




Figure . Chemical structure of trimethoprim 
 
Important physicochemical properties of sulphadiazine and trime-
thoprim are given in Table . 
Table . Physicochemical properties of sulphadiazine and trimethoprim 
 Sulphadiazinea Trimethoprimb 
Chemical formula CHNOS CHNO 
Molecular weight (g/mol) . . 
pKa ., ., . . 
Log P -., -., -. . 
a Vandenberge et al. (b). 




3.3.2 PHARMACOKINETICS AND PHARMACODYNAMIC 
PROPERTIES 
Pharmacokinetic properties vary widely among the individual sulphona-
mides. e optimal plasma ratio of trimethoprim/sulphonamide is usually 
: because trimethoprim is  times more active than sulphonamide 
(Bushby ). To achieve this ratio, combination formulations normally 
contain trimethoprim and a sulphonamide in a : ratio (Prescott ). 
Important PK properties of oral administered sulphadiazine and tri-
methoprim in swine (oral bioavailability, elimination half-life, volume of 
distribution and clearance) are summarized in Table . 
Table . Estimates of the pharmacokinetic properties of sulphadiazine and trime-
thoprim when orally administrated in non-fasted pigs 
 Sulphadiazinea Trimethoprimb 
Oral bioavailability () - - 
Elimination half-life (h) .- . 
Volume of distribution (l/kg BW) .-. . 
Clearance  .-. ml/min.kg BW . l/h.kg BW 
a Baert et al. (), Nielsen et al. (), Witt (). 
b Baert et al. (), Nielsen et al (). BW: body weight. 
 
Most sulphonamides have a good to very good oral bioavailability. e 
high oral bioavailability of sulphadiazine in pigs is not affected by the pres-
ence of feed (Baert et al. ). Trimethoprim is also rapidly absorbed and 
to a large extent aer oral administration, except in ruminants, where it 
undergoes microbial degradation in the rumen (Boothe , Prescott 
).  
Most of the sulphonamides and trimethoprim are well distributed in 




Sulphonamides are eliminated by renal excretion and biotransformation. 
e renal excretion includes glomerular filtration of free drug in the 
plasma, active carrier-mediated proximal tubular secretion of ionized un-
changed drug metabolites, and passive reabsorption of non-ionized drug 
from distal tubular fluid. e pKa of the sulphonamide and the pH of the 
fluid in the distal tubules determines the extent to which it is reabsorbed 
(Prescott ). e elimination half-lives are relatively long, due to exten-
sive binding to plasma albumin and pH-dependent passive reabsorption 
from acidic distal renal tubule fluid (Prescott ). Some very water-solu-
ble sulphonamides, e.g. sulphisoxazole and sulphasomidine, are rapidly 
eliminated via renal excretion, mostly in unchanged form, and are there-
fore primarily used to treat urinary tract infections (Boothe ). Bio-
transformation of sulphonamides through acetylation, glucuronide conju-
gation and aromatic hydroxylation occurs mainly in the liver (Prescott 
). Trimethoprim is mainly eliminated by hepatic metabolisation (oxi-
dation followed by conjugation reactions) and the elimination half-life de-
pends on the animal species. e elimination half-lives of trimethoprim 
and the combined sulphonamide are oen different, but the combination 
is normally clinically effective because of the relatively broad range over 
which synergism occurs (Prescott ). In pigs, trimethoprim and sulpha-
diazine have similar half-lives (Table ), which favours the desired plasma 
ratio. 
 
Sulphonamides-trimethoprim combinations exhibit their synergistic anti-
bacterial effect by inhibiting sequential steps of the folic acid production 
and thus of the purines required for DNA (deoxyribonucleic acid) synthe-
sis (Prescott ). Sulphonamides compete with para-aminobenzoic acid 
(PABA) for the enzyme dihydropteroate synthetase, thus preventing 
PABA from incorporation into the folic acid molecule. Consequently, the 
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bacteriostatic action can be reversed by an excess of PABA, e.g. in case of 
presence of tissue exudates and necrotic tissue. e selective bacteriostatic 
action is caused by the different sources of folic acid between mammalian 
and bacterial cells: mammalian cells use preformed folic acid, whereas sus-
ceptible microorganisms must synthesize folic acid (Prescott ). Dia-
minopyrimidines such as trimethoprim interfere with the synthesis of tet-
rahydrofolic acid from dihydrofolate by inhibiting the enzyme dihydro-
folate reductase. Here, the selective antibacterial effect is caused by the 
greater affinity for the bacterial rather than the mammalian dihydrofolate 
reductase (Prescott ). 
e synergistic effect of sulphonamides and trimethoprim on the folic 
acid metabolism is shown schematically in Figure . 
 
 
Figure . Steps in folic acid metabolism blocked by sulphonamides and trime-
thoprim. Co-administration of a sulphonamide and trimethoprim intro-
duces sequential blocks in the biosynthetic pathway for tetrahydrofolate. 
e combination is much more effective than either agent alone. PABA: 
para-aminobenzoic acid; NADP(H): nicotinamide adenine dinucleotide 
phosphate. Adopted from Brunton et al. ().  
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4 ANTIMICROBIAL RESISTANCE 
4.1 INTRODUCTION 
e availability and use of antimicrobial drugs had a huge impact on the 
practice of human and animal medicine. Bacterial infections that used to 
be lethal are now treatable, and the use of antimicrobial drugs has ad-
vanced global public health, animal health, and food safety and security. 
Unfortunately, antimicrobials are not infallible. Bacteria can be intrinsi-
cally resistant to certain antimicrobials, which means they have the ability 
to resist the action of a particular antimicrobial as a result of inherent 
structural or functional characteristics. Further, bacteria can acquire re-
sistance to antimicrobials via mutations in chromosomal genes and by 
horizontal gene transfer (Blair et al. ). Bacteria must have acquired dif-
ferent resistance mechanisms since a long time. Natural antimicrobials are 
substances that are produced by fungi or soil bacteria and as such there has 
been contact with these substances (and other antimicrobial products as 
metals) long before their clinical use (Schwarz et al. a). e current 
high use of antimicrobial products has dramatically contributed to the se-
lection of antimicrobial resistant organisms, which pose an extraordinary 
threat to human and animal health, and to the world’s ecosystem (OIE 
). It is estimated that each year, drug-resistant infections result in at 
least , deaths and the cost associated with antimicrobial resistance in 
the EU is estimated at . billion euro through increased healthcare costs 
and losses in productivity (EC ). Hence, antimicrobial resistance is 
listed as one of the greatest threats to human health worldwide (Blair et al. 
). To combat the spread of antimicrobial resistance, the WHO has 
published the ‘Global Action Plan on Antimicrobial Resistance’ in collab-
oration with the Food and Agriculture Organization of the United Nations 
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(FAO) and OIE (WHO ). Similarly, the EU adopted a new One Health 
Action Plan against antimicrobial resistance in . e new plan con-
tains concrete actions with EU added value that the Commission will de-
velop and strengthen as appropriate in the coming years for a more inte-
grated, comprehensive and effective approach to combating antimicrobial 
resistance. 
4.2 MECHANISM OF ACTION OF ANTIMICROBIALS 
Antimicrobials act selectively on vital microbial functions without com-
promising the host functions, and different classes of antimicrobials act on 
different metabolic pathways. Nevertheless, antimicrobials can cause ad-
verse effects due to direct effects on host cells, hypersensitivity, drug inter-
actions, changes in microbiota and microbial lysis (Mandell et al. ).  
Antimicrobials can act bacteriostatic and/or bactericidal. Bacterio-
static antimicrobials only inhibit the growth or multiplication of bacteria, 
whereas bactericidal antimicrobials kill the bacteria. Consequently, for the 
bacteriostatic antimicrobials the combination with the host immune sys-
tem is of much more importance than for the bactericidal antibiotics to 
eliminate the bacterial infection. However, this classification in bacterio-
static and bactericidal antimicrobial is an approximation, depending on 
both the drug concentration at the site of infection and the microorganism 
involved. e distinction between bactericidal and bacteriostatic is made 
based on the MIC (Minimum Inhibitory Concentration) and the MBC 
(Mimimum Bactericidal Concentration) of the drug. e MIC is defined 
as the lowest concentration of an antimicrobial agent (in mg/l) that, under 
defined in vitro conditions, prevents the appearance of visible growth of a 
microorganism within a defined period of time (ISO -:). Gen-
erally, the antimicrobial is considered bactericidal when the MBC does not 
exceed four times the MIC (Giguère ). Furthermore, antimicrobials 
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can be classified as exerting either time-dependent or concentration-de-
pendent activity. In the first group, the time that serum concentrations ex-
ceed the MIC determines the efficacy of the treatment, whereas in the sec-
ond group, the efficacy increases with increasing serum concentrations 
(Giguère ). 
e modes of action of antimicrobials can be subdivided in four major 
categories: inhibition of the cell wall synthesis, inhibition of ribosome 
function, inhibition of nucleic acid synthesis and alteration of cell mem-
brane function (Giguère , Levinson ). 
4.3 MECHANISMS OF ANTIMICROBIAL RESISTANCE 
4.3.1 OVERVIEW OF RESISTANCE MECHANISMS 
As mentioned above, some bacteria are intrinsically resistant against cer-
tain antimicrobials. Besides that, antimicrobial pressure has forced suscep-
tible bacteria to escape the inhibitory action of antimicrobial agents, by ac-
quiring different resistance mechanisms.  
Four main mechanisms of resistance have been identified: 
 Enzymatic inactivation of the antimicrobial. Antimicrobials can be 
enzymatically modified or degraded before they reach the target site. 
An important example is the resistance against β-lactam antibiotics 
through production of β-lactamases (Smet et al. ). 
 Alternative metabolic pathways. Bacteria can ‘bypass’ the inhibited 
metabolic pathway e.g. by overproducing the antibiotic target or pro-
duction of a modified enzyme. is mechanism is used in case of sul-
phonamides and trimethoprim, by hyperproduction of PABA or 
production of an insensitive dihydropteroate enzyme (Munita et al. 
, Prescott ). 
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 Alteration of the target. A mutation or post-transcriptional or post-
translational modification of the antimicrobial agent’s target, or the 
acquisition of an alternative less susceptible target that can replace 
the function of the susceptible target can reduce the binding of the 
antimicrobial or have the function of the target being replaced. is 
mechanism can cause resistance to for example rifampicin and quin-
olones (Ruiz , Tupin et al. ) or resistance to tetracyclines 
(ribosomal protection mechanisms) (Nguyen et al. ). 
 Lowering the internal concentration of the antimicrobial. is can 
be achieved by reduced uptake or by active efflux of the antimicro-
bial. Efflux mechanisms mediate resistance against a wide variety of 
antimicrobials, e.g. tetracyclines (Blanco et al. ). 
4.3.2 TETRACYCLINE RESISTANCE MECHANISMS 
It is not known if intestinal concentrations of doxycycline caused by cross-
contaminated feed can exert a selective effect in the intestinal microbiota 
of pigs. To investigate this, a thorough knowledge of tetracycline resistance 
mechanisms and their transfer is necessary.  
Antimicrobial resistance can occur due to mutations or the acquisi-
tion of resistance genes, but tetracycline resistance has been shown to be 
caused mainly by the latter mechanism. e prevalence of resistance 
against tetracyclines was very low when they were first introduced for clin-
ical, veterinary and agricultural use, but since then many commensal and 
pathogenic bacteria have acquired resistance genes (Chopra et al. ). 
One of the reasons for the rapid increase of the prevalence of tetracycline 
resistance is the location of the resistance genes on highly mobile genetic 
elements, such as plasmids and transposons, resulting in efficient horizon-
tal gene transfer (aker et al. ). 
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ere are four main mechanisms of tetracycline resistance: active efflux, 
ribosomal protection, enzymatic inactivation and rRNA mutations. Of 
these four, active efflux is the most prevalent one, followed closely by ribo-
somal protection. Less prevalent mechanisms are the monooxygenases 
that promote degradation of tetracyclines and mutations within the S 
rRNA that reduce the binding affinity of the drug for the ribosome 
(Nguyen et al. ). 
Efflux pumps 
irty three different efflux pump genes (Table ) have been identified to 
date (Roberts ). ese genes fall into seven defined phylogenetic 
groups (Guillaume et al. ). e group  H+ antiporters is by far the 
largest group and comprises the most prevalent tetracycline-resistance de-
terminant in Gram negative bacteria. e group  efflux pumps, like TetA, 
show high homology with the major facilitator superfamily of secondary 
active transporters. ese efflux pumps exchange a proton for the tetracy-
cline molecule against a concentration gradient (Blanco et al. ). Tetra-
cycline efflux pumps confer resistance to tetracycline, but many of them 
are less effective against second generation tetracyclines (doxycycline, 
minocycline) and confer little to no resistance to the third generation 
glycylcycline, tigecycline (Chopra et al. , Grossman et al. ). 
Because the expression of antibiotic resistance genes can be associated 
with a fitness cost or physiological impairment, many bacteria regulate the 
expression of their resistance genes by different mechanisms (translational 
attenuation, transcriptional attenuation, translational coupling) (Chopra 
et al. ). Regulation of tetracycline resistance genes oen happens by 
negative control by a TetR repressor protein. is protein binds to two 
tandemly orientated tet operators to block transcription of the efflux pump 




Table . Mechanism of tetracycline resistance for characterized tet and otr genes 
Efflux 
() 
Ribosomal Protection  
() 
Enzymatic Inactivation  
() 
tet(A), tet(B), tet(C), 
tet(D), tet(E), tet() 




tet(G), tet(H), tet(J), 
tet(V), tet(Y) 
tet(Q), tet(T), tet() 
otr(A), tetB(P)b, tet 
tet()  
tet(), tet(), tet(),  
tet(Z), tet(), tet(), 
tet(), tet() 
tet() tet(), tet(), tet(), 
tet(), tet(), tet(), 
tet()  tet() 
tet(), tet()   
tet(K), tet( L), tet(), 
tet(), tet() 
  
tetA(P), tet()   
otr(B), otr(C)   
tcr   
tet()   
tet()   
tetAB()   
tetAB()   
Adopted from Roberts () https://faculty.washington.edu/marilynr/tetweb.pdf 
 
 
TetR, which in its turn dissociates from the tet operator (Figure ). As 
such, transcription and expression of the efflux pump is induced (Moller 
et al. , Saenger et al. ).  
Tetracycline efflux pumps are frequently detected in bacterial isolates 
from pigs, e.g. E. coli, Salmonella spp., Streptococcus suis, Enterococcus spp., 
Actinobacillus pleuropneumoniae, Haemophilus parasuis, Bordetella bron-
chiseptica, etc. (Blanco et al. , Chen et al. , Lancashire et al. , 




Figure 11. TetR-mediated regulation of the tetracycline resistance TetA efflux 
pump. (A) Schematic for mechanism of action of efflux pump TetA, illus-
trating that efflux of tetracycline (but not tigecycline) is coupled to proton 
transport. (B) Schematic for TetR-mediated regulation of TetA, illustrating 
that tetracycline binding to the TetR homodimer leads to activation of 
transcription of the tet(A) gene. Adopted from Nguyen et al. (2014). 
 
Ribosomal protection 
Ribosomal protection proteins (RPPs) are a widely distributed class of tet-
racycline resistance determinants and are part of the translation factor su-
perfamily of the GTPases (Connell et al. , Leipe et al. , aker et 
al. ). ese cytoplasmic proteins share considerable homology with 
the ribosomal elongation factors EF-G and EF-Tu (Sanchez-Pescador et al. 
). Phylogenetic analysis shows that RPPs probably have been derived 
from otrA, which confers tetracycline resistance in Streptomycus rimosus, 
the natural producer of oxytetracycline (Doyle et al. ). Until now,  
different RPP genes have been identified (Table ) of which tet(M) and 
tet(O) are the most prevalent (Roberts , aker et al. ). e tet(M) 









Figure . Ribosomal protection protein (RPP)-mediated tetracycline resistance. 
(A) Tetracycline binds the ribosome at the apex of the A-site which in turn 
sterically blocks the aminoacyl-tRNA binding site and inhibits protein syn-
thesis. (B) When bound by tetracycline, RPPs along with bound GTP will 
associate with the ribosome which results in tetracycline release from the 
A-site. (C) Upon tetracycline release, GTP is hydrolyzed and the RPP sub-
sequently dissociates from the ribosome which restores protein synthesis. 
tRNA = transfer RNA; GTP = guanosinetriphosphate. Adopted from 
aker et al. ().  
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is gene has been found commonly on conjugative transposons, which 
exhibit an extremely broad host range (Roberts ). e RPPs confer tet-
racycline resistance by releasing tetracycline from the ribosome and 
thereby freeing the ribosome from the inhibitory effects of the drug, such 
that aminoacyl-tRNA can bind to the A-site of the ribosome and protein 
synthesis can continue (Figure ) (Connell et al. ). 
 Various porcine bacterial isolates have been shown to carry RPP 
genes, such as Enterococcus spp., Streptococcus suis, Actinobacillus pleuro-
pneumoniae, etc. (Blanco et al. , Chen et al. , Seputiene et al. ). 
Enzymatic inactivation 
Enzymatic inactivation of tetracycline seems relatively rare compared to 
other natural antibiotic classes such as the β-lactams and aminoglycosides, 
where drug inactivation and modification is the predominant resistance 
mechanism (Forsberg et al. , aker et al. ). To date,  different 
genes have been found to encode for inactivation of tetracyclines (Table 
), of which ten – a novel family called ‘tetracycline destructases’ – have 
been discovered only recently (Forsberg et al. , Roberts ). Of the 
three initial detected enzymes (Tet(X), Tet(), and Tet()), only TetX has 
been studied in detail. It was shown to be a flavoprotein monooxygenase 
that inactivates tetracycline antibiotics by monohydroxylation and reduces 
the binding of the modified molecule to magnesium, essential for its bind-
ing to the ribosome. is is then followed by spontaneous, non-enzymatic 
breakdown (Moore et al. , aker et al. , Volkers et al. , Yang 
et al. ). Tet(X) confers resistance to all classes of tetracyclines includ-
ing minocycline and tigecycline (Figure ). TetX has been discovered 
originally in Bacteroides fragilis but has not been detected in porcine iso-







Figure . TetX mediated tigecycline inactivation. e enzymatic inactivation of 
tigecycline is mediated by TetX, a flavin-dependent monooxygenase. In the 
presence of oxygen, TetX catalyze the regiospecific hydroxylation of tigecy-
cline at position a producing a-hydroxytigecycline. Adopted from 
aker et al. (). 
 
Other mechanisms of tetracycline resistance 
e other, less prevalent mechanisms of tetracycline resistance are reduced 
antibiotic permeability and target modification (aker et al. ).  
e permeability of the outer membrane of Gram negative bacteria 
can be reduced by downregulating the synthesis of the OmpF porin, by 
which tetracycline crosses the outer membrane, resulting in less influx 
(Cohen et al. ).  
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Bacteria can escape antimicrobial action via target modification, for ex-
ample the mutation in the S rRNA. Tetracycline has a decreased affinity 
for ribosomes bearing these so called GC mutations compared to wild-
type ribosomes. ese mutations have been found in Helicobacter pylori 
(Nonaka et al. ).  
4.4 SELECTION AND TRANSFER OF ANTIMICROBIAL RESISTANCE 
4.4.1 RESISTANCE SELECTION 
Introduction 
Although it is well known that antimicrobial use selects for antimicrobial 
resistance, it has been debated how and where exactly the resistance arises 
and is enriched (Holmes et al. ). Even though many (micro)organisms 
naturally produce antimicrobial substances, little evidence exists to suggest 
that this contributes significantly to the selection of antimicrobial-resistant 
microorganisms in their native environment (Martinez ). Neverthe-
less, the resistance mechanisms are shown to be ancient (clusters of) genes, 
oen phylogenetically related to genes encoded by the antibiotic produc-
ing micro-organism. e extensive human, veterinary and agricultural use 
of antimicrobials is considered as the key driver of antimicrobial resistance 
selection (Bell et al. , Laxminarayan et al. ).  
Many factors can influence the speed of resistance selection, but anti-
microbial exposure dynamics are considered a main factor. Clear correla-
tions between antimicrobial use and resistance development have been re-
ported. e countries that use most antimicrobials, generally also face the 
highest burden of resistance in clinically important bacteria (Bell et al. 
, Chantziaras et al. , JIACRA ). 
 Next to the exposure to antimicrobials there are several other factors  
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involved in the resistance selection dynamics, including the molecular 
mechanisms behind the resistance, the fitness cost and the location of the 
resistance gene on a mobile genetic element (Andersson et al. ). 
Mutant selection window hypothesis 
In the late s, it was suggested that for each particular type of resistant 
mutant a dangerous antimicrobial concentration zone exists in which se-
lective amplification can occur for that mutant type (Baquero et al. a). 
Later on, Drlica and Zhao concluded that the sum of dangerous zones for 
all mutant types would represent a mutant selection window. is ‘mutant 
selection window hypothesis’ became one of the dominating theories on 
the selection of resistance. It states that selection of resistant mutants oc-
curs in a concentration range spanning from the MIC of the susceptible 
strain to the MIC of the resistant mutant (Drlica , Drlica et al. ). 
More specific, the lowest antimicrobial concentration that blocks the 
growth of the majority of the susceptible cells ( inhibition = MIC) 
represents the lower boundary of the selection window. e Mutant Pre-
vention Concentration (MPC) was designated as the upper limit of the se-
lection window. e MPC is determined experimentally as the lowest con-
centration that allows no colony growth when more than  cells are ap-
plied to antimicrobial-containing agar plates (Drlica ).  
Hence, the mutant prevention window hypothesis predicts that mu-
tant growth will be severely restricted if antimicrobial concentrations at 
the site of infection are maintained above the MPC throughout therapy. In 
addition, it predicts that resistance will arise rarely for antimicrobial drugs 
that have a narrow selection window, because in this case mutant amplifi-
cation would occur only for short times. 
GENERAL INTRODUCTION 
67 
Sub-MIC selection of resistance 
e main focus of the mutant selection window hypothesis has been the 
MPC, and less attention was paid to concentrations below the MIC (sub-
MIC concentrations). Later on, questions were raised about the possible 
impact of very low, residual concentrations of antimicrobials. Bacteria are 
frequently exposed to subinhibitory concentrations of antimicrobials, in 
the initial phase of therapy and during clearance of the antimicrobial from 
the body. Furthermore, due to excretion of unmetabolised antimicrobials 
in the urine or faeces, low concentrations of antimicrobials are found in 
the environment (Andersson et al. , Finley et al. ). Cross-contam-
ination of animal feed with antimicrobials, the use of antimicrobials as 
growth promotors (sub-MIC concentrations) and accidental under dosing 
are examples of routes by which subtherapeutic concentrations of antibi-
otics may modulate the intestinal microbiota in particular (Butaye et al. 
, Filippitzi et al. ). 
 One of the first studies on low antimicrobial concentrations was pub-
lished in the late s (Baquero et al. b). is study used in vitro mod-
els with mixtures of β-lactam susceptible and low-level resistant popula-
tions (E. coli and Streptococcus pneumoniae) and showed that four hours 
of antibiotic challenge (cefotaxime or amoxicillin) produced selective 
peaks of low-level resistant variant populations at low-level antibiotic con-
centrations. Later on, other studies followed that proved the potential of 
very low antimicrobial concentrations to select for resistant bacteria 
(Gullberg et al. , Gullberg et al. ). ese studies showed that re-
sistance selection at sub-MIC levels is related to the bacterial fitness. As 
such, Gullberg and co-authors suggested an update on the selective win-
dow for resistance and introduced the Minimal Selective Concentration 
(MSC) (Gullberg et al. ). e MSC is defined as the lowest antimicro-
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bial concentration that is needed to neutralize the fitness cost of each re-
sistant determinant. e concentration range between the MSC and the 
MIC of the susceptible strain is referred to as the sub-MIC selective win-
dow (Gullberg et al. ). In Figure , the traditional selective window 
and sub-MIC selective window are presented graphically. e figure shows 
the MSC as the intercept of the growth curve of the susceptible strain and 
the growth curve of the resistant strain at increasing antimicrobial concen-
trations. In other words, as long as the growth rate of the susceptible strain 
is higher than the growth rate of the resistant strain, the susceptible strain 
will be able to outcompete the resistant strain (green interval). When the 
growth rate of the resistant strain exceeds the growth rate of the susceptible 
strain (that is, starting from the MSC), the resistant strain will be able to 
outcompete the susceptible strain. 
It was found that the MSC of an antimicrobial can be much lower than 
the MIC. For example, the MSC of tetracycline in case of competition be-
tween a susceptible wild-type Salmonella Typhimurium strain and its iso-
genic resistant mutant appeared to be -fold lower than the MIC of the 
susceptible strain (Gullberg et al. ).  
Hence, it is clear that resistant bacteria can be selected at sub-MIC 
concentrations, when the resistance mechanism confers a sufficiently high 
increase in resistance and concomitantly does not decrease fitness too 
much. It is suggested that the tendency will be that sub-MIC concentra-
tions select faster for resistant bacteria with high fitness (regardless of re-
sistance level), whereas concentrations above the MIC will select for mu-
tants with high resistance (regardless of the fitness level) (Andersson et al. 
). 
 Andersson and Hughes () state that the selection of (mutational) 
antimicrobial resistance at sub-MIC levels differs in several important as-






Figure . Growth rates as a function of antibiotic concentration.  
Schematic representation of growth rates as a function of antibiotic con-
centration. Green indicates a concentration interval where the susceptible 
strain (blue line) will outcompete the resistant strain (red line). Orange 
(sub-MIC selective window) and red (traditional mutant selective window) 
indicate concentration intervals where the resistant strain will outcompete 
the susceptible strain. MICsusc = minimal inhibitory concentration of the 
susceptible strain, MICres = minimal inhibitory concentration of the re-
sistant strain and MSC = minimal selective concentration. Adopted from 
Gullberg et al. (). 
 
‘mutational space’ is much greater at sub-MIC concentrations than at le-
thal concentrations of antimicrobials. At lethal concentrations, only the 
rare pre-existing mutants in a wild-type population that have high-level 
resistance will survive and the remaining susceptible population will be 
killed. In contrast, at sub-MIC concentrations most bacteria will grow 
slower but will not be killed, which will result in the emergence of a broader 
range of mutant variants. Second, it is suggested that selection under sub-
MIC conditions tends to be progressive, meaning that it involves multiple 
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mutations that accumulate successively. As a consequence, it is also likely 
that sub-MIC conditions select for ‘mutator bacteria’. is kind of bacteria 
show increased mutation rates, typically as a result of inactivating muta-
tions in DNA repair mechanisms, and can thus adapt quickly to a changing 
environment (Mao et al. ). ird, sub-MIC antimicrobial concentra-
tions might also affect the rate of horizontal gene transfer, recombination 
and mutagenesis. At lethal antimicrobial concentrations, these effects are 
less important, as the susceptible cells are killed before any of the associ-
ated phenotypes can be expressed or before genes can be transferred. And 
fourth, the association between low fitness cost and sub-MIC resistance 
selection could have an important implication. It means that restriction of 
antimicrobial use as a means to counter-select resistant populations could 
be less effective in populations in which resistance has emerged under sub-
MIC conditions (Andersson et al. , Andersson et al. ). However, 
more research is needed to confirm the latter hypothesis. 
4.4.2 HORIZONTAL GENE TRANSFER  
Introduction 
Selection of resistant bacteria is a major contributing factor to the spread 
of antimicrobial resistance, but also transfer of resistance genes plays a key 
role in this phenomenon. is spread of resistance also occurs without the 
selective pressure of antimicrobials (Smet et al. ). 
For most bacteria, the genetic material comprises one circular chro-
mosome, which always carries the housekeeping genes. ey may carry ad-
ditional DNA as plasmids. Sexual reproduction does not occur in bacteria, 
they divide asexually through binary fission. ‘Vertical gene transfer’ refers 
to the transfer of genetic material from a parent to the offspring. Besides 
that, an important share of genetic material exchange happens through 
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‘horizontal gene transfer’ between (possibly non-related) bacterial cells. 
is can be achieved by means of three main mechanisms: transformation 
(Figure a), transduction (Figure b) and conjugation (Figure c). 
When it comes to transfer of antimicrobial resistance genes, conjugation 
is considered as the most important mechanism because many resistance 
genes are associated with conjugative or mobilizable elements as transpos-
ons and plasmids (Boerlin et al. , Hawkey et al. ). In addition, 
conjugation events are not limited to bacteria of the same species, but can 











Transfer of DNA through conjugation (Figure c) involves a multi-step 
process that requires cell to cell contact between a donor and recipient cell, 
which is achieved via cell surface pili, named sex pili. e conjugative ma-
chinery is encoded by a set of genes that can be located on autonomously 
replicating plasmids (‘conjugative plasmids’) or on the chromosome (e.g. 
‘integrative conjugative elements’). ese genes may also enable the mobi-
lization of non-conjugative plasmids (‘mobilizable plasmids’) and integra-
tive and mobilizable elements (Smillie et al. ).  
e mechanisms to achieve cell-cell contact differ between Gram neg-
ative and Gram positive bacteria. In Gram negative bacteria, this first step 
in conjugation is promoted by extracellular filaments called sex pili. ese 
form a mating bridge that serves as a conduit for DNA. Other mechanisms, 
such as pheromones secreted by the recipient cells or aggregation, induce 
the cell-cell contact between Gram positive bacteria (Grohmann et al. 
, Smillie et al. ). e second step in the conjugation process is the 
transfer of a single stranded linear DNA molecule from the donor to the 
recipient cell. e incoming plasmid is then established in the recipient cell 
by relaxase-mediated circularization and synthesis of the complementary 
strand.  
Plasmids (Figure ) are classified in ‘Inc groups’ according to their 
incompatibility. Incompatibility is defined as the inability of two related 
plasmids to be propagated stably in the same cell line; thus, only compati-
ble plasmids can be rescued in transconjugants (Carattoli ). 
Antimicrobial resistance genes are in many cases associated with con-
jugative plasmids and transfer of these plasmids has been observed in 





Figure . Example of a conjugative plasmid. is plasmid carries genes encod-
ing for conjugation (orange), an integron (yellow) with antimicrobials re-
sistance gene cassettes, transfer and replication origins (black), etc. 
Adopted from Fernandez-Lopez et al., . 
 
the intestines,… (Davison ). Hence, plasmids, together with trans-
posons, are considered as the most important mobile genetic element in 
the dissemination of resistance genes. 
Transposons (Tn) are genetic elements with the ability to move from 
one genetic location to another (Figure ). is is accomplished via an 
enzyme called transposase, and the gene encoding this protein is generally 
located on the transposon itself. Due to the transposase, transposons can 





Figure . (A) Insertion sequences, the simplest transposable elements in bacte-
ria, contain a single gene that encodes transposase, which catalyzes move-
ment within the genome. e inverted repeats are backward, upside down 
version of each other; only a portion is shown. e inverted repeat se-
quence varies from one insertion sequence type to another. (B) Transpos-
ons contain one or more genes in addition to the transposase gene. In the 
transposon shown here, an antimicrobial resistance gene is located between 
twin insertion sequences. e resistance gene is carried along as part of the 
transposon when the transposon is inserted at a new site in the genome. 
 
In analogy with plasmids, transposons can be subdivided into two types: 
conjugative and mobilizable transposons. e conjugative transposons are 
part of a larger group of mobile genetic elements, the integrative and con-
jugative elements (ICEs). ese elements have the ability to integrate into 
and excise from the chromosome, replicate within the chromosome and 
are transferred by conjugation (Burrus et al. ). Mobilizable transpos-
ons belong to the group of integrative mobilizable elements (IMEs). e 
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smallest type of transposons, consisting only of the transposase gene and 
the flanked inverted repeats, are also called insertion sequences (Figure 
). ey are very common and can be found in almost all bacteria and on 
many conjugative plasmids (Siguier et al. ). A specific type of inser-
tion sequences, the insertion sequence common regions elements (ISCR) 
are particular of interest because of their close association with a wide va-
riety of antimicrobial resistance genes and their association with integrons 




Figure . Integron structure and function. Integrons consist of a gene for an in-
tegron-integrase (intI in case of this class  integron) that catalyses recom-
bination between the attC site of circular gene cassettes and the attendant 
integron recombination site, attI. is activity results in the sequential in-
sertion of multiple, different cassettes to form a tandem cassette array that, 
in some cases, might contain hundreds of different genes. Inserted genes 
are expressed by an integron-encoded promoter, Pc. Adopted from Gillings 
et al. (). 
 
Integrons (Figure ) are recombination based genetic systems that use 
modular genetic cassettes to generate genomic diversity (Gillings ). 
ese immobile elements consist of three basic components: two ‘con-
served regions’ (’-CS and ’-CS) and between these regions a variable 
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number of gene cassettes. Variations on this basic structure have been re-
ported, such as integrons with a deletion of the ’-CS region (Hall et al. 
) and the so called complex integrons (Quiroga et al. , Sabaté et 
al. ). All the elements necessary for the integration, expression and 
excision of gene cassettes are located within the ’-CS region, namely an 
intI gene (encoding a site-specific recombinase), a common promotor (Pc) 
and a recombination site attI. A gene cassette consists of a gene and a re-
combination site attC, by which the cassette can be integrated in the in-
tegron by site-specific recombination (Cambray et al. , Gillings ). 
When integrons are associated with mobile genetic elements such as plas-
mids or transposons, they are called mobile integrons. ey can also be 
located on the bacterial chromosome (chromosomal integrons), but anti-
microbial resistance gene cassettes are mostly integrated in mobile in-
tegrons (Domingues et al. ). Currently, five different classes of mobile 
integrons have been described, although until now only three of them have 
been associated historically with dissemination of resistance (Cambray et 
al. ). e class  integrons are more prevalent than other integron clas-
ses and are the most ubiquitous class of integrons in Enterobacteriaceae 
(Kaushik et al. ). Today, bacteria carrying multidrug resistance in-
tegrons are widespread, both in humans, animals and the environment. A 
Spanish study showed that up to  of commensal E. coli isolates from 
farm animals can carry integrons (Marchant et al. ). 
Transduction 
Transfer of DNA between bacteria that is enabled by bacterial viruses (bac-
teriophages), is called transduction (Figure b). When bacteriophages in-
fect and lyse bacteria, bacterial host DNA can be integrated in the phage 
genome or accidentally be packed instead of the viral genome. When they 
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subsequently infect a new host, these bacterial genes can be transferred and 
integrated into the genome of the recipient cell (Muniesa et al. ). 
In the past, the role of transduction in the dissemination of antimicro-
bial resistance has received less attention than conjugation and transfor-
mation, but now the contribution of transduction in horizontal gene trans-
fer is estimated to be larger than first perceived (Balcazar , Muniesa et 
al. ). Especially in livestock manure, hospital effluent water and sewage 
and river water, high numbers of phage particles carrying resistance genes 
have been found (Colomer-Lluch et al. , Marti et al. ). Moreover, 
it has been shown that the fraction of phages carrying antimicrobial re-
sistance genes increase drastically in the gut of mice treated orally with am-
picillin or ciprofloxacin (Modi et al. ). 
Transformation 
Natural genetic transformation is defined as the active uptake of free DNA 
by bacterial cells and the heritable incorporation in the genome (Lorenz et 
al. ). It involves several steps: the release of DNA from cells, uptake of 
the free DNA by competent cells, stable integration of the DNA in the re-
cipient cell and finally the expression of the acquired trait. In other words, 
several conditions have to be met in order for transformation to take place 
(omas et al. ). Bacteria can release DNA passively aer cell death or 
actively by secretion (Nielsen et al. ). Several bacterial species belong-
ing to different phyla possess natural competence for transformation, 
whereas others are able to undergo transformation under adequate condi-
tions (Johnston et al. ). Natural competence is defined as a genetically 
programmed physiological state permitting the efficient uptake of macro-
molecular DNA (Dubnau ). In addition, competence can be induced 
under laboratory conditions in a wide range of bacteria (Aune et al. ).  
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Importantly, different studies have shown that competence for transfor-
mation can be induced in many species of bacteria by exposure to antimi-
crobials (Charpentier et al. , Charpentier et al. , Prudhomme et al. 
). is could mean that antimicrobial exposure could stimulate trans-
formation of antimicrobial resistance genes.  
Mobility of tetracycline resistance genes 
Since , tetracycline-resistant bacteria have been found increasingly in 
humans, animals, food and the environment. Tetracycline resistance is 
usually the result of the acquisition of new genes and is primarily due to 
either energy-dependent efflux of tetracycline or protection of the ribo-
somes from its action. e first reports on tetracycline resistance determi-
nants were made decades ago in Japan (Roberts ). e so called tet 
genes are oen associated with plasmids, transposons and conjugative 
transposons, which can also carry other resistance determinants and/or 
heavy metal resistance genes. e type of element a specific tet gene is as-
sociated with, may greatly influence its ability to spread to new bacterial 
genera (Chopra et al. ). So far, tet genes have not been found as gene 
cassettes within integrons. Gram negative efflux genes are oen associated 
with conjugative plasmids, whereas Gram positive efflux genes are mostly 
found on small mobilizable plasmids or in the chromosome associated 
with a transposon. ese transposons have a wide host range covering both 
Gram negative and Gram positive bacteria. Likewise the ribosomal protec-
tion proteins are widely distributed among the different genera (Roberts 
). 
Well studied tet genes, such as tet(B), tet(M) or tet(A) (oen located 
on transposons Tn, Tn and Tn respectively), have been shown to 
be widely distributed (Allmeier et al. , Roberts ). is supports the 
hypothesis that tet genes are exchanged by bacteria from many different 
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ecosystems. is means that bacteria exposed to antimicrobials in the en-
vironment or in animals can ultimately influence antimicrobial resistance 
in bacteria of both animal and human origin. 
Horizontal gene transfer at sub-MIC antimicrobial levels 
It is generally assumed that antimicrobials promote horizontal gene trans-
fer, even at sub-MIC level (Aminov , Andersson et al. , Beaber et 
al. ). In the s, it was already reported that sub-MIC concentra-
tions of β-lactams promoted the transfer of tetracycline resistance plas-
mids by up to ,-fold in Staphylococcus aureus (Barr et al. ). An-
other study showed that sub-MIC tetracycline concentrations accelerated 
the mobilization of a resident non-conjugative plasmid by chromosomally 
encoded tetracycline conjugal elements in Bacteroides sp. (Valentine et al. 
). Later on, it was discovered that similar exposure conditions also en-
hanced the excision and conjugal transfer of the ICE CTnDOT (Stevens et 
al. , Whittle et al. ). Other mobile genetic elements of which trans-
fer has been shown to be stimulated by sub-MIC tetracycline concentra-
tions are the ICEs Tn and Tn, both generally carrying the tetM gene 
(Showsh et al. , Torres et al. ). ese (and other) pioneer studies 
were conducted in vitro, using standard mating techniques. e next step 
was to verify whether similar effects would arise in in vivo situations. Ex-
periments with gnotobiotic lab animals confirmed that the stimulatory ef-
fect of sub-inhibitory antimicrobials on transfer of mobile genetic ele-
ments also occurs in real in vivo situations. However, the intestinal micro-
biota of gnotobiotic animals still lack the high diversity and density of the 
microbiota of normal animals.  
Different mechanisms are responsible for the enhanced movement of 
mobile genetic elements in the presence of antimicrobials. At sublethal 
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concentrations, antimicrobials can increase the conjugation rate by acti-
vating the excision of transferrable genes from the host chromosome 
and/or by inducing the expression of the conjugation machinery, e.g. in 
the case of conjugative transposon CTnDOT (Jeters et al. , Moon et 
al. , Whittle et al. ). It has also been speculated that antimicrobials 
can induce general cellular responses, such as upregulation of key survival 
genes (Zhang et al. ) and induction of the SOS response (Beaber et al. 
, Zhang et al. ) which could indirectly promote conjugation 
(Andersson et al. ). is kind of event has been reported e.g. for Vibrio 
cholerae following ciprofloxacin exposure, for Staphylococcus aureus fol-
lowing β-lactam exposure and for E. coli following the exposure to the 
combination of kanamycin and streptomycin (Beaber et al. , Maiques 
et al. , Zhang et al. ). Furthermore, the integron integrase genes 
are oen activated in the cell via the SOS response, suggesting that antibi-
otic treatment can increase the activity of integrons in bacteria (Guerin et 
al. ). 
Interestingly, also the opposite effect, i.e. the inhibition of conjugation, 
has been reported e.g. in case of exposure of E. coli to quinolones (Viljanen 
et al. , Weisser et al. ).  
A variety of confounding factors can however complicate the inter-
pretation of conjugation studies, which makes that the mechanisms by 
which antimicrobials modulate horizontal gene transfer remain today 
poorly understood. It is still unclear whether antimicrobials regulate the 
efficiency of horizontal gene transfer directly, or serve as a selection force 
to modulate population dynamics aer such gene transfer has occurred, or 
both (Lopatkin et al. ). Lopatkin and co-authors decoupled antimicro-
bial mediated induction of the conjugation machinery from the global ef-
fect an antimicrobial might have on the conjugation efficiency and the con-
jugation event from the ensuing growth dynamics. us, it was shown that 
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particularly the physiological state of cells before conjugation and energy 
availability during conjugation, increases the conjugation efficiency sub-
stantially. ese findings underline the importance of quantifying the 
growth dynamics of microbial populations to estimate both the physiolog-
ical state of cells and the effects of antimicrobial mediated selection 
(Lopatkin et al. ). 
4.4.3 SUB-MIC RESISTANCE SELECTION AND TRANSFER IN THE 
PORCINE INTESTINAL MICROBIOTA 
e majority of the mammalian gut microbiota is represented by Bacteria, 
while Archaea, Protozoa, viruses, and fungi are present to a lesser extent 
(Leser et al. , Sommer et al. ). e porcine gut microbiota com-
prises relatively few different phyla, i.e. the Bacteroidetes and Firmicutes. 
e most abundant genera are Prevotella, Lactobacillus, Treponema, Rose-
buria, and Streptococcus, as in many other animal species (Holman et al. 
, Kim et al. , Lamendella et al. , Park et al. ). e intestinal 
microbiota is not homogenous: it depends on the individual, the sample 
location and age (Holman et al. , Isaacson et al. , Leser et al. , 
Mach et al. ).  
e currently available studies in literature concerning selective pres-
sure of sub-MIC concentrations of antimicrobials in the porcine microbi-
ota, mostly consider growth promoting agents such as chlortetracycline 
and tylosine. Early studies on this topic mostly investigated the cultivable 
porcine microbiota. For example, Dawson and co-authors described the 
effect of therapeutic ( mg/kg feed) and subtherapeutic (. mg/kg feed) 
dosages of chlortetracycline on the total cultivable anaerobic population 
(Dawson et al. ). ey only found significant higher presence of re-
sistant anaerobes in the group that received the therapeutic dose. A more 
recent study evaluated antimicrobial resistance in total anaerobes isolated 
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from the faeces of pigs fed either tylosin or virginiamycin and recorded 
that all anaerobes were resistant to both antibiotics, even in the absence of 
exposure (Kalmokoff et al. ). Another study reported a rapid signifi-
cant increase in tylosin-resistant faecal anaerobes in pigs that were fed ty-
losin-supplemented feed (Holman et al. ). On the other hand, the sub-
therapeutic dose of chlortetracycline (. mg/kg feed) had no measurable 
effect on chlortetracycline resistance in total anaerobes (Holman et al. 
).  
e challenges associated with culturing gut-associated microorgan-
isms together with the progress in molecular techniques have led to the use 
of culture-independent methods such as qPCR, single gene sequencing 
and metagenomic analysis to investigate the (porcine) microbiota. Several 
recently published studies describe the effects of subtherapeutic antimicro-
bial concentrations on the porcine microbiota using these methods. How-
ever, each of these studies lacks information on intestinal antimicrobial 
concentrations resulting from the in-feed administration. Rettedal and co-
authors reported that in piglets that were fed chlortetracycline for two 
weeks at a subtherapeutic dose ( mg/kg feed) following weaning, a sig-
nificant change in the ileal microbiota was observed. ese changes were 
mainly associated with a decrease in Lactobacillus johnsonii, Turicibacter, 
and an increase in Lactobacillus amylovorus (Rettedal et al. ). Another 
study investigated the effect of in-feed ASP [i.e. a combination of the 
performance enhancing antimicrobials chlortetracycline ( mg/kg feed), 
sulphamethazine ( mg/kg), and penicillin ( mg/kg)] administered to 
three post-weaned pigs for three weeks on the abundance and diversity of 
antimicrobial resistance genes. ey reported an increase in the diversity 
of antimicrobial resistance genes as well as an increase in the abundance of 
six different classes of resistance genes in the medicated pigs. ese re-
sistance gene classes included not only those which confer resistance to the 
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administered antimicrobials but also to antimicrobials not used in the 
study, which points to potential co-selection of these resistance gene clas-
ses (Loo et al. ). Furthermore, ASP caused shis in the porcine 
microbiota, among which a decrease in the relative abundance of Bac-
teroidetes and an increase in Proteobacteria, of which most were E. coli 
(Loo et al. ). Interestingly, many of these culture-independent stud-
ies demonstrate that there is a wide dissemination of antimicrobial re-
sistance determinants among pigs in modern production facilities, even in 
the absence of antimicrobial exposure (Agga et al. , Holman et al. , 
Kalmokoff et al. , Pakpour et al. ). Regarding tetracycline re-
sistance, in particular tet(M), tet(O), tet(Q), and tet(X) were frequently de-
tected in pigs that were not directly exposed to antimicrobials (Agga et al. 
, Barkovskii et al. , Holman et al. ).  
5 CLOSING REMARKS 
Antimicrobial feed medication is frequently applied in the pig industry. An 
unavoidable consequence of this practice is the unintended cross-contam-
ination of feed with low concentrations of antimicrobials due to carry-over 
of antimicrobials from medicated feed to non-target feed. ere is no Eu-
ropean regulation that lays down maximum levels of antimicrobial carry-
over valid yet, but a proposal for a regulation on the manufacture, placing 
on the market and use of medicated feed (repealing Council Directive 
//EEC) is currently debated.  
Based on the literature discussed above, it is to be expected that anti-
microbial concentrations in the intestinal microbiota due to cross-contam-
inated feed may select for resistance. e microbiota in the large intestines 
are particularly of interest, as they harbour the highest microbial diversity 
in the intestinal tract. 
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However, it has not been investigated if these low antimicrobial concen-
trations in the feed reach the pig’s large intestines and if so, whether these 







Antimicrobial resistance is one of the most important ‘One Health’ issues. 
It has been a hot topic in research since years, and thus numerous studies 
on resistance mechanisms, selection, and transfer have been published. 
Nevertheless, antimicrobial resistance is a very complex phenomenon and 
still many knowledge gaps are le to fill. One of these gaps concerns the 
effects of low antimicrobial concentrations, such as carry-over concentra-
tions in pig feed, on resistance selection. 
 e general aim of this doctoral thesis was therefore to evaluate the 
effect of  carry-over concentrations of antimicrobials in pig feed on re-
sistance selection and transfer in the porcine intestinal microbiota. e 
choice for  carry-over was based on the only legal rule on maximum 
allowed carry-levels valid at that time, namely the European legislation on 
coccidiostats and histomonostats in animal feed (EP ).  
is main goal was translated into three research questions: 
 Which antimicrobial concentrations can be found in the gut of pigs 
that are fed with feed that contains carry-over levels of  of the rec-
ommended dose of chlortetracycline, doxycycline and sulphadiazine-
trimethoprim? is question is answered in Chapter . 
 What are the effects of intestinal doxycycline concentrations caused 
by  and  carry-over levels in the feed on the selection of doxycy-
cline resistant porcine commensal E. coli strains and on the transfer of 
their resistance plasmids in an in vitro model with pure cultures? is 
question is answered in Chapter . 
 What are the effects of intestinal doxycycline concentrations caused 
by  and  carry-over levels in the feed on the selection of a doxycy-
cline resistant porcine commensal E. coli strain and on the transfer of 
its resistance plasmid in an ex vivo model simulating the microbiota 
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1 ABSTRACT  
Background: Cross-contamination of feed with low concentrations of 
antimicrobials can occur at production, transport and/or farm level. Con-
cerns are rising about possible effects of this contaminated feed on re-
sistance selection in the intestinal microbiota. erefore, an experiment 
with pigs was set up, in which intestinal and faecal concentrations of chlor-
tetracycline (CTC), doxycycline (DOX) and sulphadiazine-trimethoprim 
(SDZ-TRIM) were determined aer administration of feed containing a 
 carry-over level of these antimicrobials.  
Results: e poor oral bioavailability of tetracyclines resulted in rather 
high concentrations in caecal and colonic content and faeces at steady-
state conditions. A mean concentration of  mg/kg CTC and  mg/kg 
DOX in the faeces was reached, which is higher than concentrations that 
were shown to cause resistance selection. On the other hand, lower mean 
levels of SDZ (. mg/kg) and TRIM (< limit of detection of . mg/kg) 
were found in the faeces, corresponding with the high oral bioavailability 
of SDZ and TRIM in pigs.  
Conclusions: e relation between the oral bioavailability and intesti-
nal concentrations of the tested antimicrobials, may be of help in assessing 
the risks of cross-contaminated feed. However, future research is needed 
to confirm our results and to evaluate the effects of these detected concen-





Group administration of veterinary drugs through feed and drinking water 
is frequently applied in the pig industry. Antimicrobials are oen admin-
istered to pigs by mixing the feed with an oral powder or premix formula-
tion (BelvetSAC , Callens et al. , EMA ). e important role 
of group administration of antimicrobials in the selection of resistant bac-
teria is generally recognized (FASFC ). Concerns about antimicrobial 
resistance selection have already led to the prohibition of use of antimicro-
bials as growth promoters in Europe since  (EP ). However, 
group medication is still used extensively in many countries for prophy-
lactic, metaphylactic and therapeutic purposes (Callens et al. ). Major 
disadvantages of group medication are the poor control over dosage due 
to differences in feed uptake between sick and healthy animals, inflexible 
therapy duration for medicated feed, the risk of carry-over and the inevi-
table contamination of the environment with antimicrobials (FASFC 
). Different types of antimicrobial formulations can be used to treat 
animals in group. Premixes (.), oral powders (.) and solutions 
(.) each accounted for a significant share of the total amount of sold 
antimicrobials in  European countries in  (EMA ). However, the 
types of antimicrobial formulations used for group treatment vary consid-
erably between the individual countries. In some countries, such as Ger-
many, Luxembourg, Estonia and Denmark, it seems that oral powders and 
solutions are preferred over premix formulations, whereas the opposite ap-
plies for countries like Spain, Portugal, Hungary, Cyprus and the UK 
(EMA ). In Belgium, both oral powders (, for feed and drinking 
water) and premixes () are used frequently (BelvetSAC , EMA 
). In this study we focus on medicated feed produced in feed mills, and 
thus on premix formulations. 
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Carry-over of feed additives and veterinary drugs from a compound feed 
to a non-target feed is a problem inherent to the production of compound 
feed in feed mills and the transport, storage and delivery of these feeds 
(Borras et al. , Stolker et al. ). A batch of non-target feed that is 
produced directly aer a compound feed, is generally called ‘flushing feed’. 
So far, only coccidiostats and histomonostats are included in the European 
legislation regarding maximum allowed levels () in flushing feeds (EP 
). In Belgium, a covenant was established in  between the Belgian 
Federal Agency for the Safety of the Food Chain (FASFC) and the Belgian 
Feed Association (BFA) (BFA and FASFC ), in which guidelines for 
maximum levels of carry-over were set for antimicrobials ( of the min. 
approved dose, except . for some formulations in rabbit pellet feed), 
paracetamol () and anthelmintics (- of the max. approved dose, de-
pending on the type of feed). Moreover, due to additional technical re-
quirements for feed mills established in this covenant, namely adding the 
drugs or additives at the end of the production line instead of the middle, 
carry-over should be reduced significantly in Belgian feed mills. Unfortu-
nately, carry-over between different feed batches occurs not only in feed 
mills, but also during transport and at farm level, which makes it a difficult 
issue to control (McEvoy ). A study by Putier et al. (), investigat-
ing carry-over at transport level, indicated that this route should not be 
underestimated. In this study, two types of carry-over (inter-bin and intra-
bin) of antimicrobials (oxytetracycline and chlortetracycline) were meas-
ured in ten different types of delivery trucks. Inter-bin carry-over of the 
two antimicrobials ranged from . to . and intra-bin carry-over 
ranged from  to .. Carry-over at farm level remains to be elucidated 
but could be of great importance, especially in countries with a focus on 
use of oral powders and solutions as these products are mixed with feed or 
water at the farm (EMA ). 
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As a result of cross-contamination of feed, the intestinal microbiota of pigs 
can be exposed to unintended, low concentrations of antimicrobials 
(Zuidema et al. ). It is known that low antimicrobial concentrations 
can evoke selection of resistant bacteria in vitro (Gullberg et al. , 
Gullberg et al. ) and in vivo (Brewer et al. ). Moreover, in vitro 
studies with tetracycline, trimethoprim, streptomycin, erythromycin and 
ciprofloxacin show that the fitness cost for resistance-conferring muta-
tions or genes selected at sub-MIC concentrations is oen lower than for 
those selected above the MIC (Gullberg et al. , Gullberg et al. ). 
erefore, these sub-MIC selected mutants would be more stable in bacte-
rial populations and thus potentially more problematic than mutants se-
lected above the MIC (Andersson et al. , Liu et al. , Sandegren 
). 
In order to assess the true effect of cross-contaminated feed on re-
sistance selection in the intestinal microbiota, it is necessary to first deter-
mine the intestinal concentrations of antimicrobials aer administration 
of such feed. Indeed, each type of antimicrobial has different PK properties 
that determine the fraction of the orally ingested antimicrobial that re-
mains in the intestines or is excreted in the bile (Olofsson et al. ). e 
oral bioavailability is a measure of the rate and extent of a drug reaching 
the systemic circulation in its unchanged form through intestinal absorp-
tion (Hu et al. ). As such, this PK property has a significant impact on 
the fraction of drug that remains in the intestinal content. e oral bioa-
vailability is strongly dependent on the active substance and may be influ-
enced among others by the formulation type and prandial state of the ani-
mal. In this study, an in vivo experiment with pigs was set up to determine 
concentrations in the intestinal content and the faeces of chlortetracycline 
(CTC), doxycycline (DOX) and sulphadiazine-trimethoprim (SDZ-
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TRIM) when administering feed that contains  of the maximum recom-
mended dose. is percentage was chosen considering the only legally ap-
plicable guideline in Belgium regarding maximum carry-over levels at the 
time of the experiment () (EP ). e choice of antimicrobials was 
based on two aspects. First, tetracyclines and sulphonamides are among 
the most used classes of antimicrobials in Belgium when considering oral 
administration (). Second, the oral bioavailability in pigs was taken 
into account. SDZ, typically used in a combined formulation with TRIM 
because of the synergistic mode of action, has a very high oral bioavailabil-
ity in pigs, namely - (Baert et al. , Nielsen et al. ). e same 
applies to TRIM (-) (Baert et al. , Nielsen et al. ). In con-
trast, tetracyclines have a low oral bioavailability in pigs, with CTC even 
lower () than DOX (-) (Baert et al. , Nielsen et al. , 
Sanders et al. ). 
In the past, studies have been performed to examine levels of antimi-
crobials and other drugs in tissues and eggs when poultry is fed with cross-
contaminated feed (Segato et al. , Vandenberge et al. a, 
Vandenberge et al. b). Yet no data have been published regarding in-
testinal concentrations due to cross-contamination in pigs or other live-
stock. e aim of this study was therefore to determine intestinal concen-
trations in pigs of CTC, DOX and SDZ-TRIM, when they were fed a diet 




3 MATERIALS AND METHODS 
3.1 PREMIXES, REAGENTS AND STANDARDS 
e premixes used for the preparation of the experimental diets were Dox-
yprex® (active pharmaceutical ingredient, API:  mg DOX hyclate/g pre-
mix), provided by Kela Veterinaria (Sint-Niklaas, Belgium), Aurofac® (API: 
 mg CTC.HCl/g premix) and Tucoprim® (API:  mg SDZ/g premix 
and  mg TRIM/g premix), both provided by Zoetis (Brussels, Belgium). 
Analytical standards of DOX (doxycycline hyclate), CTC (chlortetracy-
cline.HCl), SDZ and TRIM were obtained from Sigma-Aldrich (Bornem, 
Belgium). e internal standards (IS) were demethylchlortetracycline.HCl 
(DMCTC, Sigma-Aldrich) and C-sulphadimethoxine and d-trime-
thoprim, both from Witega (Berlin, Germany). Methanol (CHOH) and 
acetonitrile (CHCN) were of LC-MS (liquid chromatography – mass spec-
trometry) grade and obtained from Biosolve (Valkenswaard, e Nether-
lands). Water was of LC-MS grade and was obtained from Biosolve 
(Valkenswaard, e Netherlands) for tetracycline analysis, and was gener-
ated from a Milli Q gradient purification system (Millipore, Billerica, MA, 
U.S.) for SDZ and TRIM analysis. Acetic acid (CHCOOH, >.) was 
from Sigma Aldrich, succinic acid (CHO) from VWR (Leuven, Belgium) 
and sodium sulphate (NaSO), formic acid (HCOOH), trichloroacetic 
acid (CClCOOH) and sodium hydroxide (NaOH) were from Merck 
(Darmstadt, Germany). 
3.2 PREPARATION OF STANDARD SOLUTIONS 
Standard stock solutions of CTC, DOX and the IS DMCTC were prepared 
in CHOH at a concentration of  mg/ml and stored at ≤ - °C. Working 
solutions of DMCTC at a concentration of  µg/ml and  µg/ml, and of 
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CTC and DOX at a concentration of  µg/ml were prepared by appro-
priate dilution with water. Standard stock solutions of SDZ and the IS C-
sulphadimethoxine were prepared in CHCN/water (/, V/V) at a con-
centration of  mg/ml and stored at ≤ - °C. Standard stock solutions of 
TRIM and the IS d-trimethoprim were prepared in CHOH and stored at 
≤ - °C. For C-sulphadimethoxine and d-trimethoprim, working solu-
tions of  µg/ml were prepared in water making use of an intermediate 
working solution of  µg/ml in CHCN/water (/, V/V). SDZ and 
TRIM working solutions of  µg/ml,  µg/ml and . µg/ml were prepared 
in water and used for spiking the calibration samples. To prepare sodium 
succinate . M, . g of CHO was dissolved in  ml of water,  M 
NaOH was added until pH . was reached, and water was added to obtain 
a final volume of . ml. e solution was stored at . °C. Solutions of 
HCOOH (.), CClCOOH () and CHCOOH (.) were prepared 
by appropriate dilutions with water.  
3.3 PREPARATION OF THE EXPERIMENTAL FEED 
ree different batches of experimental diets were prepared. Blank feed 
(meal n° , AVEVE, Merksem, Belgium) was mixed with the DOX, CTC 
and SDZ-TRIM premixes, respectively. A custom made mixing device (Si-
lobouw, Zulte, Belgium) was kindly provided by the Food Science and 
Technology Unit of Ghent University. e added amounts of antimicrobi-
als were calculated to yield cross-contamination levels in the feed corre-
sponding to  of the maximum recommended dose, MRD (CTC, . 
mg/kg BW (body weight)/day; DOX, . mg/kg BW/day; SDZ, . mg/kg 
BW/day; TRIM, . mg/kg BW/day). BW and daily feed intake were set at 
 kg and . kg respectively. us, a target concentration of . mg 
CTC/kg feed, . mg DOX/kg feed, . mg SDZ/kg feed and . mg 
TRIM/kg feed was aimed for. Each premix was first mixed manually with 
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 kg of blank feed, which was then mixed with the remaining blank feed 
( kg) in the feed mixer for  min. e feed was collected from the mixer 
in  bags, each containing  kg. One sample of approximately  g was 
taken from bag n° , , , , , , , ,  and  of each experimental feed to 
assess if the target concentration was achieved and to determine the ho-
mogeneity. In this way, samples were collected at the beginning, middle 
and at the end of the mixing stream, in order to monitor the whole mixing 
cycle. e samples were kept at room temperature (tR, - °C) until anal-
ysis (within a time frame of  weeks). 
3.4 ANIMAL EXPERIMENT 
Twenty-four pigs with an average BW of . ± . kg were randomly di-
vided into  equal groups ( males and  females/group): one control group 
and three experimental groups (Figure a). Each group was housed in a 
strictly separated (no airborne contact)  by  meter pen with a concrete 
floor and natural light cycle. e temperature varied between  °C and  
°C. e floor was cleaned with water every day just before sample collec-
tion. Ad libitum access to drinking water and feed was provided through-
out the experiment. Aer a one-week acclimatization period, each experi-
mental group received during ten days experimental feed containing  
cross-contamination levels of either CTC, DOX or SDZ-TRIM. e con-
trol group received blank feed (no antimicrobials). Individual faecal sam-
ples were taken by rectal stimulation, just before the start of providing the 
experimental diets and at day , , ,  and  of the experimental feeding 
period (Figure b). In case no individual sample could be obtained (which 
was the case for in total  time points from  pigs), fresh faecal samples 
were collected from the cleaned floor. On day , all animals were eu-
thanized through a combined intramuscular injection of xylazine (. 
mg/kg BW), zolazepam and tiletamine (both . mg/kg BW) followed by 
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an intracardial injection of . ml/kg BW of T® (MSD, Brussels, Belgium). 
Immediately aer euthanasia, samples of caecal content and colonic con-
tent from different sampling segments [proximal colon ascendens (PCA), 
distal colon ascendens (DCA), colon descendens (CD)] were taken from 






Figure . Experimental setup of the animal experiment. (A) Grouping of the 
animals. (B) Chronological scheme of the experiment. 
  B 
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3.5 QUANTITATION OF ANTIMICROBIALS IN FEED AND FAECES 
In-house developed methods were applied for both analysis of tetracy-
clines (Cherlet et al. , Cherlet et al. ) and SDZ-TRIM 
(Vandenberge et al. a, Vandenberge et al. b). 
a) Tetracyclines analysis 
Twenty-five ml of CHOH were added to . g of each feed sample. Aer 
 min of shaking on an in-house rotary shaker, samples were centrifuged 
( g,  min,  °C). Two-hundred µl of supernatant were transferred 
into an Eppendorf tube and  µl of CHOH were added. Aer adding  
µl of IS ( µg/ml), samples were vortex mixed. Next, the samples were 
filtered through a polyvinylidene fluoride membrane (PVDF, . µm Mil-
lex-GV, Millipore, Overijse, Belgium) and transferred to an autosampler 
vial and  µl was injected onto the liquid chromatography – tandem mass 
spectrometry (LC-MS/MS) instrument. 
To . g of intestinal content or faeces,  µl of IS ( µg/ml) were 
added. Aer vortex mixing ( s), . ml of sodium succinate solution (. 
M) were added and the samples were again vortex mixed ( s). Samples 
were then shaken ( min, in-house rotary shaker) and centrifuged ( 
g,  min,  °C). e supernatant was transferred to a new plastic tube and 
vortex mixed ( s) aer adding . ml of  CClCOOH. ese tubes 
were centrifuged again ( g,  min,  °C) and the samples were filtered 
through a Whatman filter (Whatman n°, VWR, Leuven). is filtrate 
was used for further solid-phase clean-up. Aer preconditioning an 
OASIS® HLB (hydrophilic-lipophilic balance)  mg/ ml solid phase ex-
traction column (Waters, Milford, MA, U.S.) with consecutively  ml of 
CHOH,  ml of HCl ( M) and  ml of HPLC (high-performance liquid 
chromatography) water, the filtrate was poured onto the HLB column. e 
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column was then washed with  ml of water and dried. e analytes were 
eluted with  ml of CHOH. e eluate was passed through a PVDF filter, 
transferred to an autosampler vial and  µl was injected onto the LC-
MS/MS instrument. 
e LC system consisted of an Acquity autosampler and an Acquity 
binary solvent manager from Waters (Milford, U.S.). Chromatographic 
separation was achieved on an Acquity UPLC (ultra performance liquid 
chromatography) BEH C column ( mm x . mm i.d., . µm) from 
Waters. e temperatures of the autosampler tray and column oven were 
set at  °C and  °C, respectively. Mobile phase A consisted of CHCN 
whereas mobile phase B was . HCOOH in water. Flow rate was set at 
. ml/min and the following elution program was run: -. min ( A), 
.-. min (linear gradient to  A), .-. ( A), .-. (linear gra-
dient to  A), .-. min ( A). e detection was performed with a 
Quattro Premier XE triple quadrupole mass spectrometer, equipped with 
an electrospray ionization (ESI) probe operating in the positive ionization 
mode (Waters). Masslynx soware v . was used to quantitate, based on 
the following MS-MS transitions: m/z . > . (CTC) and m/z 
. > . (DOX). 
b) Sulphadiazine-trimethoprim analysis 
Aer homogenization of the feed sample, . g of feed was weighed and  
µl of each IS ( mg/ml) and  ml of CHOH were added. e sample was 
vortex mixed, shaken on a horizontal shaker (Edmund Bühler, Hechingen, 
Germany) during  min, and centrifuged ( g,  min, tR). Five ml of 
the supernatant were evaporated to dryness at  ±  °C under nitrogen. 
e sample was redissolved in  ml of CHCN/water (/ V/V), vortex 
mixed ( s), diluted to / in CHCN/water (/, V/V), vortex mixed 
( s) and transferred to an autosampler vial. 
CHAPTER 3 
102 
For intestinal content or faeces analysis, . g of sample was weighed aer 
homogenization and  µl of each IS ( µg/ml) were added. e sample was 
carefully mixed with  g of NaSO with a spatula to obtain a dry mixture. 
If necessary, extra NaSO was added until the sample was dry. Aer add-
ing  ml of CHCN, the sample was vortex mixed, shaken during  min 
(horizontal shaker, Edmund Bühler) and centrifuged ( min,  g, tR). 
Five ml of the supernatant were then transferred into a glass tube and evap-
orated to dryness under nitrogen in a water bath of  °C. Next, the sample 
was redissolved in  ml of an CHCN/water mixture (/, V/V) contain-
ing . CHCOOH in water, vortex mixed ( s), sonicated ( min), and 
filtered through a PVDF filter into an autosampler vial. 
Chromatographic separation was performed on a Waters Acquity 
UPLC system. An Acquity UPLC BEH C column ( mm x . mm i.d., 
. µm) was used and the analysis was performed with a gradient of wa-
ter/CHCN (/, V/V) + . CHCOOH (mobile phase A) and wa-
ter/CHCN (/, V/V) + . CHCOOH (mobile phase B). e following 
elution program was run: - min ( A), - min ( A), - min 
( A), -. min (linear gradient to  A), .-. min ( A). 
Flow rate was set at . ml/min. A Xevo TQ-MS triple quadrupole mass 
spectrometer with an ESI (electrospray ionisation) probe operating in the 
positive ionization mode was used. Quantitation was done with Masslynx 
soware v .. MS-MS transitions for SDZ were: m/z . > ./. 
and for TRIM: m/z . > ./.. e detected ion ratio’s for the 
different samples were within the permitted tolerances specified in Com-
mission Decision //EC (EC ).  
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3.6 METHOD VALIDATION 
e methods were validated for feed and faeces according to a set of pa-
rameters that were in compliance with the recommendations and guide-
lines defined by the European Community (EC ) and international 
standards for validation of analytical methods in residue depletion studies. 
e following set of parameters was determined: limit of detection (LOD, 
n=), limit of quantification (LOQ, n=), linearity (R and goodness-of-fit 
coefficient (g)), precision (repeatability, RSDr (n=), and reproducibility, 
RSDR (n=), RSD = relative standard deviation) and trueness (n=). Vali-
dation samples were prepared with blank feed from the same batch as the 
feed that was administered during the experiment and blank faeces were 
obtained from pigs that were not treated with antimicrobial drugs. 
3.7 STATISTICAL ANALYSIS 
Aer determination of normality and homogeneity of variances, one-way 
analysis of variance (ANOVA) (SPSS , IBM, Chicago, IL, U.S.) was per-
formed for each antimicrobial on the concentrations from the four differ-
ent intestinal segments. A Scheffé test was performed as post-hoc test. e 





4.1 METHOD VALIDATION 
e results of the method validation are given in supplementary Table S. 
All values, except for the trueness in case of SDZ in feed, were within the 
acceptance ranges according to Commission Decision //EC.  
4.2 CONCENTRATIONS IN EXPERIMENTAL FEED 
Ten samples of each batch of experimental feed were analyzed to assess if 
the target concentrations ( of the MRD) were achieved. Mean concen-
trations ± standard deviation (SD) in the feed were . ± . mg/kg (= 
. of MRD) for DOX, . ± . mg/kg (= . of MRD) for CTC, 
. ± . mg/kg (= . of MRD) for SDZ and . ± . mg/kg (= 
. of MRD) for TRIM. In all experimental diets, there was a high vari-
ation between sample concentrations. 
4.3 CONCENTRATIONS IN FAECES 
e mean (+ SD) concentrations of CTC, DOX and SDZ in the faeces are 
shown in Figure . A steady-state was reached around day  for CTC (± 
 mg/kg), DOX (±  mg/kg) and SDZ (± . mg/kg). Concentrations of 
TRIM were very low; all results except two were lower than the LOD of 
. mg/kg. No traces of antimicrobials were found in the faecal samples 
taken on day , just before the start of the experimental period.  
 Transfer ratio’s (TR), i.e. the mean concentration in faeces taken over 
day  – day  of the experimental period, and divided by the mean con-
centration in feed, were ., . and . for CTC, DOX and SDZ, 
respectively (Table , p. ). 
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Figure . Mean concentrations (mean of six pigs + standard deviation) of 
chlortetracycline (CTC), doxycycline (DOX) and sulphadiazine (SDZ) in 
pig faeces during  days of ad libitum feeding with feed containing  
cross-contamination levels of these antimicrobials. For CTC, concentra-
tions rose from . mg/kg to a steady-state of approximately  mg/kg. 
Mean concentrations of DOX rose from . mg/kg to a steady-state of ap-
proximately  mg/kg. Mean concentrations of SDZ rose from . mg/kg 
to a steady-state of approximately . mg/kg. 
 
4.4 CONCENTRATIONS IN CAECAL AND COLONIC CONTENT 
CTC, DOX and SDZ concentrations in caecal content and contents of dif-
ferent segments of the colon aer  days of feeding are presented in Fig-
ure . Min/max/mean concentrations for CTC in the different intestinal 
segments were ././. mg/kg (caecum, CM), ././. mg/kg 
(PCA), ././. mg/kg (DCA) and ././. mg/kg (CD). For 
DOX, these concentrations were ././. mg/kg (CM), ././. 
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mg/kg (PCA), ././. mg/kg (DCA) and ././. mg/kg (CD). 
SDZ concentrations were ././. mg/kg (CM), ././. 
mg/kg (PCA), ././. mg/kg (DCA) and ././. mg/kg 
(CD). All results for TRIM were again lower than the LOD of . mg/kg. 
Concentrations in the CD approached the average faeces concentration 
found for CTC, DOX and SDZ. CTC concentrations found in the CD 
proved to be significantly higher compared to concentrations in the DCA 
and the CM, but not compared to the PCA. DOX levels in the CM were 
significantly lower than in the PCA and CD. SDZ levels in the DCA were 
significantly higher than in the PCA. e TR’s, i.e. the mean concentration 
in CM, PCA, DCA or CD divided by the mean concentration in the feed, 










Figure  (right). Concentrations of A) chlortetracycline (CTC), B) doxycycline (DOX) 
and C) sulphadiazine (SDZ) in caecal content and colonic content from three dif-
ferent sampling segments ( indepentent observations per sampling segment). 
Samples were taken from  pigs per group aer  days of ad libitum feeding with 
feed containing  cross-contamination levels of CTC, DOX and SDZ. Mean con-
centrations in caecum (CM), proximal colon ascendens (PCA), distal colon as-
cendens (DCA) and colon descendens (CD) were ., ., . and . mg/kg 
(CTC), ., ., . and . mg/kg (DOX) and ., ., . and . mg/kg 
(SDZ), respectively. e two outlying values for CTC (observation  and ) belong 
to one animal. A different letter (a or b) denotes a significant difference in concen-
tration between sampling segments (p < .). 








Table . Oral bioavailability (F) compared to transfer ratio’s (TR) of chlortetra-
cycline (CTC), doxycycline (DOX) and sulphadiazine (SDZ) 
Antimicrobial F TR 
CM PCA DCA CD faeces 
CTC  a . . . . . 
DOX - b . . . . . 
SDZ - c . . . . . 
TR’s are calculated by dividing the mean concentration ( pigs) in the content of an 
intestinal segment (caecum, CM; proximal colon ascendens, PCA; distal colon as-
cendens, DCA; colon descendens, CD) aer  days of feeding by the mean concen-
tration in the feed. e mean concentration in the faeces was taken over day  - day 
 (steady-state). 
a Nielsen et al,. . 
b Baert et al., , Sanders et al. . 
c Baert et al., ; Nielsen et al., . 
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5 DISCUSSION 
e aim of this study was to determine which concentrations of CTC, 
DOX, SDZ and TRIM could be found in intestinal content and faeces of 
pigs when feed containing a  carry-over concentration was adminis-
tered. 
In each experimental diet the target concentration of  of the MRD 
was approached (. – .). Although the best possible sampling pro-
cedure (Borras et al. ) was applied, a large variation between the sam-
ples was found. Adequate mixing of the premixes depends on multiple fac-
tors, including physico-chemical properties such as particle size and elec-
trostatic properties of the premix. Other factors that influence 
homogeneity are the composition of the final feed, type of mixing machin-
ery, mixing in stages or trituration and precision and size of the samples 
taken for analysis (EMEA ). Since very small volumes of premix had 
to be mixed with large amounts of blank feed, it is not surprising that a 
large variability among samples was found. Moreover, studies on cross-
contamination in feed mills show that antimicrobials are not homoge-
nously divided in flushing feed either (Stolker et al. ). In contrast, con-
centrations found in intestinal content and faeces showed a much lower 
variation. 
In case of SDZ-TRIM, concentrations found in faeces and intestinal 
content were very low (SDZ max. . mg/kg, TRIM < LOD). Except for 
two values, all results for TRIM were lower than the LOD. Since the ad-
ministered dose was very low (. mg/kg feed), the reported oral bioavail-
ability for TRIM is high [- (Baert et al. , Nielsen et al. )] and 
elimination occurs through renal excretion, very low intestinal concentra-
tions were indeed expected. On the other hand, quantitative results for 
SDZ were obtained, although the oral bioavailability of SDZ in pigs is even 
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higher than for TRIM. is can be explained by the higher absolute dosage 
of SDZ (. mg/kg feed) compared to TRIM, as both compounds are 
present in a / ratio (SDZ/TRIM) in the used formulation. Interestingly, 
the calculated TR’s from feed to gut of SDZ (.-.) correspond well to 
the high oral bioavailability reported in pigs [- (Baert et al. , 
Nielsen et al. )], i.e. the higher the oral bioavailability the lower resid-
ual concentrations in the gut can be expected unless extensive biliary ex-
cretion or secretion in the gut takes place. 
e concentrations of tetracyclines in faeces and caecal and colonic 
content were found to be relatively high. In general, higher concentrations 
were seen in the distal part of the colon compared to the proximal part and 
the caecum. e main explanation for these observations is probably the 
progressive absorption of water throughout the intestinal tract. As in the 
case of SDZ, the calculated TR’s from feed to gut (CTC .-., DOX 
.-.) correspond well to the reported oral bioavailability in pigs 
[CTC , DOX - (Baert et al. , Nielsen et al. , Sanders et al. 
)]. It has to be taken into account though, that the bioavailability of 
tetracyclines is highly variable, most likely due to presence of feed in the 
gastrointestinal tract. It is known that oral absorption of tetracyclines may 
be reduced in the presence of bivalent ions (Baert et al. , Santos et al. 
). Also, the study design to calculate oral bioavailability’s may vary be-
tween different studies, e.g. the prandial state of the animals. Taking into 
account that our experiment involves feed administration, references re-
garding oral bioavailability in non-fasted pigs in particular were consulted. 
Especially for DOX, the oral bioavailability seems to vary, even within the 
same study between individual animals [.-. (Baert et al. ), -
 (Sanders et al. )]. e intestinal concentrations of DOX in the 
present study correspond best to the oral bioavailability reported in a pre-
vious study that also used a premix formulation [- (Sanders et al. 
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)] when compared to administration of an oral powder [-. 
(Baert et al. )]. Besides oral bioavailability, also the excretion route can 
influence the intestinal concentrations of a drug. SDZ-TRIM and CTC are 
renally excreted whereas up to  of DOX is excreted unchanged in the 
intestinal tract (Ahrens et al. ). It would therefore be expected that the 
transfer ratio (TR) of DOX is higher than based solely on oral bioavailabil-
ity. e large variability in reported oral bioavailabilities for DOX might 
explain the relatively low TR indicating that this TR only serves as a guid-
ance value and depends on several factors.  
e oral bioavailability of a drug is usually determined for its thera-
peutic dose. Given the inverse relation found between the oral bioavaila-
bility and intestinal concentrations of SDZ, CTC and DOX, it is rather 
likely that there is a linear relation between the administered dose and in-
testinal concentrations. is information can be used in the risk assess-
ment of different cross-contamination levels of pig feed regarding poten-
tial resistance selection in the intestinal microbiota. However, this conclu-
sion can only be drawn for the tested antimicrobials and animal species. 
Furthermore, additional experiments should be performed to confirm our 
results - ideally testing a range of antimicrobial concentrations - as there is 
no previous research available to compare. A non-peer reviewed report 
though, estimated intestinal concentrations of CTC to be . mg/kg in 
case of administration of  mg CTC/kg feed. is is clearly lower com-
pared to our results (min .- max . mg/kg CTC in colonic content with 
. mg CTC/kg feed) (Burch ). 
In a recent study, manure samples obtained from different pig, poultry 
and veal calve farms in the Netherlands were examined for the presence of 
antimicrobial residues (Zuidema et al. ). In  out of  of the sampled 
pig farms, residues were detected although no recent use of antimicrobials 
was reported. Tetracyclines were found in  of these farms, with DOX 
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concentrations ranging from  µg/kg to , µg/kg. Sulphonamides were 
detected in  out of  farms, with SDZ concentrations ranging from  
µg/kg to  µg/kg. In light of these data, it is clear that one should not 
focus on the absolute results based on  carry-over levels obtained in this 
study, but rather on the relation found between the oral bioavailability of 
CTC, DOX and SDZ and intestinal concentrations. 
In recent years, more attention has been paid to the possible effects of 
low antimicrobial concentrations on selection of resistant bacteria. Pioneer 
studies revealed important effects of very low concentrations on resistance 
selection in vitro. Gullberg and co-authors performed competition exper-
iments between strains resistant and susceptible to tetracycline and found 
minimal selective concentrations of  ng/ml (competition between iso-
genic - except for the resistance determinant - Salmonella Typhimurium 
strains, Gullberg et al.  and  ng/ml tetracycline (competition between 
isogenic E. coli strains, with or without resistance plasmid pUUH., 
Gullberg et al. ). e minimal selective concentration was in this case 
defined as the concentration where the fitness cost of the resistance is bal-
anced by the antimicrobial-conferred selection for the resistant mutant. 
is would mean that even concentrations of tetracyclines x lower than 
those found in this study can cause resistance selection. Brewer and co-
authors () investigated the effect of  µg/ml of different antimicrobials 
on transfer of resistance genes in vivo in pigs and found that  µg/ml of 
tetracycline and sulphamethazine increased transfer frequency, whereas  
µg/ml of sulphathiazole did not. It is likely that intestinal concentrations 
of  µg/ml of tetracyclines can be found in pigs, considering our results and 
the maximum allowed carry-over level () established in the Belgian cov-
enant (BFA and FASFC ). 
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6 CONCLUSIONS 
is study showed an inverse relation between intestinal concentrations 
and the oral bioavailability for SDZ-TRIM as well as for CTC and DOX, 
which have a high, respectively low oral bioavailability in pigs. As different 
studies (Stolker et al. , Zuidema et al. ) indicate there is a large 
variation in cross-contamination levels of feed, this result can be an im-
portant tool to evaluate possible risks of different contamination levels. 
Further research is needed to determine the effect on resistance selection 
in the intestinal microbiota. Furthermore, it would be interesting to per-
form additional experiments, confirming our results and analysing other 
antimicrobials that are used as premix formulation, such as penicillins, 
macrolides, pleuromutilins and polymyxins (BelvetSAC ). 
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1 ABSTRACT 
Pig feed may contain various levels of antimicrobial residues due to cross-
contamination. A previous study showed that a  carry-over level of DOX 
in the feed results in porcine faecal concentrations of approximately  
mg/l. Resistant bacteria, enriched in the pig’s intestinal microbiota due to 
these residual DOX concentrations, could cycle between different environ-
mental, animal and human reservoirs and transfer their genes to patho-
genic bacteria. 
is study aimed to determine the effect of residual DOX concentra-
tions ( and  mg/l) in vitro on selection of DOX resistant porcine com-
mensal E. coli and transfer of their resistance plasmids. 
ree DOX resistant porcine commensal E. coli strains and their plas-
mids were characterized. ese strains were each brought in competition 
with a susceptible strain in a medium containing ,  and  mg/l of DOX. 
Resistant bacteria, susceptible bacteria and transconjugants were enumer-
ated aer h and h.  
e tet(A) carrying plasmids showed genetic backbones that are also 
present among human E. coli isolates. Ratios of resistant to susceptible bac-
teria were significantly higher at  and  mg/l DOX compared to the blank 
control, but no significant difference between  and  mg/l was seen. Plas-
mid transfer frequencies were affected by  or  mg/l DOX in the medium 
for only one of the resistance plasmids. 
In conclusion, DOX concentrations of  and  mg/l can select for re-
sistant E. coli in vitro. Further research is needed to determine the effect of 






As antimicrobial resistance represents a global threat to human and animal 
health, the understanding of its mechanisms and drivers is of major im-
portance (Holmes et al. ). Conventionally it was assumed that selec-
tion of resistant bacteria is promoted at concentrations between the MIC 
of the susceptible population and the MIC of the resistant population of 
the bacterial species (Drlica ). e past decade however, the possible 
impact of the widely reported presence of antimicrobial residues in differ-
ent environments gained attention (Andersson et al. ). Antimicrobial 
residues may enter the environment through various routes and cross-
contamination of pig feed through spoilage has been shown to be one of 
them (Stolker et al. ). Administration of antimicrobial drugs through 
feed medication is frequently applied in the pig industry (BelVetSAC , 
EMA ). ese medicated feeds may cause cross-contamination of 
non-medicated feed at the feed mill, during transport and/or at farm level 
(Filippitzi et al. , Stolker et al. ). Tetracyclines accounted for the 
most frequently sold veterinary antimicrobials (.) in Europe in  
(EMA ). Furthermore, approximately  of the tetracyclines sold in 
Belgium in  was represented by DOX (BelVetSAC ). In a previous 
in vivo study (Chapter ), the intestinal and faecal concentrations of DOX, 
chlortetracycline and sulphadiazine-trimethoprim, were determined in 
pigs. e animals were administered feed containing  carry-over levels 
of these antimicrobials, based on the maximum allowed carry-over level 
according to the European Commission Directive of  (EP ). In 
, however, a covenant was established in Belgium stating that cross-
contamination with antimicrobials should not exceed  of the recom-
mended dose (BFA and FASFC ). erefore, the results obtained for 
feed with  cross-contamination were in the present study also extrapo- 
IN  VITRO  STUDY 
119 
lated to a  cross-contamination level. e in vivo study showed that es-
pecially tetracyclines, with a low to moderate oral bioavailability in pigs, 
can be found in residual concentrations in caecum and colon (Chapter ). 
ese unintended concentrations possibly exert a selective pressure on tet-
racycline resistant bacteria present in the intestinal microbiota and may 
co-select for other resistance genes carried by these bacteria (Gullberg et 
al. ). Subsequently, pork can become contaminated with bacteria that 
might carry resistance genes against antimicrobials which are used in hu-
man medicine (e.g. β-lactams). Consumption of raw or undercooked meat 
may allow the spread of these bacteria to the human gut, where they could 
transfer their resistance genes to human commensals and pathogens, e.g. 
Salmonella enterica and Escherichia coli O:H (Van Meervenne et al. 
). Also contamination of the environment through faeces or dust 
might result in indirect contact between animals and humans. Hence, the 
frequently applied tetracyclines in pig feed such as DOX may indirectly 
impose a risk for human health. Indeed, very low concentrations of tetra-
cycline and/or oxytetracycline ranging from  to  µg/L have already 
been shown to select for resistant bacteria or genes in vitro (Gullberg et al. 
, Gullberg et al. , Johnson et al. ) and in different environ-
ments such as biofilms (Lundstrom et al. ), arable soils (Shentu et al. 
), and the intestinal microbiota of dairy calves (Pereira et al. ). 
e present study aimed to investigate the selective pressure on DOX 
resistant E. coli of  mg/l and  mg/l of DOX, corresponding with intestinal 
DOX concentrations caused by a cross-contamination level of the feed of 
approximately  and , respectively. Whereas previous research on se-
lective pressure at residual concentrations involved among others compe-
tition experiments between isogenic lab strains (Gullberg et al. , 
Gullberg et al. ), mathematical models (Bengtsson-Palme et al. ), 
or in vivo studies (Johnson et al. , Pereira et al. ), E. coli field strains 
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isolated from pig faeces were preferred as model bacteria for the pig mi-
crobiota in this study. 
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3 MATERIAL AND METHODS 
3.1 BACTERIAL STRAINS 
e E. coli strains used in this study originated from a collection that was 
obtained between  to  for an antimicrobial resistance monitoring 
program of the Belgian Federal Agency for the Safety of the Food Chain 
(Hanon et al. ). ree tetracycline resistant commensal E. coli strains 
(EC , EC , EC ) isolated from pig faeces were selected to be used 
as donor strains in competition experiments. MIC values of these E. coli 
isolates were determined for ampicillin, chloramphenicol, ciprofloxacin, 
colistin, florphenicol, cefotaxime, gentamicin, kanamycin, nalidixic acid, 
sulphamethoxazole, streptomycin, tetracycline and trimethoprim using 
Sensititre micro broth dilution (TREK Diagnostic Systems, West Sussex, 
UK) according to EU Reference Laboratory for antimicrobial resistance 
(EURL-AR ) guidelines. One strain (EC ) showed the most preva-
lent phenotypic resistance profile (Table ). e MIC of DOX for the three 
donor strains was determined by the broth microdilution method accord-
ing to the CLSI document M-A. Presence of common tetracycline re-
sistance genes tet(A), tet(B), tet(C), tet(D) and tet(G) was verified by PCR 
assays (Ng et al. ).  
From the same collection, three E. coli strains (EC , EC , EC 
) susceptible to all antimicrobials tested, were selected as recipient 
strains and to compete with the donor strains. 
As bacterial fitness plays a major role in competition between strains, 
bacterial growth curves were set up for each strain separately, in three dif-
ferent conditions (,  and  mg/l DOX), using an automated microbiology 
growth curve analysis system (Infinite Pro, Tecan Group Ltd., Männe-
dorf, Switzerland). Briefly, in each well of a -well plate,  µL of an over- 
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night bacterial culture in Miller’s LB broth (LB) of approximately  col-
ony forming units (CFU)/ml was added to  µL of LB with a final con-
centration of ,  or  mg/l DOX, respectively. e plate was incubated at 
°C during h and every  min OD (optical density at wavelength 
nm) was measured. Each curve was done in triplicate. e growth rate 
was calculated manually as described by Hall et al (Hall et al. ). 
3.2 CONJUGATION EXPERIMENTS AND PLASMID ANALYSIS 
e mobility of the DOX resistance conferring plasmids (DOXR plasmids) 
in the selected donor strains was first verified under blank standard condi-
tions with as acceptor a rifampicin (RIF) resistant E. coli lab strain (JRIF) 
(Bertrand et al. ). Conjugation experiments were performed over-
night in LB at °C with a donor/recipient ratio of :. Transconjugants 
were grown selectively on MacConkey n° agar (MC, Oxoid Ltd, Basing-
stoke, UK) with filter sterilized solutions of  mg/l DOX and  mg/l RIF 
(both from Sigma-Aldrich, Bornem, Belgium).  
A disk diffusion test  was performed in triplicate on each transconju-
gant to verify if co-transfer of resistance determinants occurred. Genomic 
DNA from the E. coli J transconjugants obtained by a standard boiling 
method was used to define the Incompatibility group of the DOXR plas-
mids (Carattoli et al. ). 
e three susceptible strains were checked for the presence of repli-
cons of the same type as the donor plasmids using the same method as 
described above. Subsequently, standard conjugation experiments for each 
donor strain were conducted to confirm if the three mobile plasmids could 
be transferred to the susceptible strains. 
Finally, DNA from the DOXR plasmids, extracted with a Qiagen (Ant-
werp, Belgium) plasmid midi kit (manufacturer’s protocol), was checked 
for purity by gel electrophoresis and sent to Baseclear B.V. for sequencing 
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purposes (Leiden, e Netherlands). Briefly, Illumina genomic Nextera XT 
library preparation was followed by Illumina HiSeq  sequencing. 
FASTQ sequences were trimmed and assembled using CLC Genomics 
Workbench version .. e scaffolds were annotated using Prokka 
(Seemann ). Similar nucleotide sequences were identified using 
BLAST analysis (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Nucleotide se-
quences were visualized using the BLAST Ring Image Generator (BRIG) 
(Alikhan et al. ). 
e plasmid nucleotide sequences were deposited in the EMBL-EBI 
database under accession numbers FMWN (pEC), 
FNLP (pEC) and FNLQ (pEC). 
3.3 COMPETITION EXPERIMENTS 
Two types of competition experiments were carried out. Experiment type 
 was performed with recipient strains EC  (non-conjugating strain) 
and EC  (conjugating strain). Experiment type  was carried out with 
conjugating recipient strains EC  and EC . One experiment each 
time involved one recipient strain that was brought in competition with 
each of the donor strains separately. Each experiment was repeated four 
times. e experimental setup is shown in Figure . 
To be able to distinguish donor strains from recipient strains in mixed 
cultures, non-lactose fermenting mutants of the donor strains were se-
lected (Smet et al. ). ese mutants form white colonies on MC, while 
natural, lactose-fermenting E. coli form red colonies Figure . 
 Experiment type  was conducted as follows. e three donor strains 
and one of the recipient strains were separately grown overnight in LB 
broth at °C on a horizontal shaker (IKA KS  basic, IKA-Werke GmbH 
& Co. KG, Staufen, Germany) and then mixed in a / ratio (donor/re-






Figure 22. Setup of the competition experiments. DOX, doxycycline, LB, Luria 
Bertani; MC, MacConkey n°3 agar; RIF, rifampicin 
 
 
   
 
Figure 23. Morphology of lactose fermenting (Lac +) and non-lactose ferment-
ing (Lac -) E. coli on MacConkey n°3 agar.  
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a final concentration of ,  and  mg/l DOX, respectively. ese cultures 
were incubated at °C during h on a horizontal shaker. Aer h and 
h of incubation,  ml was taken from each tube and appropriate dilutions 
were plated in duplicate or triplicate on MC with and without  mg/l DOX 
and incubated overnight at °C. e donor strain was enumerated by 
counting white colonies on MC+DOX plates and the total number of re-
cipient bacteria was counted on MC (red colonies).  
Experiment type  was designed to be able to enumerate transconju-
gants, and thus to calculate the transfer frequency of the plasmids and to 
count the total of resistant bacteria (donor + transconjugants) and suscep-
tible bacteria (total recipients – transconjugants). Enumeration of trans-
conjugants was made possible by using RIF resistant mutants (EC RIF 
and EC RIF) of the conjugating recipient strains. e mutants were se-
lected by consecutive plating on MC plates with RIF gradient (- mg/l) 
and MC plates containing  mg/l RIF,  mg/l RIF and finally  mg/l 
RIF. Preparation of the competition cultures was done as in experiment 
type . Appropriate tenfold dilutions were now plated on MC with DOX ( 
mg/l) to count the donor strain, with RIF ( mg/l) to count the recipient 
(total count) and with DOX ( mg/l) + RIF ( mg/l) to count transconju-
gants (DOX resistant recipient). e transfer frequency of the plasmids 
was calculated by dividing the number of transconjugants (CFU/ml) by the 
total number of recipients (CFU/ml). 
e stability of DOX in LB at both  and  mg/l during h at °C was 
verified using LC-MS/MS. Samples of LB ( ml) with or without DOX 
and with or without bacterial culture (EC ) were taken aer , , , , , 
, , , , ,  and  hours of incubation and stored at -°C. For the 
sample preparation, a  µL aliquot of the medium sample was spiked with 
 µL of the internal standard demethylchlortetracycline ( µg/ml, Sigma 
Aldrich, Bornem, Belgium) and vortexed. Aerwards, the samples were  
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times diluted in . formic acid in water and transferred to an au-
tosampler vial. e LC-MS/MS analysis was performed with a method de-
scribed by Vandenberge and co-authors (a). 
3.4 STATISTICAL ANALYSIS 
Aer determination of homogeneity of the results, a linear mixed model 
was used to assess the effect of medium, resistant donor strain, susceptible 
recipient strain and time on the resistant/susceptible ratio (R/S) and trans-
fer frequency (SPSS , IBM, Chicago, IL, U.S.).  
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4 RESULTS 
4.1 CHARACTERIZATION OF BACTERIAL STRAINS 
e characteristics of the lactose negative mutants of DOX resistant por-
cine E. coli strains EC , EC  and EC  are shown in  Table . e 
same characterization (+ growth curve analysis) was done for the original 
lactose fermenting strains (data not shown) but no differences with the lac-
tose negative mutants were observed. e MIC’s of DOX for susceptible 
strains EC , EC , EC RIF, EC  and EC RIF were , , ., 
 and  mg/l respectively. e growth curves and growth rates of all strains 
are given in Figure . In the absence of DOX, EC RIF showed a lower 
growth rate than EC . In contrast, EC  and EC RIF showed more 
similar growth rates. erefore, only EC RIF was included in the com-
petition experiments. Growth rates of resistant strains EC  and EC  
were hardly affected by  or  mg/l DOX, while  mg/l DOX reduced the 
growth rate of EC  by . min- (Figure ). All susceptible strains 
showed a lower growth rate at  and  mg/l DOX than at  mg/l DOX. 
Table . Characteristics of the doxycycline resistant E. coli strains (lactose nega-
tive mutants) that were used as donor strains in the competition experiments 
Strain  
n° 














EC  AMP-SMX-STR-TET-TMP 
(.) 
AMP-SMX-STR-TET-TMP  mg/l tet (A) IncI 
EC  AMP-CHL-STR-TET 
(.) 
CHL-STR-TET  mg/l tet (A) IncFII 
EC  CHL-SMX-STR-TET-TMP 
() 
CHL-SMX-STR-TET-TMP  mg/l tet (A) IncFII-FIB 
AMP, ampicillin; SMX, sulphonamides; STR, streptomycin; TET, tetracycline (and doxycycline); TMP, trimethoprim; 
CHL, chloramphenicol. The prevalences of the phenotypic resistance profiles in the - collection of porcine 




Figure . Growth curves of non-lactose fermenting mutants of doxycycline re-
sistant E. coli EC , EC  and EC , susceptible E. coli EC , EC 
 and EC  and rifampicin resistant mutants EC RIF and EC 
RIF.  
In each well of a -well plate,  µL of an overnight bacterial culture in 
Miller’s LB broth (LB) of approximately  colony forming units (cfu)/mL 
was added to  µL of LB with a final concentration of ,  or  mg/L 
DOX, respectively. e plate was incubated at °C in an automated micro-
biology growth curve analysis system (Infinite Pro, Tecan Group Ltd., 
Männedorf, Switzerland) during h and every  min OD was measured. 




 Each graph compares the growth of a strain in blank LB broth and LB with 
 and  mg/L doxycycline, incubated at °C during h (mean values of 
triplicates). e y-axis represents ln transformed OD values and the x-
axis shows the incubation time (hours). e growth rates (µ, min-) were 
calculated manually according to Hall et al. and are given in the figure leg-
ends. e growth curves of the resistant strains EC , EC  and EC  
represent the lactose negative mutants of these strains. Growth curves of 
the original lactose fermenting strains were also performed but are not 
shown. ese growth curves did not differ from the growth curves of the 
lactose negative mutants. 
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4.2 GENETIC MAPPING OF TET(A)-CARRYING PLASMIDS  
Replicon typing showed that plasmids pEC, pEC and pEC be-
longed to the IncI, IncFII, and the IncFII-FIB group, respectively. Plasmid 
sequencing of pEC revealed that the tet(A) gene (Figure ) was flanked 
by tetR and located on a transposon (Tn), together with mercury re-
sistance genes. e co-transfer of four other resistance determinants to-
gether with the tetracycline resistance (Table ) was confirmed by the pres-
ence of the corresponding resistance genes on pEC: the blaTEM- gene 
encoding resistance to narrow-spectrum β-lactamases was located on a 
second transposon (Tn) close to an integron class  that carried genes con-
ferring resistance to sulphonamides (sul), streptomycin (strA and strB) 
and trimethoprim (dr) and a multidrug efflux pump coding gene 
(emrE). BLAST analysis showed that this plasmid shared nucleotide se-
quence identity with three other plasmids previously described from 
chicken caeca (pE., accession number CP) (Brouwer et al. ), 
human faeces (FHI, accession number LM) and pig faeces 
(PND_, accession number HQ) (Johnson et al. ). 
Comparison of nucleotide sequences of pEC and pEC revealed 
that they shared the same backbone (Figure ). e tet(A) gene of pEC 
was flanked by tetR and located on a Tn transposon that also carried genes 
conferring resistance to streptomycin, chloramphenicol and trimethoprim 
(ant_ and ant_, drug transporter of bcr/CflA subfamily, dfrA, respec-
tively). is explains the co-transfer of these resistances (Table ). Addi-
tionally, the transposon carried metal resistance coding genes and a multi-
drug efflux pump encoding gene. For plasmid pEC, the direct environ-
ment of tet(A) was identical to that of pEC. Both pEC and pEC 
shared their backbone sequence with a plasmid from a previously described 
human E. coli isolate (accession number KJ) (Wang et al. ). 
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All susceptible strains, except for EC  that carried an IncFIB plasmid, 
were negative for plasmids of the same Inc group as plasmids pEC, 




Figure . Partial nucleotide sequence of plasmid pEC (yellow) compared 
with sequences of plasmids FHI (dark blue, of human origin), pND_ 
(light blue, of porcine origin) and pE (red, of poultry origin). Relevant 
genes are indicated as black arrows. e tet(A) gene and the transposon 
were it is located on, are indicated with blue arrows. e transposon carry-
ing the bla_tem_ gene is indicated with an orange arrow. e integrase 




Figure . Partial nucleotide sequences of plasmid pEC (yellow) and pEC 
(light blue) compared with plasmid pH- of human origin (purple). 
Relevant genes are indicated with an arrow. Note: the gene denoted by ‘bcr’ 
encodes for a drug transporter of the bcr/CflA subfamily conferring re-
sistance to chloramphenicol. e tet(A) gene and the transposon were it is 
located on, are indicated with blue arrows. 
4.3 RESIDUAL DOX CONCENTRATIONS (1 AND 4 MG/L) CAN 
SELECT FOR DOX RESISTANT E. COLI 
Figure  shows the ratios between DOX resistant strains EC , EC  
and EC  and susceptible strains EC , EC , EC RIF and EC 
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RIF during h of competition in LB with different concentrations of 
DOX. EC  and its RIF resistant mutant ECRIF were included as 
different strains because of their difference in growth rate and MIC for 
DOX. 
e selective effect on the resistant strain in the competition experi-
ments is represented by the resistant/susceptible ratio (R/S). For every 
strain combination, statistical analysis revealed a significant higher R/S at 
 and  mg/l DOX when compared to the blank LB. In contrast, no signif-
icant difference in R/S was found between  and  mg/l DOX.  
EC  in particular seemed to show a different behaviour compared 
to the other susceptible strains. Indeed, the R/S in DOX media for EC  
looks slightly lower aer h of incubation than aer h, whereas the op-
posite occurred for the other susceptible strains.  
Enumeration data of donor, recipient and transconjugant strains and data 
used for statistical analyses of R/S and transfer frequencies are given in Ta-
ble S (EC ), Table S (EC ), Table S (EC RIF) and Table S 
(EC RIF).  
 e transfer frequencies of plasmids pEC, pEC and pEC to 
recipient strains EC RIF and EC RIF under the experimental con-
ditions are given in Table . e transfer frequency of pEC and pEC 
did not increase in LB with  or  mg/l DOX compared to the blank control. 
However, the transfer frequency of pEC was significantly higher at  
mg/l DOX than at  (p=.) and  mg/l DOX (p=.) when EC 
RIF was used as recipient and significantly higher at  and  mg/l (both 
p=.) than in blank LB in case of recipient strain EC RIF.  
LC-MS/MS analysis showed that the recovery of DOX in LB at con-
centrations of  and  mg/l ranged from  to  of the initial concen-
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Figure . (previous page, this page) Results of competition experiments be-
tween doxycycline resistant strains EC, EC and EC and suscepti-
ble recipient strains EC (blue), EC (gray), ECRIF (green) and 
ECRIF (yellow). e bars represent the ratio of logarithmic transformed 
counts of resistant bacteria (R, cfu/ml) to logarithmic transformed counts 
of susceptible bacteria (S, cfu/mL) (+ standard deviation), as indicated on 
the y-axis. In case of susceptible strains EC  and EC , R = total 
counts of donor (cfu/mL) and S = total counts of recipient (cfu/mL). In 
case of susceptible strains EC RIF and EC RIF, R = total counts of 
donor + tranconjugants (cfu/mL) and S = total counts of recipient – trans-
conjugants (cfu/mL). Different concentrations of DOX in the medium 
(DOX  =  mg/l; DOX  =  mg/l; DOX  =  mg/l) and sampling time 
points (h, h) are indicated on the x-axis. Significant differences are de-
noted in Additional files S, S, S and S. Note: Statistical analysis was 
done using the log transformed ratios log(R/S) but the graph shows 





Table . Transfer frequency of resistance plasmids to susceptible E. coli  
EC RIF and EC RIF 
 EC RIF EC RIF 
  h h h h 
pEC 
Blank ,E- ,E- ,E- ,E- 
 mg/l DOX ,E- ,E- ,E- ,E- 
 mg/l DOX ,E- ,E- ,E- ,E- 
pEC 
Blank ,E- ,E- ,E- ,E- 
 mg/l DOX ,E- ,E- ,E- ,E- 
 mg/l DOX ,E- ,E- ,E- ,E- 
pEC 
Blank ,E- ,E- ,E- ,E- 
 mg/l DOX ,E- ,E- ,E- ,E- 
 mg/l DOX ,E- ,E- ,E- ,E- 
Mean values of  replicates. Transfer frequency was defined as the number of transconjugants 
(CFU/ml) divided by the total number of recipients (CFU/ml) and was determined in three 
types of LB medium: Blank,  mg/l DOX and  mg/l DOX. Enumerations were performed aer 
h and h of competition between donor and recipient strain. CFU: colony forming units; LB: 
Miller’s LB broth; DOX: doxycycline 
 
 
Table . Stability of DOX in LB broth ( ml) with or without inoculation of 





Percentage of initial 
concentration 
aer h 




LB   
LB + EC    
 
LB   
LB + EC    
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5 DISCUSSION 
Characterization of the tet(A) carrying plasmids indicated that all three 
plasmids had well conserved backbones that circulate between E. coli 
strains from different hosts (human, poultry, pigs) (Brouwer et al. , 
Johnson et al. , Wang et al. ). In all three characterized resistance 
plasmids, tet(A) was located on a Tn transposon together with several 
metal resistance genes. A transposon has the ability to transfer from the 
plasmid to another plasmid or chromosome in the same or another cell, 
and therefore can quickly spread resistance genes among bacteria (Salyers 
et al. ). Indeed, it has been shown that Tn preferentially inserts into 
bacterial plasmids that can conjugate between cells (Wolkow et al. ). 
In case of pEC, additional resistance genes were located on an integron, 
a genetic element that has the ability to capture resistance gene cassettes 
(Cambray et al. ). Consequently, although tetracyclines may not be the 
most critical or most frequently used group of antimicrobials for human 
medicine, the horizontal spread of these integron containing plasmids 
could be relevant because of co-transfer or acquisition of resistance genes 
other than tet(A). 
None of the investigated conjugative plasmids were able to transfer to 
the susceptible strain EC . EC  carried a plasmid of the same Inc 
group as pEC, which counteracts conjugation with EC  because 
plasmids of the same Inc group cannot be propagated within the same cell 
line (Carattoli et al. ). Conjugation with the other strains (EC  and 
EC ) could possibly be counteracted by surface exclusion or a re-
striction system of strain EC  (omas et al. ). 
Competition between the strains containing the tetA-carrying plas-
mids and susceptible strains at different residual DOX concentrations re-
vealed one main observation: selection of the DOX resistant strain was in 
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all cases significantly higher in LB with  and  mg/L of DOX compared to 
the blank control. Surprisingly, no significant difference in selective effect 
was found between the two concentrations of DOX. is could partially be 
explained by the growth curve analysis of the susceptible strains (Figure 
). First, growth rates of the susceptible strains showed minor differences 
when comparing  and  mg/l of DOX. Second, all strains except EC 
RIF reached the same maximum OD value in both  and  mg/l of 
DOX. On the other hand, the rather high standard deviation (SD) values 
for the mean R/S (Table SS), indicate that more replicates of the ex-
periments might reveal more significant differences in selective effect be-
tween  and  mg/l of DOX, especially in case of EC RIF.  
Not only the presence of DOX in the growth medium affected the 
competition results, also strain fitness played its role. First, the three re-
sistant strains showed similar growth rates. As a result, no significant dif-
ferences in R/S between these strains in competition with any of the sus-
ceptible strains were found. In contrast, the susceptible strains did show 
significant differences in R/S, except when comparing EC  and EC 
RIF. ese differences are probably mainly caused by the (sometimes 
small) differences in growth rates (fitness) between the susceptible strains 
(Figure ). Moreover, the differences in fitness between EC  and EC 
RIF and between EC  and EC RIF could possibly be assigned to 
the RIF mutation (Hughes et al. ). e fitness cost caused by the RIF 
mutation may also have affected the results of the standard MIC test with 
fixed incubation time, that showed different MIC values for the original 
strains and their RIF mutant, respectively. 
Susceptible strain EC  in particular showed an interesting behav-
iour: the selective effect on any of the resistant strains in competition with 
EC  decreased with time. is observation could be caused by de novo 
resistance development with low fitness cost of EC  or a type of re- 
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sistance called ‘adaptive resistance’, a phenotype that can emerge through 
contact with subinhibitory concentrations of antibiotics (Andersson et al. 
, Sandoval-Motta et al. ). Moreover, these hypotheses were sup-
ported by the growth curve of EC  (Figure ) that reaches a platform 
aer approximately - hours but increases again aer - hours, indicat-
ing that the bacteria were adapting to the DOX supplemented environ-
ment.  
Only the transfer frequency of pEC was increased due to the pres-
ence of  or  mg/l DOX. e lower transfer frequency to recipient EC 
RIF at  mg/l than at  mg/l could possibly be explained by the lower 
fitness of EC RIF at  mg/l than  mg/l DOX. Indeed, our experimental 
design implicates that the transfer frequency is likely a combined result of 
both plasmid transfer and enrichment of transconjugants (Lopatkin et al. 
). Hence, EC RIF transconjugants were probably enriched signifi-
cantly less at  mg/l of DOX than at  mg/l.  
Interestingly, DOX appeared to be rather unstable under the experi-
mental conditions: aer h of incubation the recovery ranged between 
- (Table ). is partial recovery was not translated into lower se-
lective effects at h compared to h of incubation. In contrast, re-
sistant/susceptible ratios were found to be significantly higher aer h in-
cubation time than h incubation time in all cases except for the experi-
ments with EC . No previous reports about DOX stability in LB are 
available, but it has been shown that DOX is stable in deionized water at 
°C during at least  days (Honnorat-Benabbou et al. ). In contrast, 
hardness and pH of drinking water are main parameters determining sta-
bility of DOX in medicated drinking water. Moreover, the samples were 
protected from light during incubation, which rules out degradation due 
to light exposure. erefore, it is more likely that the chemical properties 
of LB, e.g. the presence of divalent cations with subsequent binding of 
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DOX, caused the incomplete recovery but further investigation is needed 
to confirm this.  
To our knowledge no previous studies on the selective pressure of re-
sidual concentrations of DOX are available in literature, except for one 
study that determined a Predicted No Effect Concentration (PNEC) for 
resistance selection of all common antimicrobials through a mathematical 
model (Bengtsson-Palme et al. ). According to this model the PNEC 
for DOX should be . mg/l, which means that the present results do 
not contradict the model.  
In conclusion, this study showed that residual concentrations of DOX 
( and  mg/l), likely to be found in the porcine caecum and colon due to 
cross-contamination of feed, have the potential to enrich tetracycline re-
sistant commensal E. coli in vitro. Consequently, cross-contamination of 
pig feed could be an important contributor to the spread of bacterial re-
sistance (Andersson et al. ). Tetracycline resistant bacteria from the 
porcine microbiota can subsequently spread to the human microbiota 
through the consumption of pork or via the environment. erefore, the 
presence of residual concentrations of DOX in the porcine microbiota may 
form a threat to human health, in particular because of co-transfer of im-
portant resistance genes in human medicine together with the tetracycline 
resistance genes. However, further research is needed to fully understand 
the long term effect of cross-contaminated feed in the complex environ-
ment of the intestinal microbiota. 
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1 ABSTRACT 
e aim of this study was to investigate the effect of subtherapeutic intes-
tinal DOX concentrations ( and  mg/l), caused by cross-contamination 
of feed, on the enrichment of a DOX resistant commensal E. coli and its 
resistance plasmid in an ex vivo model of the porcine caecum. 
A DOX resistant, tet(A) carrying, porcine commensal E. coli strain 
(EC ) was cultivated for  days in the porcine caecum model under dif-
ferent conditions (,  and  mg/l DOX). EC , other coliforms and an-
aerobic bacteria were enumerated daily. A selection of isolated DOX re-
sistant coliforms (n=) was characterized by rep-PCR clustering, PCR 
assays [Inc and tet(A)] and micro broth dilution susceptibility tests (Sen-
sititre). 
Both  and  mg/l DOX enriched medium had a significantly higher 
selective effect on EC  and other resistant coliforms than medium with-
out DOX. Transconjugants of EC  were isolated more frequently in the 
presence of  and  mg/l DOX compared to medium without DOX. 
Subtherapeutic intestinal DOX concentrations have the potential to 
select for DOX resistant E. coli, and promote the selection of transconju-
gants in a porcine caecum model. 
Cross-contamination of feed with antimicrobials such as DOX likely 
promotes the spread of antimicrobial resistance. erefore it is important 
to develop or fine-tune guidelines for the safe use of antimicrobials in ani-




Antimicrobial resistance has traditionally been considered as a problem 
linked to the (mis)use of antimicrobials in human and veterinary medi-
cine. During the last decade however, it has become clear that also low 
concentrations of antimicrobials may contribute to the selection and 
spread of antimicrobial resistance (Andersson et al. ), however the ex-
tent of this has not been quantified. Pig feed may become contaminated 
with antimicrobials through carry-over from medicated to non-medicated 
feed at the feed mill, during transport or at the farm (Filippitzi et al. , 
Stolker et al. ). As the preferred administration methods for antimi-
crobials differ between countries, the main routes and levels of cross-con-
tamination are also country-specific. Production of antimicrobial medi-
cated feed at the feed mill has been banned in e Netherlands in , 
consequently cross-contamination at the feed mill is ruled out in this coun-
try. e levels of cross-contamination at the feed mill can be highly varia-
ble. A wide range of antimicrobial concentrations have been found in a 
study concerning carry-over in  feed mills in e Netherlands (Stolker et 
al. ). Furthermore, it should be noted that the actual concentrations to 
which the pigs will finally be exposed to is also dependent on the half-life 
of the antimicrobial and other factors that influence the stability of the an-
timicrobial. 
A mathematical model estimated that when  of the pig feed pro-
duced in a country per year is antimicrobial medicated feed, . ( CI 
= .; .) of the total feed produced in a year is likely cross-contami-
nated with different concentrations of antimicrobials due to practices re-
lated to production, transport, storage and distribution of medicated feed 
(Filippitzi et al. ).  
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e concentrations of DOX, CTC or SDZ-TRIM in pigs’ intestines, due to 
a  carry-over level in the feed, have been determined before in an in vivo 
study (Chapter ). Based upon this information, it is possible to investigate 
the effect of the observed intestinal concentrations on the selection of re-
sistant bacteria in the intestinal microbiota. e maximum concentration 
of DOX was approximately  mg/l in the porcine caecum and colon. Be-
cause the above mentioned study showed a high transfer rate of tetracy-
clines from feed to gut, it was decided to test the selective effect of the max-
imum observed concentration of DOX in caecum and colon ( mg/l). As a 
consequence of a recent Belgian covenant (BFA and FASFC ), stating 
that carry-over levels of antimicrobials in pig feed should not exceed  of 
the recommended dose, the results of the in vivo study were also extrapo-
lated to a  cross-contamination level ( mg/l DOX). 
e selective pressure of these two concentrations of DOX has re-
cently been investigated using pure bacterial cultures (Chapter ). ese 
competition studies between DOX resistant and susceptible porcine com-
mensal Escherichia coli strains showed that both  and  mg/l DOX supple-
mented medium select for the resistant strain compared to blank medium. 
Taking into account the latter results, these low DOX concentrations 
might also exert a selective pressure on the porcine intestinal microbiota.  
e low DOX concentrations may not only select for DOX resistant 
bacteria but may also promote the transfer of the tetracycline resistance 
genes. Moreover, other resistance genes carried by these bacteria could be 
co-selected and/or be co-transferred (Gullberg et al. , Leverstein-van 
Hall et al. ). 
e aim of the present study was thus to investigate the enrichment in 
the porcine caecal microbiota of a well characterized DOX resistant E. coli 
field strain, using an ex vivo model simulating the porcine caecum. is 
experiment allowed to observe two different mechanisms of resistance 
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spread: selection of the donor strain and transfer of its resistance plasmid, 
followed by selection of transconjugants. e resistant donor strain was 
characterized in a previous study (Chapter ) and carried tet(A), encoding 
the efflux pump TetA, which is a concentration dependent resistance 
mechanism that confers resistance to tetracyclines (Moller et al. ). In 
addition, resistant coliforms other than the donor strain were character-
ized to determine whether the resistance plasmid of the donor strain was 
transferred to other strains. 
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3 MATERIAL AND METHODS 
3.1 BACTERIAL STRAIN 
EC  is a commensal E. coli strain that was isolated from pig faeces during 
a national Belgian antimicrobial resistance monitoring program (Hanon 
et al. ). EC  carries a mobile IncI plasmid (pEC, EMBL acces-
sion number FNLQ) conferring resistance to ampicillin, sul-
phonamides, streptomycin, tetracyclines and trimethoprim. Resistance to 
tetracyclines was encoded by the tet(A) gene located on the mobile plasmid 
pEC (Chapter ). A non-lactose fermenting mutant of this strain was 
selected to be able to distinguish it from other (lactose fermenting) E. coli 
on MacConkey n° agar, on which this mutant forms white colonies (Smet 
et al. ). e non-lactose fermenting mutant showed the same MIC for 
DOX as the original strain, namely  mg/l. e in vitro growth rate of this 
strain (. min-) was not affected by the presence of  mg/l DOX, 
whereas  mg/l DOX reduced the growth rate slightly by . min-. e 
transfer frequency (ratio transconjugants/total recipients aer h incuba-
tion) of pEC to two different recipient strains (,.- and ,.-, re-
spectively) was not affected significantly by the presence of  mg/l DOX or 
 mg/l DOX (Chapter ). 
3.2 CÆCAL CULTURE CONDITIONS 
e microbial ecosystem of the porcine caecum was simulated in an ex vivo 
model, described by (Messens et al. ). Briefly, the bacterial growth 
conditions of the porcine caecum were simulated in two parallel bioreac-
tors, operated as continuous culture systems. e bioreactors both con-
sisted of a BioFlo / unit (New Brunswick Scientific, Enfield, CT, USA) 
and a . l reactor vessel. At day , the reactor vessel was filled with . l of 
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nutritional medium (Table ) and autoclaved (°C,  min) and cooled 
down until °C. From that moment on, a constant temperature (°C), 
pH (.) and agitation ( rpm) were maintained and the headspace of the 
vessel was flushed constantly with a  nitrogen- carbon dioxide 
mixture at  ml/min to create anaerobic conditions.  
Table . Composition of the nutritional medium 
  g/l 
Starch from corn ()  
Casein from bovine milk ()  
Casein hydrolysate acid () . 
Soybean oil (Carrefour sojaolie) ()  
L-cysteine hydrochloride anhydrous () . 
Pectin from citrus peel () . 
Alphacel () . 
Mucin from porcine stomach, type II ()  
Vitamin-mineral premix () . 
KHPO () . 
NaHPO HO () . 
() Sigma-Aldrich, Bornem, Belgium 
() MP Biomedicals 
() Merck, Overijse, Belgium 
() N.V. Carrefour, Evere, Belgium 
() Vitamex N.V., Drongen, Belgium 
e medium was acidified to pH  with  ml/l HCl  (Merck) 
 
Fermentation was started by adding  ml of pooled caecal content of  
organic raised pigs that did not receive antimicrobials during rearing, and 
 ml of a . OD suspension of EC  (containing approximately  
cells/ml). Immediately aer inoculation, a sample was taken to determine 
the initial total count of EC  in the fermentation system. Subsequently, 
the reactor was operated in batch mode during h (day ). Starting from 
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day , fresh medium of pH  (stored at °C in an autoclaved  l pyrex ves-
sel) was added at a constant rate of approximately . ml/min and waste 
liquid and cells were removed at the same rate to obtain a constant working 
volume of . l. is corresponds with a retention time of approximately 
. h. A constant pH of . was maintained using a  mol/l NaOH solution. 
At day three, the nutritional medium was supplemented with  or  mg/l 
DOX (doxycycline hyclate, Fagron,Waregem, Belgium) and continuously 
administered until the end of the experiment, i.e. day nine. For each con-
dition (,  and  mg/l DOX), three reactor runs were conducted. Addi-
tionally, one run without EC  and without DOX was performed as a 
negative control experiment to determine whether IncI and tet(A) carry-
ing plasmids were already present in the inoculum.  
3.3 BACTERIAL POPULATION DYNAMICS  
Tenfold serial dilutions of reactor content samples were plated daily in du-
plicate on MacConkey n° agar (MC) (Oxoid, Basingstoke, UK) with or 
without  mg/l DOX [= maximum cut-off value of DOX considering coli-
form bacteria according to EUCAST (e European Committee on Anti-
microbial Susceptibility Testing)] and incubated overnight at °C. Sam-
ples of the negative control run without EC  were plated on MC, MC + 
 mg/l DOX [= EUCAST ECOFF (epidemiological cut-off value) DOX for 
E. coli)] and MC +  mg/l DOX. EC  (white colonies) and other coli-
forms (red colonies) were counted on both MC with and without DOX. 
e number of susceptible coliforms was calculated by subtracting the re-
sistant coliforms count from the total coliforms count. e same dilutions 
of the reactor content were also plated in duplicate on Reinforced Clos-
tridial Agar (RCA, Oxoid) as a control to detect possible fluctuations in the 
culturable (facultative) anaerobic microbial population. e RCA plates 
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were incubated anaerobically during h at °C and the total number of 
colonies was counted. 
3.4 ISOLATION OF DOX RESISTANT E. COLI AND 
IDENTIFICATION OF TRANSCONJUGANTS OF EC 682 
Each day,  red colonies were randomly picked from MC +  mg/l DOX 
(resistant coliforms), further purified and stored at -°C for further char-
acterization. As the purpose of the negative control run was to detect IncI 
and tet(A) carrying isolates in the inoculum, a broad variety of resistant 
coliforms needed to be isolated. erefore, also from the MC plates with  
mg/l DOX,  colonies per day were isolated and stored. In this way, also 
resistant coliform species such as E. coli with a MIC value between  and  
mg/l could be isolated. A representative collection (all isolates from day , 
,  and ; in total ) was selected for further characterization. ese iso-
lates were grown on RAPID’ E. coli  agar (Bio-Rad, Temse, Belgium) to 
distinguish E. coli from other coliforms. 
Genomic DNA of the  isolates was obtained using a boiling 
method. Briefly, one colony was suspended into  µl of ultra-pure water, 
heated during  min at °C in a warm water bath and finally centrifuged 
at , g during  min.  
First, the  isolates originating from the negative control run without 
EC  were subjected to both IncI and tet(A) detecting PCR assays 
(Carattoli et al. , Ng et al. ) to check whether coliforms carrying 
both tet(A) and the IncI replicon were already present in the inoculum. 
Next, the  isolates from the other runs were subjected to the IncI PCR 
assay to verify if they harboured plasmids with the IncI replicon. For iso-
lates that carried the IncI replicon, the presence of tet(A) was also verified 
by PCR assay. Isolates that carried both the IncI replicon and the tet(A) 
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gene could be considered as possible transconjugants of donor strain  
EC . 
All  isolates were then clustered into groups of indistinguishable or 
closely related isolates using rep-PCR with (GTG) primers and under PCR 
conditions (Versalovic et al. ). e PCR mix consisted of × Red dia-
mond buffer (Eurogentec, Seraing, Belgium), (GTG) primer ( pmol), 
. mM MgCl (Eurogentec),  U Red Diamond Taq DNA Polymerase (Eu-
rogentec) and . mM of deoxynucleotide trisphosphates (GE Healthcare 
Europe, Munich, Germany) in a total reaction volume of  μl. is PCR 
mix was placed in a Gene Amp PCR System  Gold (Applied Biosys-
tems, Fostercity, CA, US). Amplicons were separated using capillary gel 
electrophoresis (QIAxcel Advanced System, QIAGEN, Hilden, Germany) 
with the QIAxcel DNA High Resolution Kit (QIAGEN) using method 
OM with an additional -seconds separation time and the QX 
Alignment Marker ( bp/ kb, QIAGEN) added to each PCR product. e 
similarities between the obtained fingerprints were calculated using the 
Pearson correlation and clustered using UPMGA ( curve smoothing) in 
BioNumerics version . (Applied Maths, Sint-Martens-Latem, Belgium).  
Subsequently,  IncI and tet(A) carrying isolates (at least one per 
rep-PCR cluster) and two isolates from the negative control run were se-
lected for Sensititre micro broth dilution analysis with EUVSEC plates 
(TREK Diagnostic Systems, West Sussex, UK) according to EURL-AR 
(EURL-AR ) guidelines. e MIC’s of the following panel of antimi-
crobials were determined: ampicillin, cefotaxime, ceazidime, mero-
penem, nalidixic acid, ciprofloxacin, tetracycline, colistin, gentamicin, tri-
methoprim, sulphamethoxazole, chloramphenicol, azithromycin and 
tigecycline. Isolates were considered resistant or susceptible based on the 
cut-off values given in the EURL-AR guidelines (EURL-AR ). As such, 
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isolates showing resistances encoded by plasmid pEC (except for strep-
tomycin, which is no longer included in the standard Sensititre plates) 
could be detected. e latter could then be considered as pEC carrying 
transconjugants, regarding that no such strains were isolated from the neg-
ative control run without EC . 
3.5 STATISTICAL ANALYSIS 
Significant changes as a response to the inclusion of DOX in the medium 
over a period of six days were analysed using a linear mixed effects model 
(Rpackage lme, Bates et al. ), including ‘medium’ and ‘time’ as fixed 
factors. e reactor run number was considered as a random factor to in-
clude reactor variability in the model. 
Statistical analysis was conducted on log transformed counts of EC 
, resistant and susceptible coliforms, total culturable anaerobes from 
reactor runs with  and  mg/l DOX compared to the runs with the blank 
medium. Only population sizes starting from day four until day nine were 
included for statistical analysis. P-values of significant results were calcu-
lated using ANOVA and the function lsmeans. 
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4 RESULTS 
4.1 CAECAL BACTERIAL DYNAMICS AT 0, 1 AND 4 MG/L DOX  
e EC  population size in the simulated porcine caecum was signifi-
cantly higher (p<.) in reactors supplemented with  and  mg/l DOX 
(average increase of . ± . log CFU/ml and . ± . log CFU/ml 
respectively) compared to the blank controls (Figure ).  
 
 
Figure . Enumeration of DOX resistant E. coli strain EC  in the simulated 
pig caecum containing  (blank ),  ( ) or  ( ) mg/l DOX. 
Strain EC  (white colonies) was enumerated daily in duplicate on Mac-
Conkey n° agar with  mg/l DOX (overnight incubation at °C) during  
days. e population size of EC  is given in log transformed CFU/ml 
(mean values of three runs + SD) and plotted against time (days). e start of 
DOX administration is indicated with a red dashed line. e population size 
of the DOX resistant E. coli EC  aer DOX administration (starting from 
day ) was significantly higher in the presence of  and  mg/l DOX com-
pared to blank medium. No significant difference in population size was ob-
served between  and  mg/l DOX. 
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However, no difference in population sizes of EC  was observed be-
tween the two DOX concentrations. In addition, a significant effect (p < 
.) of the factor ‘time’ on the population sizes of EC  was observed, 
since the EC  counts in blank medium decreased with time. 
 
  
Figure . Enumeration of DOX resistant coliforms other than EC  in the 
simulated pig caecum containing  (blank ),  ( ) or  ( ) 
mg/l DOX. Resistant coliforms (red colonies) were enumerated daily in du-
plicate on MacConkey n° agar with  mg/l DOX (overnight incubation at 
°C) during  days. e population size of resistant coliforms is given in 
log transformed CFU/ml (mean values of three runs + SD) and plotted 
against time (days). e start of DOX administration is indicated with a red 
dashed line. Starting from day , the population size of the resistant coli-
forms was significantly higher in the presence of  mg/l DOX compared to 
the blank controls. No other significant differences were observed. Note: 
No growth could be observed at day  in the blank experiments and experi-
ments with  mg/l DOX. e value given for day  of the experiments with 
 mg/l DOX, represents the count of only one of the three runs. e other 
two runs showed no growth at day . 
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In the experiments with  mg/l DOX, the resistant coliforms (Figure  ) 
showed a significantly (p < .) higher population size (average increase 
of . ± . log CFU/ml) compared to the population size in the blank 
controls. No other significant differences in population sizes of resistant 
coliforms were observed. Also, no effect of time was observed for the pop-
ulation sizes of the resistant coliforms. 
No significant differences in population sizes of the susceptible coli-
forms (Figure ) were seen between any of the experiments, although the 




Figure . Enumeration of DOX susceptible coliforms in the simulated pig cae-
cum containing  (blank ),  ( ) or  ( ) mg/l DOX. Total 
coliforms and resistant coliforms (red colonies) were enumerated daily 
during  days in duplicate on MacConkey n° agar without DOX and with 
 mg/l, respectively (overnight incubation at °C). e number of suscep-
tible coliforms was calculated by subtracting the resistant coliform count 
from the total coliform count and is given in log transformed CFU/ml 
(mean values of three runs + SD) and plotted against time (days). e start 
of DOX administration is indicated with a red dashed line. No significant 
differences in population sizes of the susceptible coliforms were observed 
between any of the experiments. 
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Besides the coliforms, the population size of a more representative bacte-
rial group of the microbiota was monitored by counting the total anaerobic 
bacteria on RCA (Figure ). A significantly higher population size of these 
anaerobes was found in the experiments with  mg/l compared to those 
with  mg/l DOX (average increase of . ± . log CFU/ml, p = .) 
and the blank controls (average increase of . ± . log CFU/ml,  
p < .). 
 
 
Figure . Enumeration of total anaerobes in the simulated pig caecum contain-
ing  (blank ),  ( ) or  ( ) mg/l DOX. Total anaerobes 
were enumerated daily in duplicate on Reinforced Clostridial Agar without 
DOX (h anaerobic incubation at °C) during  days. e number of to-
tal anaerobes is given in log transformed CFU/ml (mean values of three 
runs + SD) and plotted against time (days). e start of DOX administra-
tion is indicated with a red dashed line. A significantly higher population 
size of anaerobes was observed in the experiments with  mg/l compared to 
those with  mg/l DOX and the blank controls. No other significant differ-
ences were seen. 
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4.2 DOX RESISTANT COLIFORMS AND PEC682 CARRYING 
TRANSCONJUGANTS 
e donor strain EC  showed a rep-PCR pattern that was different from 
all DOX resistant coliforms that were isolated from the experiments. Of 
the  DOX resistant strains isolated from the blank experiments (n=), 
the experiments with  mg/l DOX (n=), those with  mg/l DOX (n=) 
and the negative control experiment without EC  (n=),  showed 
E. coli morphology on RAPID’ E. coli  agar (Table ). ese  E. coli 
isolates were assigned to  different clusters by rep-PCR. One cluster (n° 
), including  E. coli isolates originating from the three different exper-
imental runs, was remarkably larger than the others. Interestingly, no iso-
lates from the negative control run were assigned to this large cluster. 
Other clusters comprised isolates originating from only one or two exper-
iment type(s). 
Table . Clustering of DOX resistant E. coli by rep-PCR and tet(A) and IncI 
carrying isolates 
Run conditiona Number of isolatesb Clustersc tet(A) and IncI carrying iso-
lates (clusters)d 
Blank    () 
 mg/l DOX    () 
 mg/l DOX    () 
a For each condition, 3 runs were performed. Strains were isolated from all runs 
b E. coli strains isolated on day 3 (just before DOX administration), 5, 7 and 9 
c Total number of detected Rep-PCR clusters 
d Total number of isolates with both IncI1 and tet(A) and between brackets the num-
ber of different clusters they were assigned to 
Note: No tet(A) and IncI1 carrying isolates could be identified from the run without 




Fiy-one of the  E. coli isolates carried the IncI replicon, of which  
originated from the blank runs,  from the runs with  mg/l DOX and  
from the runs with  mg/l DOX. All  isolates also carried the tet(A) gene 
(Table ) and were assigned to  clusters (Table ). None of these  iso-
lates could be assigned to the large cluster (n° ). 
e  isolates that showed different morphology on RAPID’ E. coli  
agar than E. coli, were assigned to  different clusters and did not carry the 
IncI replicon or tet(A) gene. 
e  tetracycline resistant E. coli isolates originating from the nega-
tive control run without EC  were assigned to five different rep-clusters, 
of which four clusters also included isolates originating from the experi-
mental runs. None of these  isolates were found to be both IncI and 
tet(A) positive, but  of them, belonging to  different clusters, did carry 
tet(A). 
Sixteen IncI and tet(A) positive E. coli isolates (at least one isolate per 
cluster, see Table ) were characterized with Sensititre. Eleven of these 
isolates showed the same resistance profile as EC  (Table ). e other 
isolates from the experimental runs (n=), only showed resistance against 
tetracycline. One of the two tet(A) carrying isolates from the negative con-
trol without EC  only showed resistance against tetracycline, the second 
isolate showed resistance to tetracycline and trimethoprim (Table ). 
  
EX VIVO  STUDY 
169 
Table . Phenotypic resistance profile of tet(A) and IncI carrying E. coli isolates 
Run condition  Cluster n° (a, b)* Strain n°  Phenotypic resistance profile 
Blank  (, )  tet 
  (, )  amp-smx-tet-tmp 
   amp-smx-tet-tmp 
 mg/l DOX  (, )  amp-smx-tet-tmp 
  (, )  amp-smx-tet-tmp 
  (, )  tet 
   tet 
  (, )  amp-smx-tet-tmp 
   amp-smx-tet-tmp 
   amp-smx-tet-tmp 
  (, )  amp-smx-tet-tmp 
 mg/l DOX  (, )  tet 
  (, )  tet 
  (, )  amp-smx-tet-tmp 
  (, )  amp-smx-tet-tmp 
   amp-smx-tet-tmp 
Blank without 
EC   (, )§  tet-tmp 
  (, )†  tet 
amp, ampicillin; smx, sulphamethoxazole; tet, tetracycline; tmp, trimethoprim 
* a: total number of isolates assigned to this cluster; b: total number of both IncI1 and 
tet(A) positive isolates in this cluster 
§ Isolate n° 1011 belonged to a cluster with five tet(A) positive isolates originating from 
the negative control run and one IncI1 and tet(A) positive isolate originating from an 
experiment with 1 mg/l DOX. 
† Isolate n° 960 belonged to a cluster with eight tet(A) positive isolates and one tet(A) 






Resistance selection in the pig microbiota caused by cross-contamination 
of feed with antimicrobials is worrisome, especially since it is assumed that 
resistant bacteria can be persistent and are thus not necessarily outcom-
peted by susceptible bacteria when antimicrobial selective pressure is with-
drawn (Andersson et al. ). It has also been stated that, theoretically, 
sub-MIC selected resistant mutants of bacteria would be more stable in 
bacterial populations than those selected at high antimicrobial concentra-
tions because of the lower fitness cost (Sandegren ). erefore, the aim 
of this study was to investigate the selective effect of intestinal DOX con-
centrations due to cross-contamination of feed on the porcine microbiota. 
e enumerations of DOX resistant E. coli EC  in the simulated 
porcine caecum clearly showed that both  and  mg/l of DOX have a se-
lective effect on this strain. e population size of the phenotypically re-
sistant EC  was maintained or increased slightly in the DOX supple-
mented media, while in the blank medium this population size decreased. 
Presumably, EC  was not able to maintain its population size in this 
latter medium due to the lack of selective advantage compared to the sus-
ceptible microbial population present in the reactor. In addition, EC  
might have started eliminating its resistance plasmid (pEC) in the ab-
sence of antimicrobial pressure because of the cost of fitness to replicate 
(Sherratt ), although we were not able to demonstrate this in this type 
of experiment. Furthermore, similar trends were observed in a previous 
study with a cefotaxime resistant E. coli strain in bioreactor experiments 
simulating the human caecum and ascending colon (Smet et al. ). In-
terestingly, no significant difference in selective effect between  and  mg/l 
was found. is finding could possibly be explained by the tetracycline re-
sistance mechanism of EC , i.e. the TetA efflux pump and regulation 
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protein TetR, as a recent study showed that TetA producing E. coli exhibit 
a prolonged generation time with increasing tetracycline concentrations 
(Moller et al. ). Consequently, it is likely that the fitness of EC  was 
affected more in the medium with  mg/l compared to  mg/l DOX, thus 
neutralizing the potential higher selective effect of  mg/l DOX.  
As EC  was not the only tetracycline resistant coliform present in 
the microbial population, the counts of coliforms were also investigated in 
general, and more specific to see whether transconjugants were arising. 
e resistant coliform counts were also affected by DOX supplementation 
(Figure ), although statistical analysis only confirmed a selective effect 
in medium with  mg/l DOX. e coliform population comprises many 
different species, which likely harbour different types of resistance mecha-
nisms concomitant with different fitness costs, which can explain variable 
selective effects depending on the DOX concentration (Vogwill et al. ). 
e prolonged generation time with increasing tetracycline concentrations 
of bacteria using an efflux pump as resistance mechanism could, in this 
case, also explain the lower selective effect of  mg/l DOX compared to  
mg/l DOX (Moller et al. ). 
Probably, the enrichment of the EC  population and other resistant 
coliforms did not affect the size of the susceptible coliform population be-
cause they represent a small minority in the total microbiota present in the 
bioreactor. Indeed, over  of the bacteria in the porcine caecum belong 
to the phyla Firmicutes and Bacteroidetes, whereas E. coli have been re-
ported to represent between . and . of the microbiome (Leser et 
al. , Yang et al. ). 
e diversity of anaerobes that are culturable on RCA (i.a. Clostridia, 
Lactobacilli) presumably masks the effect of DOX supplementation on the 
anaerobic population. Different species can show different growth rates 
and can harbour different resistance mechanisms, which can each affect 
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the bacterial fitness differently (Vogwill et al. ). In general, the popu-
lations of anaerobes seemed to maintain more or less the size that was es-
tablished before the start of DOX supplementation. 
Regardless of the mechanism of selection, the characterization of the 
resistant coliforms showed that more pEC carrying E. coli could be iso-
lated from the experiments with DOX supplementation compared to the 
blank experiment (Table ). In other words, not only EC  itself but also 
its resistance plasmid pEC, conferring resistance to five different anti-
microbials, was enriched more in the experiments with DOX supple-
mented medium compared to the experiments with blank medium. It 
should be noted though that this was not a quantitative study, as this would 
require at least a systematical characterization of all isolates growing on 
one agar plate. Consequently, it was not possible to confirm the observed 
trends statistically. Although the clustering seemed to show a slightly 
larger variety of transconjugants in the experiments with DOX supple-
mented media, it is unclear whether the positive selection of the plasmid 
was caused by a higher plasmid transfer frequency, or by enrichment of 
transconjugants. is is only one of the various confounding factors that 
complicate the interpretation of plasmid transfer frequency, which make 
that conjugation dynamics under antimicrobial selective pressure are to 
date poorly understood (Lopatkin et al. ). 
Our results are in line with previous in vitro competition experiments 
between susceptible commensal E. coli strains and EC  and two other 
tet(A) carrying commensal E. coli, where similar selective effects of  and  
mg/l DOX with the same statistical significance were observed (Chapter 
). In addition, different studies confirm our finding that resistance genes 
conferring resistance to other antimicrobials than the one(s) administered 
can be co-selected (Agga et al. , Leverstein-van Hall et al. , Loo 
et al. ). e selection of tetracycline genes on multidrug resistance 
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plasmids obviously contributes to a widespread dissemination of multi-
drug resistant enteric bacteria.  
In conclusion, caecal concentrations of DOX ( and  mg/l) caused by 
a  and  carry-over level of DOX in pig feed, have the potential to en-
rich tet(A) carrying E. coli in the porcine caecum. Since this study revealed 
that  mg/l DOX does not necessarily have a higher selective effect than  
mg/l DOX, and previous observations indicate that very low antimicrobial 
concentrations (ng/ml) can select for persistent (de novo) resistance 
(Andersson et al. , Gullberg et al. , Gullberg et al. ), questions 
could be raised about the relevance of current maximum levels of cross-
contamination of feed with respect to resistance selection. However, the 
type of antimicrobial and associated resistance mechanisms may strongly 
influence the extent to which selection of resistant bacteria occurs. ere-
fore, additional research is needed to elucidate quantitative differences in 
selective effect of different contamination levels of antimicrobials used in 
medicated pig feed, to be able to optimize legal limits for cross-contami-







1 CROSS-CONTAMINATION OF PIG FEED 
AS A DRIVER FOR ANTIMICROBIAL 
RESISTANCE SELECTION 
e continuing worldwide spread of antimicrobial resistance in both com-
mensal and pathogenic bacteria is worrisome. e research results on 
doxycycline, described in this doctoral thesis, indicate that cross-contam-
ination of pig feed with antimicrobials is a contributor to this phenome-
non. It is however difficult to quantify this contribution as different factors 
may contribute: () the type and concentration of antimicrobial present in 
the feed, () the pharmacokinetic properties of the antimicrobial driving 
the intestinal concentrations of the drug and () the properties of the in-
testinal microbiota (MIC, resistance mechanisms, bacterial fitness, etc.). 
e main findings and results obtained in this doctoral thesis are shown in 
Figure . 
1.1 ANTIMICROBIALS IN CROSS-CONTAMINATED FEED 
e type and concentration of the antimicrobial that is present in the cross-
contaminated feed is the first factor that will determine the effect on the 
intestinal microbiota. Unfortunately, only a minimal number of published 
studies investigated which type and concentrations of antimicrobials can 
be found in cross-contaminated feed. Only one study described quantita-
tive data on cross-contamination at the feed mill (Stolker et al. ), 
whereas another study (Putier ) investigated cross-contamination 
during feed transport with trucks. No data, however, have been published 
regarding carry-over of antimicrobials at the farm. The study by Stolker 
and colleagues () showed that cross-contaminated feed batches can 




Figure . Schematic overview of the main results obtained in this doctoral thesis 
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even more than one type of antimicrobial), which impedes a quantitative 
estimation of the consequences of cross-contaminated feed (Stolker et al. 
). e route of antimicrobial carry-over influences the final antimicro-
bial concentration in the cross-contaminated feed. In general, the level of 
contamination is expected to be higher when carry-over has taken place at 
the feed mill compared to carry-over at transport or farm level (Filippitzi 
et al. ). e Belgian Feed Association (BFA) estimated that the carry-
over level at the feed mill reaches on average  when a main mixer is used, 
whereas it would stay below  when mixing at the end of the feed line is 
applied. Subsequently, a covenant with the Belgian Federal Agency for the 
Safety of the Food Chain (FASFC) was signed, which banned the use of 
main mixers in Belgian feed mills starting from Jan . 
Moreover, guidelines stating that carry-over of antimicrobials should 
not exceed  of the minimal allowed dose, were established (BFA and 
FASFC ). 
e question remains if the residual antimicrobial quantities in feed 
resulting from cross-contamination remain stable until the feed is con-
sumed. Manufacturers of premix formulations claim that these formula-
tions are stable under normal conditions of use. is has been confirmed 
in a peer reviewed report concerning therapeutic doses of a sulfadimidine 
premix (Bernabeu et al. ), and for oxytetracycline when applied in a 
pellet feed (Counotte et al. ). Some studies have shown that tetracy-
cline residues can be detected, and even accumulate, in organic matter 
such as farm dust and dried pig manure (Hamscher et al. , Hamscher 
et al. ), which may also point towards good stability in feed. Similarly, 
sulphonamides could also be affected by UV exposure, although it has been 
reported for tetracycline-HCl that light exposure doesn’t cause degrada-
tion when in dry state (Wu et al. ).  
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In short, there exists an important lack of data regarding exposure of ani-
mals to cross-contaminated feed. Quantitative data on carry-over levels 
(especially at the level of the transport, storage and distribution at the 
farm), as well as information on the destination of the cross-contaminated 
feed and the stability of the antimicrobial residues are very scarce. e 
mathematical model developed by Filippitzi and co-authors, that estimates 
the percentages of cross-contaminated feed produced in a certain country 
per year, could be refined substantially in case quantitative data would be-
come available.  
1.2 DISPOSITION AND PHARMACOKINETICS OF THE 
ANTIMICROBIAL DRIVING INTESTINAL CONCENTRATIONS 
e disposition and pharmacokinetic properties of the antimicrobial pre-
sent is another very important factor that contributes to the impact of 
cross-contaminated feed on resistance selection. e antimicrobial expo-
sure of the intestinal microbiota aer oral administration can be affected 
by the extent of drug absorption (i.e. oral bioavailability), the intestinal site 
of drug absorption, the extent of drug secretion from the systemic circula-
tion into the gut and the proportion of drug that remains active in the gas-
trointestinal tract (i.e. unmetabolized and unbound). ese properties are 
characteristic for each type of antimicrobial. In our first study (Chapter ), 
we found a correlation between the oral bioavailability and the intestinal 
concentrations of the tested antimicrobials (doxycycline, chlortetracycline 
and sulphadiazine-trimethoprim). is means that transfer of the antimi-
crobial from feed to gut was high to very high in case of the tetracyclines, 
which have generally low oral bioavailability’s in pigs (doxycycline - 
and chlortetracycline -), whereas sulphadiazine and trimethoprim 
(with a high oral bioavailability, sulphadiazine - and trimethoprim 
-) showed a low transfer from feed to gut. However, this correlation 
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of intestinal concentrations should be carefully interpreted, as other (un-
known) pharmacokinetic properties might also influence intestinal con-
centrations. Furthermore the results should certainly not be extrapolated 
to other antimicrobials because each drug has its own specific properties. 
One of these typical properties of tetracyclines is enterohepatic circulation, 
which means that they are reabsorbed from the intestines and re-enter the 
systemic circulation via the liver (del Castillo ). is might have con-
tributed to the high intestinal concentrations found in our study, and 
might imply a longer exposure of the microbiota. Although it seems logic 
that oral administration implies the highest risk for resistance selection in 
the intestinal microbiota, other administration routes should not be un-
derestimated. A recent study by our group showed that sulphadiazine un-
dergoes intestinal secretion to the gut lumen of pigs, independent of the 
administration route (oral and parenteral), although a renal excretion 
route has always been assumed for this drug. is causes an accumulation 
of sulphadiazine towards the distal parts of the gastrointestinal tract. Re-
markably, trimethoprim did not show such an accumulation, pointing to-
wards molecule-dependent mechanisms. In particular, ion-trapping in the 
gut lumen could explain the accumulation of sulphadiazine (De Smet et al. 
). Accumulations were also observed in our study: maximum mean 
concentrations of sulphadiazine (. mg/kg) were found in the distal co-
lon ascendens and for both doxycycline and chlortetracycline in the colon 
descendens (doxycycline . mg/kg; chlortetracycline . mg/kg). No 
conclusions could be made for trimethoprim as all values except two were 
below the detection limit. We also observed accumulation towards the end 
of the gastrointestinal tract for doxycycline and chlortetracycline. is 
might partly be due to intestinal secretion via P-glycoproteins and biliary 
excretion, although tetracyclines are also reabsorbed from the intestines 
CHAPTER 6 
182 
(del Castillo ). e accumulation may also (partly) be due to the pro-
gressive water absorption from the intestinal content towards the end of 
the intestinal tract, as the antimicrobials were administered orally in our 
study. 
Taking into account this important role of pharmacokinetics, a gen-
eral limit for carry-over levels, e.g. the  proposed by the EU, can result 
in completely different intestinal concentrations for different antimicro-
bial drugs. As such, the different antimicrobials used in feed medication 
(amoxicillin, oxytetracycline, colistin, lincomycin, tilmicosin, tylosin, 
apramycin, spectinomycin, tiamulin and valnemulin) should be tested in-
dividually. For example, the frequently applied antimicrobial amoxicillin, 
has an oral bioavailability in pigs that ranges between  and  and is 
mainly excreted renally (Agerso et al. , Reyns et al. ). Intestinal 
concentrations aer oral administration of amoxicillin might thus be ra-
ther high, as was found for the tetracyclines. On the other hand, it has been 
shown that penicillins are unstable in faeces matrix (Berendsen et al. ). 
1.3 THE INTESTINAL MICROBIOTA, RESISTANCE MECHANISMS 
AND THEIR GENETIC ENVIRONMENT 
Taking into account the current knowledge on resistance selection and 
transfer at sub-MIC antimicrobial concentrations, there is a high proba-
bility that the gut ecosystems of animals and humans are important hot 
spots of resistance selection and transfer.  
Making a link between antimicrobial use in pig production and anti-
microbial-resistant bacterial infections in the human population is rather 
challenging, although some studies have demonstrated such a link. ese 
studies however mainly focus on zoonotic bacteria and their resistance, ra-
ther than on the transfer of resistance to non-zoonotic human pathogens 
(Lu et al. , Maguire et al. , Molbak et al. ).  
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It is clear that resistance genes can be very persistent in the intestinal mi-
crobiota, even in long term absence of antimicrobials (Gerzova et al. , 
Gumpert et al. , Jakobsson et al. ). On the other hand, reductions 
in the use of antimicrobials can reduce the load of resistant bacteria suc-
cessfully, as was shown in Belgian and Dutch monitoring reports in live-
stock (Callens et al. , Dorado-Garcia et al. , Hanon et al. ). 
Nevertheless, medication remains necessary in justified cases so the need 
to investigate resistance selection in the porcine intestinal microbiota re-
mains actual. 
e mammalian gut harbours approximately -, species of bac-
teria which are present in large numbers, e.g. no less than  bacteria per 
gram human colon content. e majority of these bacteria is strictly anaer-
obic and most of them are uncultivable in the laboratory (Dowd et al. , 
Lamendella et al. , Sommer et al. ). Hence, it is difficult to repro-
duce both the environmental conditions and the symbiotic relationships 
among micro-organisms found in the gut (Nocker et al. ). In contrast, 
the total intestinal microbiota is potentially affected by the presence of any 
antimicrobial. is makes that the study of antimicrobial selection in the 
microbiota remains a challenging topic. For this particular reason, we 
chose to start our research with an in vitro study (Chapter ) using pure 
cultures of E. coli, a well-known bacterial species that is frequently used as 
an indicator. is study was then followed by more complicated ex vivo 
experiments with a model simulating the pig microbiota (Chapter ), using 
an E. coli donor strain originating from the in vitro study. is had the 
advantage that the results obtained in more controlled conditions (Chap-
ter ) could be compared with the results obtained in less controlled but 
more realistic conditions (Chapter ). Both studies proved the selective ef-
fect of  and  mg/l doxycycline (representing intestinal concentrations due 
to  and  cross-contamination) on resistant tet(A) carrying E. coli donor 
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strains. It is remarkable that the experimental set-up of both studies re-
sulted in no significant difference between the selective effect of  and  
mg/l doxycycline. In this context, it is important to underline that our re-
sistant E. coli strains all carried tet(A), a tetracycline resistance gene that 
encodes the efflux pump TetA. is is an energy dependent resistance 
mechanism, which may influence the fitness of the bacteria carrying this 
mechanism. In other words, the fitness of these bacteria might decrease 
with increasing antimicrobial concentrations, which might explain why no 
difference in selective effect was found between  and  mg/l doxycycline. 
Other tetracycline resistance mechanisms (e.g. ribosomal protection, en-
zymatic inactivation) are not energy dependent, which may result in dif-
ferent selective effects. With this in mind, we conducted additional re-
search, involving the faecal samples that were collected during the in vivo 
experiment with pigs (Chapter ). Real-time PCR was performed on faecal 
samples of the blank control group and the doxycycline group to deter-
mine the abundancy of common tetracycline resistance genes in the por-
cine microbiota: tet(A), tet(B), tet(L) (encoding efflux pumps), tet(Q), 
tet(W), tet(O) and tet(M) (encoding ribosomal protection). In contrast 
with the studies in Chapter  and , no influence of doxycycline on tet(A) 
abundancy (present in approximately  out of  to  out of  of the total 
bacteria) was observed. is suggests that the complexity of the intestinal 
microbiota might ‘mask’ the impact of antimicrobials on resistance selec-
tion in certain bacterial groups of the intestinal microbiota. Only in case of 
the efflux pump encoding gene tet(L), a difference was observed between 
the control group and the doxycycline group. e abundancy of this gene 
rose by approximately  log units (from - to -) compared to the con-
trol group during the experimental period. It is currently difficult to find 
out the underlying reason for these observations, as these data could not 
yet be linked to for example abundancy of bacterial species. Several factors 
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may be involved. A first factor is the difference in bacterial species in which 
these genes are found: tet(A) is mostly associated with Gram negative bac-
teria such as Enterobacteriaceae, whereas tet(L) is found in Gram negative 
as well as Gram positive bacteria typical for the intestinal microbiota such 
as Clostridium spp., Lactobacillus spp., etc. A second factor is the genetic 
environment of the different genes and their ability to transfer horizon-
tally. e tet(L) gene is generally found on small mobile plasmids, and oc-
casionally becomes integrated in the chromosome (Roberts ). e 
tet(A) gene of the three E. coli strains used in our in vitro experiments was 
in all cases located on a transposon, which was associated with a mobile 
plasmid. is is the most common genetic location that has been reported 
for tet(A) and Gram negative tetracycline efflux genes in general. 
Only one of the three plasmids (pEC) seemed to be transferred 
more at  and  mg/l doxycycline compared to blank controls in the in vitro 
experiments. is was not observed in vitro for the resistant strain EC  
(plasmid pEC), which was also used as donor strain in the ex vivo ex-
periments. In contrast, the results of the ex vivo experiments did suggest a 
broader dissemination of this plasmid both at  and  mg/l doxycycline 
supplementation. is highlights that plasmid transfer frequencies differ 
depending on the environment (Aminov ), and that conjugation dy-
namics are difficult to investigate due to confounding factors (Lopatkin et 
al. ). It has been suggested that the conditions in the gut microbiota 
such as the diversity and density of the microbial population may stimulate 
horizontal gene transfer (Aminov , Salyers ). Furthermore, the se-
lective effect on the resistant strain (EC) and the resulting larger popu-
lation of this strain, could have resulted in more opportunities for conju-




A recent study from our research group, using the same model for the pig 
caecum as in our ex vivo experiments, showed that the counts of resistant 
Enterobacteriaceae and cultivable anaerobes increased significantly upon 
administration of  or  mg/l doxycycline. Furthermore, no clear selective 
effect of  mg/l doxycycline on any of the resistant populations was found 
in this study (De Mulder et al. ), as was also the case for the resistant 
coliforms in Chapter . e diversity of bacteria and resistance mecha-
nisms present in the total microbiota might have caused the different ob-
servations in counts of resistant coliforms or Enterobacteriaceae compared 
to the counts of the resistant E. coli strain (EC ) in our pig caecum 
model. 
In conclusion, our results showed that intestinal doxycycline concen-
trations due to cross-contaminated feed can select for tet(A) carrying E. 





2.1 REDUCE FEED MEDICATION 
Carry-over of antimicrobials is a challenging issue to deal with. It is gener-
ally assumed that cross-contamination of feed is unavoidable, due to the 
technical and economic challenges the feed and pig industry face today. It 
seems likely that the risk of cross-contamination during the production, 
transport, storage and distribution of medicated feed, cannot be avoided 
totally, though it should be minimalized as much as possible. Hence, the 
best way to reduce the amount of cross-contaminated feed would be a re-
duction in the production of medicated feed.  
A first important step to achieve a reduction would be the prohibition 
of prophylactic antimicrobial treatments (and growth promoters outside 
the EU). It has already been shown that prophylactic treatments can be 
avoided through improved herd management, vaccination schemes and 
biosecurity. Postma and co-authors showed that improving herd manage-
ment and biosecurity (e.g. appropriate anthelminthic therapy, vaccination 
strategies, hygiene standards etc.) resulted in a reduction of antimicrobial 
usage of  in finisher pigs (from birth to slaughter) and  in breeding 
animals and even improved production results. Alternatively, the posology 
of existing antimicrobials could also be revised and optimized, since the 
current posology is mainly established solely on clinical efficacy, without 
taking resistance selection of pathogenic or commensal bacteria into ac-
count. is could lower the recommended dose and thus the possible carry 
over quantities. e Belgian FPS-funded project DOSERESIST “Influence 
of dosage, administration route and intestinal health on antibacterial re-
sistance selection in pig intestinal commensal flora and optimization of 
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dosage regimen of selected antibacterial drugs” might amongst others con-
tribute to this topic. 
In case an antimicrobial group treatment is unavoidable, the choice of 
the antimicrobial should always be based on a correct laboratory identifi-
cation of the bacterial pathogen followed by an accurate assessment of its 
in vitro antimicrobial susceptibility. Unfortunately, in practice, this kind 
of laboratory testing is oen too expensive or time consuming, which 
forces the veterinarian to choose an antimicrobial based on the clinical di-
agnosis and his/her experience. is experience can be increased and sup-
ported by regular susceptibility testing, even when the result comes late 
and a treatment had to be started. 
e route of administration should be by preference parenteral injec-
tion when a limited number of animals needs to be treated. In this respect, 
future research could be focussed on the early detection of infectious dis-
eases using alternative and innovative biomarkers. Depending on the epi-
demiology of the pathogen, in particular the ease of spread, the early de-
tected infected animals could be separated and treated individually.  
When group medication is unavoidable, alternatives for feed medica-
tion that involve less risk on cross contamination should be pursued, pro-
vided that other possible risks of the alternative administration are inves-
tigated thoroughly.  
Drinking water or milk medication may be an alternative for group 
medication. e most important arguments in favour of water medication 
are the flexibility of the therapy and the opportunity to select smaller 
groups of animals for therapy. Another advantage is that water uptake of 
sick animals tends to be better than feed uptake. Unfortunately, a switch 
to water medication oen implies high costs for the farmer, due to the high 
quality drinking water system that would need to be introduced in most 
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farms. Furthermore, more data on the risk of environmental contamina-
tion, resistance development in the drinking water systems, drinking be-
haviour of the animals during medication and the risk of improper use of 
the medication by the farmer are needed to be able to finally conclude if 
water medication is the best method for group administration (Schouten 
, van Krimpen ). Also, the commercial drug formulations used 
need to be physically and chemically stable over a sufficient period of time 
to allow a homogenous dose administration and consequently an efficient 
therapy. erefore, an adapted formulation of the active substance is es-
sential for medication through drinking water to help to improve solubility 
and stability of the drug. 
In conclusion, water medication could be an acceptable alternative 
provided that technical superior and well maintained drinking water in-
stallations are used, drinking water quality and pharmaceutical drug for-
mulations used are optimal, and spilling of medicated water into the envi-
ronment is avoided as much as possible. In some countries, e.g. e Neth-
erlands, Germany and Denmark, water medication is already preferred in 
pig industry and feed medication is not or rarely applied. 
2.2 REDUCE THE RISK OF CROSS-CONTAMINATION 
Besides a reduction of feed medication, the lowest possible risk of carry-
over during production, transport and storage practices of medicated feed 
should be pursued. Apart from the GMP guidelines that always need to be 
applied during the production of medicated feed, some extra measure-
ments can be taken to reduce the risk of carry-over. At the feed mill, carry-
over can be reduced by targeting the practices (flushing aer medicated 
feed production), the process (reducing the process length), the feed (se-
quencing medicated feed production and/or the active product used, 
choosing less- or non-dust producing products. e risk of cross-contam- 
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ination can be avoided considerably by mixing at the end of the feed line 
instead of in the main mixing line, as is in the case in Belgium (Filippitzi et 
al. ). Carry-over during transport and delivery can be minimised by 
the use of new, modified trucks, the use of back bins that reduce the length 
of the circuit and careful purging aer each delivery. 
A more recent practice of medicated feed production is the fine dosing 
system (FDS) truck. In this case, cross-contamination at the feed mill is 
avoided because the drug is mixed with the feed at the time of delivery at 
the farm. Compared to top dressing/mixing, the FDS truck has the ad-
vantage of a better homogeneity of the feed. e use of these trucks is how-
ever still limited because of their high cost. Moreover, also appropriate cal-
ibration of the FDS system is mandatory. 
Cross-contamination at the farm mainly depends on the farmers’ 
practices. Consequently, raising their and their personnel’s awareness on 
the importance of purging is essential to minimise carry-over at the farm. 
Besides that, a separate feed silo for medicated feed would be optimal 
(Filippitzi et al. ). Feed medication via top dressing/mixing of the an-
timicrobial at the farm rules out cross-contamination at the feed mill or 
during transport and storage, but most likely results in improper dosage 
due to inhomogeneity of the medicated feed and is therefore not recom-
mended (FASFC , Schouten ). 
2.3 ESTABLISH NEW REGULATION 
Keeping in mind the One Health concept, the ban of the use of subthera-
peutic antimicrobials as growth promoters, which was established in Eu-
rope in , should be extended to a worldwide ban. A second step that 
would lead to a great reduction of antimicrobial use is the prohibition of 
prophylactic treatments. Unfortunately, these kind of global measure-
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ments are likely to be held back or postponed because of economic inter-
ests. For example, it is suggested that the rising incomes in countries such 
as Brazil, Russia, India, and South-Africa will cause a shi from extensive 
farming systems to large-scale intensive farming operations that use anti-
microbials in subtherapeutic doses for growth promoting purposes (Van 
Boeckel et al. ). 
e establishment of legal limits for carry-over of antimicrobials in 
feed should have a beneficial effect, as this would reduce the quantity of 
antimicrobial residues in the environment in general. In , the Euro-
pean Commission adopted a proposal for a regulation on the manufacture, 
placing on the market and use of medicated feed and repealing Council 
Directive, because the rules dating from  (//EEC) needed to be 
updated. One of the changes proposed, is the introduction of a general 
limit for carry-over of antimicrobials of  of the active substance of the 
last produced batch of medicated feed. It needs to be mentioned though 
that several agencies such as AGRI (Committee on Agriculture and Rural 
Development), FEFAC (European Feed Manufacturers’ Federation) and 
COPA-COGECA (European farmers and cooperatives foundation) ques-
tion the proposed  limit because they claim it is not feasible in practice 
and because they find that the proposed limits should be based on a scien-
tific risk assessment. e European Consumer Organisation (BEUC) even 
suggests a total ban of antimicrobials in feed (EC ). When introducing 
the  limit, some practical concerns arise. e control of the carry-over 
levels at a feed mill is complicated by the fact that flushing batches are very 
inhomogeneous (Stolker et al. ). Consequently, very thorough sam-
pling and controls of flushing batches would be needed to be sure if the 
proposed maximum limit of  is achieved. Because of these observations, 
NEVEDI (Association of Dutch Feed Producers), as the first in Europe, 
voluntarily decided to stop the production of medicated feed in feed mills 
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in . ey concluded that the production of medicated feed compliant 
with new strict standards regarding carry-over would be too expensive to 
keep it profitable. 
Regulatory authorities should focus in the first place on guidelines and 
regulations to reduce the use of medicated feed, and second on feasible 
standards to reduce cross-contamination of feed. For example, the prohi-
bition of prophylactic feed medication would be a straightforward ap-
proach that can reduce feed medication substantially and consequently re-
duce the risk on resistance selection. Avoiding cross-contamination of feed 
is equally important, as this also reduces the spread of antimicrobial resi-
dues into the environment. However, several questions arise when it comes 
to establishing legal limits for cross-contamination of feed. What is a fea-
sible maximum level of carry-over that can be achieved in practice? As 
mentioned before, some feed producers doubt that strict rules regarding 
carry-over are feasible from an economical point of view. And more im-
portant, which maximum carry-over level will have a clear beneficial effect 
when it comes to resistance selection? In this thesis, it was concluded that 
a  carry-over level of doxycycline possibly does not reduce the risk on 
resistance selection substantially compared to a  carry-over level. Fur-
thermore, other studies indicate that even antimicrobial concentrations a 
-fold lower can still select for resistant bacteria (Gullberg et al. ). 
Presumably, the selective pressure will also depend on the type of antimi-
crobial and the bacteria they are exposed to.  
Another approach could be to prohibit the use of antimicrobials that 
cause the highest risk on resistance selection as feed medication. More re-




3 FUTURE RESEARCH 
It was shown in this doctoral thesis that carry-over of antimicrobials in pig 
feed has an influence on resistance selection in the microbiota. Hence, 
carry-over should be avoided at all times. However, many questions re-
main and the following future research subjects can help to further eluci-
date the impact of cross-contamination on the spread of antimicrobial re-
sistance. 
 First of all, there is a lack of data on intestinal antimicrobial concen-
trations aer oral administration of cross-contamination levels of 
antimicrobials. Attention should go first to this basic information, in 
particular concerning antimicrobials that are commonly applied as 
feed medication. e tested antimicrobials in this thesis are a useful 
start, but other typical feed medication antimicrobials (e.g. amoxicil-
lin) should be investigated in the near future. A cross-contamination 
level of the feed of  may be a good choice for the experimental set-
up, as this level is considered by the EU to be established as maxi-
mum carry-over level. However, a range of concentrations should be 
tested to be able to make extrapolations to different contamination 
levels. 
 Regarding residual antimicrobial concentrations in the gut in gen-
eral, also parenteral dosing should be tested, since it was demon-
strated that certain antimicrobials such as sulphadiazine are secreted 
in the gut, with possible ion-trapping in the intestinal content.  
 More information is needed with respect to antimicrobial concentra-
tion levels in the feed and drinking water when mixed at the farm. To 
what extent cross-contamination occurs at the pig farm aer admin-
istration of antimicrobials in feed and drinking water? What are the 
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critical factors of the entire chain, from production to consumption 
of feed and drinking water with added drugs, to guarantee optimal 
drug delivery in pigs and to control cross-contamination? 
 In this doctoral thesis, we focussed on two specific antimicrobial 
concentrations, caused by a  and  cross-contamination level, to 
evaluate the effect on resistance selection. Another interesting ap-
proach would be to determine MSC of selected antimicrobials for a 
selection of indicator bacteria (e.g. E. coli, Enterococcus spp.) that 
harbour different resistance mechanisms as they may have a different 
MSC and thus the selection for resistance may be different. It is thus 
crucial to include the different known resistance mechanisms. We 
investigated selection of tet(A) carrying bacteria, an energy depend-
ent efflux mechanism, but we have no information on the selection 
of other (non-energy dependent) tetracycline resistance mechanisms 
such as ribosomal protection and enzymatic inactivation. All tetracy-
cline inactivators cause high MIC values for tetracycline and oxytet-
racycline compared to the other tetracycline resistance mechanisms, 
and may thus be less prone to be selected at very low antimicrobial 
concentrations (Forsberg et al. ). Comparing the resulting MSCs 
with the intestinal concentrations that are found at a  cross con-
tamination level would give a first indication of the effect of the es-
tablishment of a  carry-over limit for antimicrobials.  
 Aer the in vitro determination of the MSCs for different indicator 
bacteria, the effect of these concentrations on the intestinal microbi-
ota should be investigated using the porcine caecum model that was 
described in this thesis. ere is however a need for more detail in 
these studies. e newly developed Exon-Primed Intron-Crossing 
(EPIC)-PCR allows to link functional genes and phylogenetic mark-
ers in uncultured single cells (Spencer et al. ), and thus makes it 
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possible to make a link between increase or decrease of a resistance 
gene with an increase or decrease in abundancy of bacterial species. 
In this way, the impact of the antimicrobial selection pressure can be 
assessed more in detail: which resistance genes are prone to selection 
and/or transfer, which bacterial species carry these genes, are the 
genes transferred to potential pathogenic bacterial species, etc. At the 
same time, taxonomical shis in the microbiota can be evaluated in 
order to estimate the impact on the intestinal health of the animals. 
In these models, it will also be possible to study the persistence of re-




4 CONCLUSION  
is doctoral thesis indicates that lowering legal maximum levels of carry-
over of antimicrobials may not be the most efficient or fastest way to coun-
ter resistance selection in pigs. Our results show that  carry-over of 
doxycycline in the feed does not select significantly less for resistance com-
pared to a  carry-over level. It is not yet clear if this also accounts for 
other antimicrobials. In our opinion, authorities should firstly use their re-
sources to promote preventive health measures in order to reduce the total 
use of antimicrobials in pig production. Meanwhile, the (complex) re-





Cross-contamination of feed with low concentrations of antimicrobials is 
an inevitable problem that results from the application of feed medication 
in the pig industry. As a result, a large number of pigs can be exposed to 
low concentrations of antimicrobials via the feed. To date, little is known 
about the possible effects of these low antimicrobial concentrations on the 
intestinal microbiota concerning resistance selection. 
 
e General Aim of this doctoral thesis (Chapter ) was to investigate re-
sistance selection at the level of the intestinal microbiota when pigs con-
sume feed that contains carry-over levels of antimicrobials.  
erefore, the intestinal concentrations aer feeding with cross-con-
taminated feed needed to be determined first. In Chapter , an animal ex-
periment was set up to determine the intestinal concentrations of chlortet-
racycline, doxycycline and sulphadiazine-trimethoprim in pigs when they 
are fed with experimental feed that contains  carry-over concentrations 
of these antimicrobials. ree groups of six pigs were fed during  days 
with an experimental feed that contained a  carry-over concentration of 
the three antimicrobials respectively. Another six pigs were fed blank feed 
and served as control group. e carry-over level of  was based on the 
only legal limit for carry-over valid at the time, as was set for coccidiostats 
(//EG). During the -day experimental period, faeces samples were 
collected every two days and at the end the animals were euthanized and 
samples of caecal and colonic content were taken. In general, relatively 
high concentrations were detected for tetracyclines and relatively low con-
centrations were found for sulphadiazine. A mean concentration of  
mg/kg chlortetracycline and  mg/kg doxycycline in the faeces was 
reached, whereas mean sulphadiazine concentration was . mg/kg. Tri-
methoprim values were below the limit of detection of the analytical 
method. e mean transfer ratio’s from feed to intestinal content (= ratio 
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of intestinal content concentration to feed concentration) were  for 
doxycycline,  for chlortetracycline and . for sulphadiazine. Trans-
fer ratios were not calculated for trimethoprim. e transfer ratio’s corre-
spond well with the oral bioavailability of these drugs in pigs. In short, this 
study showed that the low to moderate oral bioavailability of tetracyclines 
can result in relatively high concentrations of these drugs in the caecum, 
colon and faeces of pigs, even at a  carry-over level in the feed. 
e next step was to determine the effect of the intestinal concentra-
tions found for doxycycline on resistance selection, first by means of an in 
vitro model with pure bacterial cultures of Escherichia coli (Chapter ) and 
second with an ex vivo model of the porcine caecum (Chapter ). Doxycy-
cline was chosen based on the results of the in vivo experiment (high intes-
tinal concentrations of tetracyclines) and because it is frequently applied 
as feed medication. Considering the recently established regulation on 
maximum carry-over limits in Belgium (), intestinal concentrations cor-
responding to  as well as  were included in these bacteriological stud-
ies. In both studies, the selective effect of  mg/l (corresponding with a 
carry-over concentration of approximately ) and of  mg/l doxycycline 
(corresponding with a carry-over concentration of approximately ) was 
compared with the selective effect of a blank medium. 
In Chapter  an in vitro experiment was conducted to determine 
whether and to what extent a doxycycline resistant E. coli is selected when 
it has to compete with a fully susceptible E. coli strain, in three different 
media ( mg/l doxycycline,  mg/l doxycycline and blank medium). ree 
different resistant E. coli and four different susceptible E. coli strains were 
used. Each experiment was done in triplicate and involved one resistant 
strain that was brought in competition with one susceptible strain (initial 
ratio resistant/susceptible: /). Numbers of resistant and susceptible 
bacteria were counted aer h and h of competition and the selective 
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effect of the medium was then calculated as the ratio resistant bacteria/sus-
ceptible bacteria. e results showed that the medium with  mg/l doxycy-
cline as well as the medium with  mg/l doxycycline had a significant 
higher selective effect than the blank medium. Moreover, no significant 
difference in selective effect between  mg/l doxycycline and  mg/l doxycy-
cline was observed. In addition, transconjugants (initially susceptible bac-
teria that have acquired resistance from the resistant strain) were counted 
in part of the experiments to determine the transfer rate of the resistance 
plasmids. Only one of the three plasmids (pEC) showed a higher trans-
fer rate at  and/or  mg/l doxycycline, dependent on the recipient strain. 
In Chapter , the caecal microbiota of the pig was simulated using a 
bioreactor. e bioreactors were inoculated with pooled caecal content of 
organic raised pigs and a pure culture of the known resistant E. coli strain 
(EC) from the in vitro study (Chapter ). Aer h of batch fermenta-
tion, the continuous fermentation was started. Forty-eight hours later, 
doxycycline was administered via the medium ( mg/l or  mg/l). For each 
condition, the experiment was done in triplicate. Growth of the E. coli do-
nor strain (EC ) was monitored during ten days at three different con-
ditions:  mg/l doxycycline,  mg/l doxycycline or blank medium. Further-
more,  doxycycline resistant E. coli, isolated from the different experi-
ments, were characterized to verify whether they acquired the plasmid of 
donor strain EC . Both  mg/l and  mg/l doxycycline showed to have a 
significant higher selective effect on EC  compared to blank medium. 
Remarkably, no significant difference in selective effect was found between 
 mg/l and  mg/l doxycycline, similarly as in the in vitro study (Chapter 
). Characterization of the  E. coli isolates from the different reactor 
runs showed that plasmid pEC was transferred to other E. coli strains 
in all three conditions (,  and  mg/l doxycycline). In absolute numbers, 
more transconjugants (E. coli that received pEC) were isolated from the 
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experiments with  mg/l and  mg/l doxycycline compared to the blank 
control experiments. It is plausible that the larger numbers of transconju-
gants are caused by a higher transfer frequency due to the selective pres-
sure of doxycycline or the enrichment of transconjugants due to this selec-
tive pressure. Additional experiments would however be needed to con-
firm the observations on transfer frequency statistically. 
 
In conclusion, this doctoral thesis showed that the poor oral bioavailability 
of tetracyclines results in relatively high concentrations in caecal and co-
lonic content and faeces at steady-state conditions, even at a carry-over 
level of  in the feed. In vitro experiments with E. coli as well as ex vivo 
experiments simulating the pig caecum showed that intestinal doxycycline 
concentrations corresponding with approximately  and  carry-over 
levels in the feed, both select for a tet(A) carrying doxycycline resistant E. 






Kruiscontaminatie van voeders met lage concentraties antimicrobiële mid-
delen is een onvermijdelijk probleem dat voortvloeit uit de toepassing van 
voedermedicatie in de varkenssector. Als gevolg van dit fenomeen komt 
een aanzienlijk aantal varkens in contact met lage dosissen antimicrobiële 
middelen via het voeder. Er bestaat nog veel onduidelijkheid over de mo-
gelijke effecten van deze lage concentraties op resistentieselectie in de in-
testinale microbiota.  
 
De Algemene Doelstelling van dit doctoraatsonderzoek (Hoofdstuk ) 
was de resistentieselectie te onderzoeken ter hoogte van de intestinale mi-
crobiota van het varken na opname van voeder dat verslepingsconcentra-
ties van antimicrobiële middelen bevat.  
In Hoofdstuk  werd tijdens een dierproef bepaald wat de concentra-
tie van antimicrobiële middelen is in de darm van varkens wanneer er ge-
voederd wordt met lage dosissen van deze geneesmiddelen. Zowel tetracy-
clines (chloortetracycline en doxycycline) als sulphadiazine-trimethoprim 
werden onderzocht. Drie groepen van telkens zes varkens werden gedu-
rende  dagen gevoederd met experimenteel voeder dat een verslepings-
concentratie van  bevatte van respectievelijk chloortetracycline, doxy-
cycline en sulphadiazine-trimethoprim. Een derde groep van zes varkens 
diende als blanco controlegroep. De keuze voor het verslepingsniveau was 
gebaseerd op de wettelijke aanvaardbare grens van versleping van coc-
cidiostatica (//EG). Gedurende de proefperiode werden om de  da-
gen individuele meststalen genomen en na  dagen werden de dieren ge-
euthanaseerd waarbij ook stalen van caecum- en coloninhoud werden ge-
nomen. Over het algemeen werden voor de tetracyclines relatief hoge 
concentraties teruggevonden, en voor sulphadiazine relatief lage concen-
traties. De gemiddelde concentratie in de mest was  mg/kg en  mg/kg 
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voor chloortetracycline en doxycycline, respectievelijk, terwijl voor sulp-
hadiazine een concentratie van . mg/kg werd gemeten. De gehaltes voor 
trimethoprim lagen onder de detectielimiet van de analysemethode. De ge-
middelde transfer ratio’s van voeder naar darminhoud (= verhouding van 
concentratie in darminhoud tot de concentratie in het voeder) waren  
voor doxycycline en  voor chloortetracycline. In het geval van sulpha-
diazine was dit ,; de transfer ratio van trimethoprim werd niet bere-
kend. Deze transfer ratio’s komen goed overeen met de gekende orale bio-
logische beschikbaarheden van deze geneesmiddelen bij varkens. Uit de 
resultaten kon besloten worden dat de lage biologische beschikbaarheden 
van tetracyclines kunnen leiden tot vrij hoge concentraties in caecum, co-
lon en mest, zelfs bij een  kruiscontaminatie van het voeder. 
Vervolgens werd aan de hand van bacteriologische experimenten, 
eerst in vitro met zuivere bacteriële culturen van Escherichia coli (Hoofd-
stuk ) en vervolgens met een ex vivo model dat de microbiota van het 
varkenscaecum nabootst (Hoofdstuk ), de invloed van lage concentraties 
aan doxycycline op resistentieselectie en -transfer getest. Doxycycline werd 
gekozen gebaseerd op de resultaten van de in vivo proef (hoge intestinale 
concentraties van tetracyclines) en omdat dit geneesmiddel vaak toege-
diend wordt onder de vorm van voedermedicatie. Wegens de recente ont-
wikkelingen in de regelgeving rond versleping, werd er bij deze proeven 
naast het verslepingsniveau van  ook rekening gehouden met een ver-
slepingsniveau van . Er werd nagegaan hoe groot het selecterend effect 
is van  mg/l (corresponderend met een versleping van ongeveer ) en  
mg/l doxycycline (corresponderend met een versleping van ongeveer ), 
in vergelijking met een blanco milieu.  
In Hoofdstuk  werd een in vitro experiment opgezet waarbij werd 
nagegaan of en in welke mate een resistente E. coli stam uitgeselecteerd 
wordt wanneer deze in competitie gebracht wordt met een niet-resistente 
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E. coli stam, bij de twee doxycycline concentraties en ter controle in een 
blanco milieu. Deze testen werden uitgevoerd met drie verschillende resis-
tente E. coli stammen en vier gevoelige E. coli stammen, waarbij telkens 
één resistente met één gevoelige stam in competitie gebracht werd (initiële 
verhouding resistent/gevoelig: /). Resistente en gevoelige kiemen 
werden geteld na u en na u competitie en het selectief effect van het 
medium werd vervolgens berekend als de verhouding van het aantal resis-
tente/aantal gevoelige kiemen. Hieruit bleek dat zowel het milieu met  
mg/l als met  mg/l doxycycline een significant hoger selectief effect hee 
dan een blanco milieu. In blanco milieu groeit de gevoelige stam verder uit 
ten koste van de resistente stam. In de doxycycline milieus echter, keert de 
initiële verhouding van / (resistent/gevoelig) om, en krijgt de resis-
tente stam de overhand. Slechts voor één resistente stam werd een signifi-
cant hogere transfer frequentie van het resistentieplasmide (= aantal trans-
conjuganten/totaal aantal recipiënten) bij  mg/l of een significant hogere 
transfer bij  mg/l en  mg/l doxycycline waargenomen, aankelijk van de 
recipiënt stam. Bij de andere resistente stammen werden geen significante 
verschillen waargenomen tussen de transfer frequenties in de verschillende 
milieus.  
In Hoofdstuk  werden bioreactors gebruikt om het caecum van het 
varken te simuleren. Deze werden geïnoculeerd met gepoolde caecale in-
houd van biologische varkens en op hetzelfde moment met een pure cul-
tuur van een gekende doxycycline resistente E. coli uit Hoofdstuk  (EC 
). Na een h batch cultuur werd het continue fermentatiesysteem op-
gestart. Vervolgens werd h later deze microbiota verstoord door het toe-
dienen van doxycycline via het medium ( mg/l of  mg/l). De groei van de 
gekende E. coli werd opgevolgd gedurende  dagen onder drie verschil-
lende condities:  mg/l doxycycline,  mg/l doxycycline en een blanco con-
trole. Per conditie werd het experiment  maal herhaald om een trend te 
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kunnen waarnemen. Daarnaast werden  doxycycline resistente E. coli’s, 
die geïsoleerd werden uit deze experimenten, moleculair gekarakteriseerd 
om na te gaan of zij hun resistentie al dan niet via de donorstam verworven 
hadden. Zowel supplementatie van het medium met  als met  mg/l doxy-
cycline had een selectief effect op de donor, maar er werd geen significant 
verschillend selectief effect tussen  en  mg/l doxycycline aangetoond. De 
karakterisatie van  doxycycline resistente E. coli’s uit de verschillende 
reactor runs toonde aan dat plasmide pEC getransfereerd werd van de 
donor naar andere E. coli stammen onder elke conditie (,  en  µg/ml 
doxycycline). Er werden echter duidelijk meer transconjuganten geïso-
leerd uit zowel de experimenten met  mg/l doxycycline als deze met  mg/l 
doxycycline vergeleken met de blanco experimenten. Dit groter aantal kan 
te wijten zijn aan ofwel een hogere transfer frequentie van plasmide onder 
de selectieve druk van doxycycline, ofwel het aanrijken van transconjugan-
ten onder deze selectieve druk. Meer uitgebreide experimenten zijn echter 
nodig om de waarnemingen rond transfer statistisch te bevestigen. 
 
Dit doctoraatsonderzoek toonde aan dat de lage orale biologische beschik-
baarheid bij varkens van tetracyclines kan leiden tot relatief hoge concen-
traties in de darm, zelfs bij verslepingsconcentraties in het voeder van . 
Zowel de in vitro experimenten met E. coli als ex vivo simulaties van het 
varkenscaecum toonden aan dat intestinale concentraties doxycycline ten 
gevolge van ongeveer  en  versleping in het voeder, beiden een tet(A) 
dragende, doxycycline resistente E. coli stam uitselecteren vergeleken met 
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